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Abstract 
 
Human fungal infections among severely immunocompromised individuals  
have increased dramatically over the last 30 years and that coincidence  
with an expanding patient numbers of bone marrow and solid organ 
transplantation and those receiving aggressive cytotoxic chemotherapy for 
neoplastic diseases or immunosuppressive drugs. In recent years, many of 
opportunistic fungi have emerged as serious human pathogens and causing 
life-threatening infections of humans such as Fusarium species. Due to lack of  
a highly accurate diagnostic test for tracking the pathogenic Fusarium species, 
fusariosis is frequently misdiagnosed as aspergillosis. Delays in identification 
and differentiation of Fusarium spp. from other causative agents of 
hyalohyphomycetes associated with high morbidity and mortality rate among 
immunocompromised patients. This research aimed to develop a highly specific 
monoclonal antibody (mAb) using hybridoma technology to produce a highly 
genus-specific murine mAb ED7 that could be used for tracking and early 
detecting circulating Fusarium species antigens from other opportunistic 
pathogens. At present, a very little is known about the pathogenicity and 
interaction of human pathogenic F. solani and cells of the innate immune 
system like alveolar macrophages (AMØ), the residential innate immune cells  
of alveoli. For this reason, F. solani was genetically transformed with GFP gene 
and a model of immunoassay was developed to investigate the interactions  
of F. solani with AMØ that would allow studying the fungal pathogenicity, 
visualising and quantification of the pathogen during the process of 
macrophage phagocytosis. In addition, this model can be used to evaluate the 
effect of a mAb on fungal uptake by AMØ. Habitates providing direct human 
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exposure to infectious propargules are largely unknown, but there is growing 
evidence that plumbing systems are sources of human pathogenic strains in the 
F. solani and F. oxysporum species complexes, the most common groups 
infecting humans. Using mAb ED7 specific to the Fusarium species, this work 
demonstrates how the mAb can be used as a powerful immunodiagnostic tool 
for accurately tracking the Fusarium species antigens in sink drain biofilms and 
water system samples containing mixed populations of human opportunistic 
filamentous and yeasts pathogenic fungi across a University campus and  
a tertiary care hospital. Specificity of the ELISA was confirmed by sequencing of 
the internally transcribed spacer 1 (ITS1)-5.8S-ITS2 rRNA-encoding regions of 
culturable yeasts and moulds that were recovered using mycological culture, 
while translation elongation factor (TEF)-1 analysis of Fusarium isolates 
included FSSC 1-a, FOSC 33 and FDSC ET-gr, the most common clinical 
pathotypes in each group. The mAb ED7 is, therefore, suitable to be carried 
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Chapter 1. General Introduction 
1.0 Overview 
The human disease invasive fusariosis, caused by species in the fungal genus 
Fusarium, has emerged as a serious life-threatening disease with high rates of 
mortality and morbidity in immunocompromised patients. Specific and sensitive 
diagnostic tests for this infectious fungal pathogen are currently lacking, and 
early detection of Fusarium infections is vital for the prompt and appropriate 
management of disease (Jain et al., 2011; Thornton, 2011; van Diepeningen  
et al., 2015). Very little is known about the interaction of emerging human 
pathogenic fungi such as Fusarium and the immune system (Nucci & Anaissie, 
2007). Furthermore, the response of Fusarium to antifungal drugs is poorly 
defined (Al-Hatmi et al., 2015; Azor et al., 2009). Arguably, one of the main 
reasons for this lack of knowledge is the insufficiency of techniques that allow 
accurate detection of the fungus in vivo and for tracking the fungus in 
epidemiological and immune cell interaction studies (Muhammed et al., 2011).  
 
This chapter will introduce the Kingdom Fungi, and will discuss the importance 
of Fusarium species as agents of disease in crops, animals and humans. The 
pivotal role of innate and adaptive immune system also will be highlighted, as 
will the immune response to fungal infections. This overview will encompass 
diagnosis of the Fusarium genus using conventional methods such  
as mycological culture and direct microscopic examination, in addition to  
non-cultural-base methods including nucleic acid-based techniques and antigen 
detection using mAbs. The concept of water-borne fungal disease and  
 nosocomial infections, fungal dispersal, and the potential role of biofilms as  
  Chapter 1                                                                                       General Introduction 
 2 




1.1 Kingdom Fungi 
Fungi are heterotrophic eukaryotic microorganisms that occur ubiquitously  
in almost all environments encompassing terrestrial, aquatic, polar, temperate  
and tropical ecosystems (Moore et al., 2011; Poole et al., 2013; Timling et al., 
2014) They constitute a single kingdom, Kingdom Fungi, comprising seven 
phyla, Chytridiomycota, Blastocladiomycota, Glomeromycota, Microsporidia, 
Zygomycota, Ascomycota and Basidiomycota (Figure 1.1) (Berbee, 2001; 
Bonfante et al., 1996; Das et al., 2007; Mohanta & Bae, 2015; Moore et al., 
2011; Pöggeler & Wöstemeyer, 2011; Rossman, 2008). Since fungi can 
produce a broad range of enzymes such as α-amylase, cellulase, lipase, 
protease, and xylanase (Green & Beezhold, 2011) they are the main 
decomposers and recyclers of organic substrates in terrestrial ecosystems, with 
saprotrophism (or saprotrophic) enabling colonisation and utilisation of organic 
matter for nutrition. Since fungi are unable to fix carbon, they obtain nutrients 
from different organic sources to provide the energy required for growth and 
reproduction and so are called heterotrophic organisms. Fungi produce 
extracellular enzymes to degrade complex organic compounds into simpler 
metabolisable units such as glucose or amino acids and absorb these into the 
cell through the cell wall and plasma membrane. Most fungi have a saprotrophic 
phase in their life cycles, obtaining their nutrients from decaying organic matter 
of plants or animals (Jung et al., 2013). Pathogenic fungi are also able to derive 
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nutrients from parasitized hosts either biotrophically or via necrotrophism   
(Lowe & Howlett, 2012).  
 
 
Figure 1.1. Phylogeny tree of the Kingdom Fungi. Strain names are given 
only when more than one organism in that species appeared in our 
dataset. Blocks coloured in red, blue, green, yellow and purple correspond 
to the Ascomycota, Basidiomycota, Chytridiomycota, Mucoromycotina and 
Microsporidia, respectively. The majority of fungi are related to the 
Ascomycota and Basidiomycota are distinguished by alternate red and 
blue colours, respectively. (Wang et al., 2009). 
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The structure and composition of the fungal cell wall is a defining characteristic 
of these eukaryotes and may differ in architecture and dynamic function. The 
cell wall plays a vital role in in several biological processes including the fungal 
cell morphogenesis, growth, cell-cell interaction, and it provides a protective 
barrier from environmental conditions as it acts as a sensor and response to 
surrounding environment change such as osmotic pressure (Adams, 2004; Klis, 
2001). For the pathogenic fungi, the cell wall components involve in virulence 
and pathogenicity through mediating fungal cell adhesion, colonization and 
biofilm developing (Bowman & Free, 2006; Free, 2013). The fungal cell wall is  
a complex structure composed of glycoproteins embedded within  
a polysaccharide matrix including of chitin and glucan, and there is evidence of 
extensive cross-linking between these components together to generate  
a three-dimensional structure with the cell membrane that contains a fungal 
unique lipid, ergosterol (Figure 1.2) (Bowman & Free, 2006; Latgé, 2010; 
Masuoka, 2004; Parks & Casey, 1995; Pasanen et. al., 1999). For this reason 
carbohydrates is the first component to contact host tissue (Hall et al., 2013; 
Masuoka, 2004). The inner layer of cell wall consists of chitin which is 
synthesized by chitin synthases, and glucan which is a homopolymer of glucose 
that include β-1,3-glucan, mixed β-1,3- with β-1,4-, β-1,6-, and α-1,3-glucan. 
The glucan–chitin complex is covalently bound to other polysaccharides, and 
that varies in the pathogenic fungi. For example, Aspergillus fumigatus 
polysaccharides are composed of galactomannan and β-1,3 and β–1,4-glucan, 
whereas in Candida albicans β-1,6-glucan is the main contain (Aimanianda  
et al., 2009; Fontaine et al., 2000). Glycoproteins including galactomannnan 
and/or mannan are the main composition of the outer layer of the cell wall. 
Once the glucan braches, chitin, and glycoproteins are released into the cell 
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wall space, the components covalently cross-linked to form a rigid cell wall 
(Barreto-Bergter & Figueiredo, 2014; Free, 2013; Latgé, 2010; Masuoka, 2004) 
 
 
Figure 1.2. Fungal cell wall architecture. Transmission electron micrographs of 
the Candida albicans cell walls are shown on the left. The right illustrates the 
structure of the C. albicans cell wall. (Brown et. al., 2014). 
 
Fungi are a major source of beneficial bioactive compounds used in medicine 
and agriculture, such as antibiotics (Bérdy, 2005) and plant-growth-promoting 
compounds (Naznin et al., 2013), but also produce highly toxic secondary 
metabolites and allergens deleterious to human health (Brase et al., 2009; 
Desjardins & Proctor, 2007). As opportunists, fungi can cause serious life-
threating infections both in immunocompetent and immunocompromised 
individuals, particularly those with haematological malignancies or bone marrow 
tansplants (Perfect, 2012). 
 
In 2001, it was estimated that one and a half million species of fungi exist on the 
planet (Hawksworth, 2001). However, more recent molecular studies using 
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analysis of the ITS rRNA region suggests that more than 5 million fungal 
species exist (Blackwell, 2011; O’Brien et al., 2005). 
 
The majority of fungal species that have been  discovered belong to the phyla 
Ascomycota and Basidiomycota, and so they are combined into a separate 
fungal sub-kingdom called Dikarya (Hibbett et al., 2007). Pathogenic fungi are 
often found in the phyla Basidiomycota, Ascomycota, and Zygomycota 
(Galagan et al., 2005).  
 
The Basidiomycota includes important human pathogens such as the  
yeast Cryptococcus spp. (causative agent of the disseminated human disease 
cryptococcosis), Trichosporon spp. (disseminated trichosporonosis) and 
Malassezia spp. that causes superficial skin diseases (Anaissie et al., 2009; 
Gaitanis et al., 2012). Species of Rhizopus, Mucor and Lichtheimia are the main 
pathogenic agents of mucormycosis (Ribes et al., 2000; Skiada et al., 2011).  
 
 
1.1.1 Phylum Ascomycota 
Ascomycota is the largest fungal phylum and contains, at present, 64,000 
species (Weete et al., 2010). The main characteristic feature of this phylum is 
the formation of a sac-like structure (ascus) containing ascospores (Carlile  
et al., 2001; Webster & Weber, 2007). Many ascomycetes reproduce asexually 
by producing copious airborne conidia or spores generated from mycelia. 
Alternatively, they can reproduce sexually, indicated by a teleomorphic phase 
(Hogg, 2005). For example, Nectria haematococca is the teleomorph state of 
Fusarium solani (the anamorph or asexual stage). 
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Ascomycetes include filamentous (hyphal)-organisms and yeasts. Unlike 
zygomycetes, ascomycete hyphae are septate with cross walls called septa. 
These fungi are ubiquitous and associated with food spoilage and are  
the main producers of mycotoxins. Examples include the filamentous fungi 
Aspergillus and Fusarium species (Pitt & Hocking, 2009). Many ascomycetes 
produce carcinogenic mycotoxins, such as aflatoxins and trichothecenes that 
can cause serious harm to animals and humans (Nelson et al., 1993; Yazar & 
Omurtag, 2008; Yli-Mattila, 2010). Nevertheless, ascomycetes can be 
beneficial, and are amenable biotechnologically for the production of antibiotics 
such as penicillin, immunomodulatory compounds such as cyclosporins and 
edible mycoproteins. However, many ascomycete species are recognizable as 
aggressive plant pathogens, causing destructive crop diseases, such as 
Panama disease of banana caused by F. oxysporum f.sp. cubense race 4 
(Dean et al., 2005; De Ascensao & Dubery, 2000).  
 
The clinical importance of opportunistic ascomycete fungi, such as Aspergillus 
(the cause of invasive pulmonary aspergillosis), Fusarium (fusariosis),  
and Candida (candidiasis) is increasing amongst the ever expanding 
populations of immunocompromised patients such as those with neutropenia, 
haematological malignancies and recipients of bone marrow transplants. 
Opportunistic ascomycetes are emerging as the most significant source of 
mortality and morbidity in these high-risk patient groups (Hanson, 2008; 
Kauffman et al., 2011; Moore et al., 2011).  
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1.1.1.1 The fungus Fusarium  
The genus Fusarium is one of the most ubiquitous groups of filamentous  
fungi and contains several economically important plant pathogens and 
producers of mycotoxins such as fumonisins and trichothecenes. This 
heterogeneous genus is also an important producer of bioactive metabolites, 
including antibiotics and anti-cancer agents (Baker & Tatum, 1989; Chakravarthi 
et al., 2008; Gerber & Ammar, 1979; Mohamed, 2012; Qureshi et al., 2003; 
Tayung et al., 2011). 
 
A saprotroph and general opportunist, it is increasingly recognised as a serious 
human pathogen (Leslie & Summerell, 2006). This genus has been found in 
virtually all ecosystems on the planet and more than 1000 species of the genus 
have been described (Rios & Ortega, 2012; Summerell et al., 2003). 
 
Fusarium was initially described based on the presence of fusiform spores in 
1809 by Link and validated by Fries in 1821 (Booth, 1971). The anamorphic 
(asexual) stage of Fusarium species is dominant and often produces both 
microconidia and macroconidia. The microconidia are small in size and oval to 
ovoid in shape and grow from the aerial mycelium on phialides.  
The macroconidia are distinctive, large, and septate, with curved to straight 
appearances, and are initiated from cushion-like structures called sporodochia 










Figure 1.3. Gross morphology of F. solani (CBS224.34) in axenic culture on 
potato dextrose agar (A), with mycelia (B), macroconidia (C) and microconidia 
(D). Scales bars = 20 m. Images of Marwan Al-Maqtoofi. 
 
 
1.1.1.2 Classification of the genus Fusarium  
The first Fusarium taxonomical system was established in 1935 by 
Wollenweber and Reinking and in the 1940s by Snyder and Hansen (Nelson, 
1975; Nelson, 1991). Since then, many species have been added or removed 
from the Fusarium genus due to morphological similarity (Rossman & Palm-
Hernández, 2008). Plant pathogenic species within morphological groupings 
were further divided based on host specificity. As a consequence, varieties 
(var.) and formae speciales (f. sp.) are used to describe host specificities of 
Fusarium species (Agrios, 2005; Ma et al.,2010). For example, F. oxysporum f. 
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sp. lycopersici and F. solani f. sp. pisi are narrow in host infection, infecting the 
only tomato and pea plants, respectively (Lievens et al., 2009; Namiki et al., 
1994; Suga et al., 2002), while  F. graminearum or F. verticillioides are selective 
pathogens for cereal crops (Shim et al., 2006). However, some species, such 
as F. oxysporum, infect a broad range of hosts. As such, F. oxysporum is 
currently ranked as the fifth most important plant pathogen (Dean et al., 2012; 
Ma et al., 2010).  
The genus Fusarium is currently classified as follows: 









1.2 Etiology and Pathogenesis 
Recently, the incidence of fungal infections has increased dramatically 
concomitant with the ever-expanding population of immunocompromised 
humans. This population is highly susceptible to fungal infections due to 
impaired host immune responses. Many health factors have been associated 
with suppression of host immune defence, including AIDS, malignant diseases, 
especially patients those receiving toxic chemotherapy agents like 
corticosteroids and intensive broad-spectrum antibiotic therapy, and solid organ 
transplantation (SOT) and bone marrow transplantation (BMT) (Low & Rotstein, 
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2011; Sganga, 2011; Silva, 2010). In the US between 1980 and 1997, the death 
rate due to invasive fungal infections (IFI) increased 320%. The most common 
fungal pathogens causing serious nosocomial life-threatening infections are 
Candida and Aspergillus species (Anaissie, 1992; Lockhart et al., 2009; Low & 
Rotstein, 2011; McNeil et al., 2001; Silva, 2010; Walsh & Groll, 1999). 
Significant increases in IFIhave also been reported with emerging pathogens, 
including hyaline septated filamentous fungi, such as Fusarium, Acremonium, 
Scedosporium, Paecilomyces, and Trichoderma. In addition, yeasts such as 
Trichosporon, Rhodotorula, and Geotrichum, the mucormycetes Rhizopus and 
Mucor species and dematiaceous fungi, including Pseudallescheria, Bipolaris, 
Exophiala, Phialophoraand Cladophialophora, have all been reported as 
opportunist pathogens of humans (Pfaller & Diekema, 2004; Ponton et al., 
2000; Walsh et al., 2004; Walsh & Groll, 1999). The mortality rate of 
hematologic malignancy patients with invasive mould infections is far greater 
than that associated with yeasts infections with 64% mortality for 
mucormycosis, 53% for fusariosis, 42% for aspergillosis and 33% for 
candidiasis (Araujo et al., 2010; Pagano et al., 2006). 
 
 Fusariosis is the second most common invasive fungal infection among high-
risk patients after Aspergillus (Boutati & Anaissie, 1997; Nucci et al., 2004; 
Stanzani et al., 2007; Walsh & Groll, 1999) and can be cutaneous or 
disseminated. These infections can occur in both immunocompromised and 
healthy individuals. In severely immunodeficient patients, invasive infection is 
more persistent (Jain et al., 2011; Nucci & Anaissie, 2007). Because Fusarium 
is unresponsive to standard antifungal therapy, the incidence of the invasive 
fusariosis significantly increases with intensive use of cytotoxic agents and 
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immunosuppressive drugs (Nucci et al., 2014; Ponton et al., 2000). Some 
Fusarium species comprise complexes of strains that vary in virulence towards 
humans. F. solani, for example, comprises the F. solani species complex 
(FSSC) (Zhang et al., 2006). The two most virulent species complexes involved 
in disseminated fusariosis are FSSC, followed by the F. oxysporum species 
complex (FOSC) (Campbell et al., 2013; Mayayo et al., 1999; Moore et al., 
2011; Diepeningen et al., 2014). The FSSC is also well known as a complex 
containing economically important crop pathogens. This species complex is one 
of the most common causes of fungal keratitis in immunocompetent people. 
Patients with hematologic malignancies receiving cytotoxic chemotherapy, SOT 
and stem cell transplant recipients, and patients with extensive burns are  
at high risk for invasive fusariosis associated with FSSC (Zhang et al., 2006). 
 
Pathogenic  fungi can make biofilms in environment and even host tissues by 
proliferating and expanding extensive living forms of hyphae and conidia in an 
extracellular matrix (ECM) allowing adhesion to surfaces for penetration (Pierce 
et al., 2008). Accordingly, this ability has identified as a serious clinical issue 
(Ramage et al., 2012). Many of medically important fungi such Candida 
(Deorukhkar et al., 2014; Ramage et al., 2012), Aspergillus (Kaur & Singh, 
2014) and Fusarium (Imamura et al., 2008; Mukherjee et al., 2012) that produce 
biofilms tend to display high resistance to host immunity response and 
antifungal agents. Recent studies have suggested that biofilm formation is one 
of the most important pathogenicity virulence factors in invasive mycoses, and 
associated with high mortality rates (Rajendran et al., 2016; Tumbarello et al., 
2007). Since a biofilm is a surface-associated fungal community, a typical 
fungal biofilm development involves in four sequential steps including the cell 
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adhesion to a surface, cells colony formation, maturation into a three-
dimensional structure, and dispersion of cells (Ramage et al., 2009), as shown 
in a model of filamentous (Figure 1.4) (Ramage et al., 2011) and in yeasts 
(Chandra et al., 2001) (Figure 1.5). Since Fusarium keratitis outbreat during 
2005/6 in the US, Fusarium biofilm formation on soft contact lenses has been 
studied (Imamura et al., 2008; Mukherjee et al., 2012). Glycoprotein with 
mannose residues in the extracellular fibrillar matrix located on the outer cell 
wall layer of the Fusarium spore is thought to be a start point of adhesion and 
biofilm developing (Kwon & Epstein, 1997; Kwon & Epstein, 1993; Pan et al., 
2011; Gauthier & Keller, 2013; Kwon & Epstein, 1997). At present, little is 
known about Fusarium biofilm formation and its role in survival and 
pathogenicity of the fungus during invasive infections (Peiqian et al., 2014).  
 
 
Figure 1.4. Aspergillus fumigatus biofilm development. The different phases of biofilm 
development are represented schematically, from initial adhesion of conidia, germling 
formation (8 h), a monolayer of intertwined hyphae (12 h) and mature 3D filamentous 
biomass (c. 200 µm) encased within exopolymeric sub- stance (24 h). (Ramage et al., 
2011).  




Figure 1.5. Schematic representation of biofilm development in C. albicans.  
(a and b) Biofilm grown on polymethylmethacrylate (PMA) strips. (c and d) 
Biofilm grown on silicone elastomer (SE) disks. Panels (a) and (c) represent the 
substrate seen from the top, while panels c and d show the view from the sides 
of the PMA strip and SE disk, respectively. ECM, extracellular material. 
(Chandra et al., 2001). 
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1.3 The Human Immune System 
The human immune system is comprised of a complex network of immune cells 
and soluble chemical components that interact effectively to prevent access and 
defend against fungal invasion. The innate and adaptive immune systems are  
a vital part of the immune responses towards infectious diseases (Romani, 
2004). The innate immune system is the first line of protection (Brown, 2011; 
Figueiredo et al., 2011). It is non-specific, mounting a rapid response to 
potential pathogens, and it lacks immunological memory. The main components 
of the innate immunity are a physical barrier, such as the skin, epithelium, and 
mucus that is produced in the airways and gastrointestinal tract (Romani, 2004; 
Romani, 2011). In addition, soluble components such as cytokines, 
complement, antimicrobial compounds and inflammatory mediators interact to 
deliver immunity (Abbas et al., 2007) alongside innate phagocytic cells such 
macrophages and neutrophils, natural killer cells, and dendritic cells (Folds, 
2008).  
 
The adaptive immune system can be activated once fungal propagules breach 
the innate immune system. The adaptive immune system provides a specific 
response and can generate immunological memory for life-long-acquired 
immunity. Both immune systems cooperate effectively to eliminate infectious 
pathogens (Williams et al., 2012).  
 
 
1.3.1 The innate immune system and fungal infection 
The innate immune system provides an initial line of defence against potential 
pathogens by recognising PAMPs, foreign antigens, such as carbohydrates and 
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proteins, unique to pathogens and which evoke a host immune response 
following recognition by PRRs. Innate immunity to fungi consists of physical 
barriers, serum factors including complement, cytokines, and natural 
immunoglobulins, and phagocytic cells (Carvalho et al., 2010). These 
components work efficiently to prevent and control fungal dissemination and 
halt potential infections. The innate immune response lacks immunological 
memory and is non-specific, but is rapid. Each part of the innate immune 
system has an essential role against fungal invasion either directly or indirectly 
within a complex network of signalling.  
 
The first line of protection is the physical barrier of the skin and the mucosal 
layer at potential portals of entry for fungi. Therefore, individuals with severe 
burns are at a high risk of fungal infections (Church et al., 2006). Epithelial 
tissues participate against microbial invasion via releasing antimicrobial 
compounds that either inhibit or kill microbial cells whilst also activating cellular 
innate immunity. Cellular innate immunity comprises phagocytic and antigen-
presenting cells including sentinel M, circulating polymorphonuclear 
neutrophils (PMN), natural killer cells (NK), and dendritic cells (DC). Innate 
immune cells aid in the clearance of infectious agents via phagocytosis and 
have antigen-presenting functions in the lymphoid organs that stimulate the 
adaptive immune response. Unlike human cells, fungi have a distinct cell wall 
that contains chitin, glucans, mannans and glycoproteins (Bowman & Free, 
2006). Innate immune cells have specific surface receptors, such as the  
-glucan receptor Dectin-1, mannose receptors, and TLRs, for fungal cell wall 
components and can discriminate between infectious cells and human cells 
(Folds, 2008; Shoham & Levitz, 2005). Despite this, some pathogenic fungi, 
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such as Cryptococcus, have developed mechanisms to avoid the innate 
immune system (Voelz & May, 2010). For example; phagocytosed 
Cryptococcus can be multiple inside macrophages and then escape either by  
a novel non-lytic mechanism (Johnston & May, 2010) or lysis host cells (Alvarez 
& Casadevall, 2006). 
 
 
1.3.2 The adaptive immune system and fungal infection  
The adaptive immune system differs in some aspects to the innate immune 
system, not least in that it has immunological memory. Humoral immunity and 
cell-mediated immunity are the main arms of the adaptive immune system with 
adaptive cellular immunity consisting of T and B-lymphocytes. Humoral 
immunity refers to antibodies produced by B-cells. These antibodies can be 
either non-specific or specific for a certain pathogen, binding to conserved or 
pathogen-specific epitopes (antigenic determinants) on immunoreactive 
antigens. Antibodies participate in fungal elimination via a range of 
mechanisms, including preventing spore adhesion, neutralising extracellular 
enzymes, inhibiting yeast-hyphal morphological transitions, preventing spore 
germination, agglutinating and opsonizing fungal spores, and facilitating 
phagocytosis. There are different classes of antibodies or immunoglobulins (Ig). 
Ig classes that circulate in the bloodstream include Ig class M (IgM) and IgG. 
Others, including IgA and IgE, are located within mucous membranes (Romani, 
2002). In response to the fungal invasion, T-helper cells (Th) and cytotoxic  
T-cells (CTLs) differentiate from a common lymphoid progenitor cell. Th cells 
produce cytokines and interferon-γ (IFN-γ) to activate macrophages to kill 
phagocytosed pathogens. CTLs play critical roles in the elimination of 
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1.4 Antifungal Treatment 
Unlike antibacterial antibiotics, the therapeutic options for managing fungal 
infections using antifungal compounds are limited, particularly with the dramatic 
increase in immunocompromised population and diversity of emerging human 
pathogenic fungi (Kanafani & Perfect, 2008; Richardson & Warnock, 2003). 
This limitation is associated with a poor prognosis (Ashley, et. al., 2006). The 
reason behind that is because fungal pathogens were not recognized as 
serious life threatening agents (Anaissie & Bodey, 1989). Furthermore, fungi 
and human beings are eukaryotes microorganisms and therefore have closely 
related to cellular machinery, structure and function. This necessities robust 
development of antifungal agents with little or minimal to mammalian host cells 
(Dixon & Walsh, 1996; Masuoka, 2004). Currently, three main classes of 
antifungal drugs including polyenes, the azoles and the echinocandins have 
been developed for treatment of fungal infections (Lattif & Swindell, 2010).  
In addition, there is a miscellaneous group of compounds, such as flucytosine 
and griseofulvin are also utilised (Richardson & Warnock, 2003). The 
pharmaceutical form of antifungal are mainly administered orally, intravenous 
and eye drops (Arthur et. al., 2004; Kawamura et. al., 2000). 
 
Antifungal agents target only unique fungal cell structure and processes that 
involve synthesis of cell wall components such as chitin, β-glucans, ergosterol 
in addition to disrupting the in cell membrane. This selectively kills the fungal 
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cells without affecting the mammalian cells (Figure 1.6) (Free, 2013; 




Figure 1. 6. Sites of action of antifungals. (Gubbins & Anaissie, 2009). 
 
Azoles compounds such voriconazole and psoaconazole interfere with the 
synthesis of ergosterol in the fungal cell membrane through inhibiting the 
cytochrome P450 enzyme, lanosterol demethylase in fungi (Kanafani & Perfect, 
2008). Amphotericin B deoxycholate and its lipid-form belong to polyenes 
antifungal group and act with ergosterol by making holes in the fungal 
membrane allowing leakage of essential cytoplasmic materials, such as 
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potassium, leading to cell death (Ghannoum & Rice, 1999; Kanafani & Perfect, 
2008).  The echinocandins have a unique mechanism of action, inhibiting  
β-(1,3)-D-glucan synthase an essential component of the fungal cell wall 
(Sucher et. al., 2009). In comparison to the azoles and polyenes, the 
echinocandin group including caspofungin , micafungin and anidulafungin are 
not widely used for therapy of invasive mycoses due to their  large molecular 
weight and therefore poor absorption through the digestive tract (Lattif & 
Swindell, 2010). 
 
Pathogenic fungi have developed mechanisms to resist antifungal compounds 
thereby reducing drug efficiency. The main strategies employed to reduce 
efficiency of the antifungal compounds by pathogenic fungi include reduction of 
drug accumulation in the fungal cell, reduction of the target affinity for the drug 
and changes to the metabolism. (Pemán et al., 2009; Terra et al., 2014). 
 
Managing fusariosis is a serious challenge since most of pathogenic Fusarium 
species are  resistant to most antifungal agents thereby limiting treatment 
options for invasive infections (Azor et. al., 2007; Muhammed et. al., 2011; 
Mukherjee et. al., 2012; Nucci et. al., 2013). There is no clear and optimum 
treatment strategy for Fusarium infections (Blyth et al., 2014; Carneiro et al., 
2011; Liu et al., 2014; Muhammed et al., 2011; Nucci & Anaissie, 2007). 
Therefore, treatment of immunocom-promised patients with disseminated 
fusariosis is difficult and is compounded by the wide variation of Fusarium 
species complex that leads to variability in response to the antifungal agents 
(Stanzani et al., 2007). That may explain the low survival rate of persistent 
neutropenic and transplant recipient patients (Nucci et al., 2014). However, 
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some studies showed that Amphotericin B (AMB) was the best active antifungal 
agent with minimal inhibitory concentration (MIC) no lower than 2 g/ml  
(Azor et al., 2007). In contrast, terbinafine (TBF) was the most active drug for 
treating fusariosis at MIC of 0.60 g/ml compared to the other rest azole drugs 
such as  ravuconazole (RVC), albaconazole (ABC), itraconazole (ITC), and 
ketoconazole (KTC), fluconazole (FLC), flucytosine (5-FC) (Azor et al., 2009) 
which had relatively high MIC ranging from 4.24  to 32 g/ml) . Treatment 
immunocompromised patients with high  intravenous  doses of amphotericin B 
or the lipid formulations is recommended as a first choice therapy for invasive 
fusariosis (Wheat et. al., 2002) with voriconazole and posaconazole as an 
alternative therapies (Muhammed et. al., 2011). Granulocyte colonies 
stimulating factor (G-CSF) or granulocyte-macrophage colony stimulating factor 
(GM-CSF) are also tools for managing fusariosis (Jain et. al., 2011). In 
conclusion, evidence available indicates there no single effective strategy for 
treating invasive fusariosis with response to antifungals such azole varying 
widely (Gubbins & Anaissie, 2009). 
 
 
1.5 Diagnosis of invasive fungal infections 
In comparison with other infectious diseases, the diagnosis of fungal infections 
(mycosis) is still underscored by the management of the disease. It is a major 
problematic health issue, especially in the absence of a clear understanding of 
the epidemiology of fungal infections. The need for accurate and sensitive 
diagnostic approaches for invasive mycosis is becoming more important, 
particularly with the dramatic increase in severely immunocompromised patients 
and the rise in nosocomial infections. Early diagnosis allows timely treatment 
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with appropriate antifungal drugs and successful management of the fungal 
disease. Establishing a sensitive and rapid diagnostic test for fungal infections 
is complicated. Traditional methods of diagnosis that are used include direct 
microscopy, mycological culture, histopathology, clinical symptoms, radiology 
and serological tests. The direct microscopic examination is the primary method 
used to identify fungal propagules in clinical samples visually. Definitive 
diagnosis of disseminated mycosis requires the recovery and identification of 
fungal pathogens from samples such as skin, sinuses, lung, and body fluids  
(in particular blood) using culture and microscopy (Nucci & Anaissie, 2009). 
Selective stains are used to detect fungal elements. For example, calcofluor 
white and India ink are used to visualise fungal cells with fluorescence or 
contrast microscopy (Stevens, 2002). 
 
Identification of fungal pathogens at the species level is often needed  
for appropriate antifungal treatment. Direct microscopical examination is cheap 
and widely available but is not able to identify pathogenic fungi at a species 
level. Furthermore, it requires expertise in medical mycology to discriminate 
different morphological features of infectious agents (Alexander & Pfaller, 2006; 
Steinbach et al., 2003). A notable example is the invasive hyaline fungal 
pathogens (causative agents of hyalohyphomycosis). This group of organisms, 
which includes Aspergillus, Fusarium, Scedosporium, Penicillium and 
Acremonium all have hyaline septate hyphae with narrow-angle branching 
(Arvanitis et al., 2014; Tortorano et al., 2014; Nguyen et al., 2012; Nucci & 
Anaissie, 2009). Moreover, some pathogenic fungi, such Acremonium spp., 
grow slowly and require around 14 days (Park et al., 2011).  
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Clinical manifestations of deep mycosis are non-specific, and variable, 
depending on infection site and patient status. For example, severely 
immunocompromised hosts more frequently undergo fever, chest pain, skin 
lesions, pulmonary infiltration and other clinical features. A broad range of 
fungal pathogens, such as Fusarium, Curvularia, Bipolaris, Exserohilum, 
Alternaria, Aspergillus species and Pseudallescheria boydii can all mimic the 
same clinical signs (Guarner & Brandt, 2011; Park et al., 2011; Pauw & Meis, 
2005). Radiological findings, including X-ray and computed tomography (CT) 
scans, are similarly non-specific, but can indicate invasive fungal infection. 
Therefore, a combination of diagnostic approaches is indispensable to prevent 
misdiagnosis (Alexander & Pfaller, 2006; Barnes, 2008; Oh et al.,  2000; 
Richardson & Warnock, 2003). 
 
The fungal cell wall has a wide variety of antigenic structures that can stimulate 
the adaptive immune system. In this case, activated B-cells produce antibodies 
that aid in opsonization and clearance of propagules by phagocytic cells. 
Fungal-specific serum antibody titers tend to be elevated during fungal 
infections in patients that can mount a B cell response and so can be used in 
some instances to detect circulating antigens released during disseminated 
disease (Blanco & Garcia, 2008; Shoham & Levitz, 2005). However, in patients 
with impaired immune responses, it is not possible to generate detectable 
antibody titers against systemic fungal infections (Stevens, 2010). 
 
Conversely, serodiagnostic tests using polyclonal or monoclonal antibodies, 
generated against fungal antigens in rabbits or mice, have been developed and 
used to track infections using crude antigen extracts or recombinant proteins 
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(Brandt & Warnock, 2003). Serodiagnostic tests are rapid and are achieved 
using immunoassays such as ELISA or immunodiffusion (ID) (Morrison & 
Warnock, 2007). Because polyclonal antibodies are not specific to a given 
genus or species (Badiee & Hashemizadeh, 2014), serological assays are less 
likely to be able to discriminate between the many different fungal pathogens 
(Ahmad et al., 2010; Alexander, 2002; Limper, 2010). For this reason, highly 
specific monoclonal antibodies generated using hybridoma technology are 
needed for accurate serological diagnosis. With the broad variety of emerging 
opportunistic fungal pathogens, conventional diagnostic methods are 
considered time-consuming, inaccurate, and/or not sensitive enough. This leads 
to an increased chance of misidentification and mistreatment (Alexander & 
Pfaller, 2006; Arvanitis et al., 2014). 
 
 
1.5.1 Non-Cultural Based Methods 
Non-culture based methods have been developed to improve the accuracy and 
speed of diagnosis of invasive fungal infections. These methods include 
molecular (nucleic acid-based) detection methods and fungal antigen detection 
using mAbs (Alexander & Pfaller, 2006; Kozel & Wickes, 2014). 
 
 
1.5.1.1 Molecular Diagnosis 
The increasing incidence of emerging pathogenic fungi has necessitated  
the development of more accurate and rapid techniques for fungal diagnosis. 
DNA sequence-based approaches are considered the pivotal methods  
in the fungal identification, with a turn-around time of about 24 h (Balajee et al., 
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2009). Molecular diagnostic techniques are culture-independent methods that 
do not require morphological features of living cells or colonies for identification. 
Most of the molecular based tools are based on the use of PCR. This technique 
amplifies and analyses constant genetic markers of fungal cells that provide rich 
data for fungal identification (Kozel & Wickes, 2014).  
 
PCR-based techniques are increasingly being used as a rapid tool for detection 
and amplification of marker genes specific to each fungal species, such as  
TEF-1α for Fusarium species, β-tubulin for Aspergillus, endo-polygalacturonase 
for Alternaria, and calmodulin for P. boydii (Romanelli et al., 2014). Several 
regions of the fungal genome have been evaluated as potential targets for 
detection, such as the ITS region of the nuclear ribosomal DNA (rDNA) 
(Richardson & Warnock, 2003). However, getting sufficient DNA yield from 
clinical samples is not always feasible (Guarner & Brandt, 2011). Furthermore,  
it has been shown that PCR-based techniques cannot completely replace 
culture-based methods due to their variable sensitivities and the possibility of 
contamination in the diagnostic laboratory (Alexander & Pfaller, 2006). 
 
 
1.5.1.2 Antigen Detection Using Monoclonal Antibodies 
Hybridoma technology enables the produce of highly specific mAbs against  
a specific antigen in vitro, and can make a significant contribution to the 
improved accuracy and speed of diagnosis for fungal pathogens. This 
technology was first described by Georges Köhler and Cesar Milstein in 1975 
(Köhler & Milstein, 1975) and allows the identification of B-cells secreting 
antibodies of predefined specificity.  Antibody-producing B-cells cannot survive 
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in vitro unless they are first fused with a myeloma cell, to produce a hybridoma 
cell. These immortalised B-cells cell lines can then be grown in culture and their 
antibodies harvested for use in immunodiagnostics (Abbas et al., 2007). 
 
MAbs can identify fungi at the genus (Thornton et al., 2002) and species levels 
(Thornton et al., 1993). Highly specific mAbs have been developed to identify 
pathogenic fungi in soil and plants (Dewey & Thornton, 1995; Dewey et al., 
1997; Thornton et al., 1993; Thornton, 2008a; Thornton et al., 2002; Thornton & 
Talbot, 2006; Thornton et al., 2004). For medical purposes, specific mAbs have 
been developed for the early diagnosis of mycoses, particularly invasive 
infections (Thornton, 2009a; Thornton, 2008b). Successful diagnosis of human 
pathogenic fungi using mAbs developed previously against plant pathogens 
have also been reported (Thornton, 2009b; Thornton, 2008b; Thornton & Wills, 
2013).  
 
Many mAbs have been developed for accurate, sensitive and rapid detection of 
opportunistic fungal pathogens. Specifically, mAbs for Aspergillus (Thornton, 
2008), P. boydii (Thornton, 2009), Scedosporium prolificans (Thornton et al., 
2015), and Trichosporon asahii (Davies & Thornton, 2014a) have all been 
developed. In medical mycology, the availability and accuracy of new diagnostic 
tests have a significant impact on the management of fungal infections and 
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1.6 Focus of This PhD 
The ever expanding population of patients with compromised immune systems 
is at risk of disseminated infections associated with opportunistic fungal 
pathogens (Crabol et al., 2014; Kriengkauykiat et al., 2011). The most common 
disseminated fungal infections are caused by species of Candida and 
Aspergillus, with considerable rates of morbidity and mortality (Nucci & Marr, 
2005). However, some opportunistic fungi such as Fusarium and 
Scedosporium, Rhizopus, Mucor, Trichosporon, Rhodotorula,  Paecilomyces 
and Exophiala have emerged as  significant causes of life-threatening infections 
in humans, but relatively little is known about their pathobiologies (Anaissie  
et al., 1989; Boutati & Anaissie, 1997; Kauffman, 2004; Nucci et al., 2002; 
Pfaller & Diekema, 2004).  
 
Furthermore, these fungi are typically less susceptible to antifungal agents 
currently used in the clinical setting (Srinivasan et al., 2014). Early diagnosis of 
these organisms is critical, but rapid and accurate detection remains a serious 
challenge (Barnes, 2008; Low & Rotstein, 2011).  
 
The aim of this work was to develop and characterise highly Fusarium-specific 
mAb that can be used to detect this important emerging human pathogen and 
as a tool to study its epidemiology and interaction with cells of the innate 
immune system.  
 
The specific aims of these investigations were:  
1. To characterize a Fusarium-specific mAb (mAb ED7) by investigating the 
chemical nature and cellular localization of its target antigen (Chapter 2); 
  Chapter 1                                                                                       General Introduction 
 28 
2. To use mAb ED7 to study the interaction of Fusarium spores with cells of 
innate immunity (Chapter 3); 
3. To use mAb ED7 to identify sources of the pathogen for nosocomial and 
community-acquired infections (Chapter 4).  
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2.1.1 Fusarium as a Plant Pathogen 
Fusarium species are major plant pathogens causing a range of diseases in  
a large number of economically important crops with yield losses of up to 100% 
(Burgess, Knight, Tesoriero, & Phan, 2008; Leslie & Summerell, 2006). The 
genus causes diseases of cereals (Abbas et al., 1998; Francis & Burgess, 
1977; Moretti, 2009), fruits (Jiménez et al., 1993; Zhang et al., 1999), and 
vegetables (Naef & Défago, 2006; Roy, 1997), with species listed in the top 10 
fungal plant pathogens according to economic importance including  
F. graminearum (fourth) and F. oxysporum (fifth) (Dean et al., 2012). The best 
known Fusarium disease in plants is Fusarium Head Blight (FHB), a disease 
affecting cereal crops, rice and wheat. FHB is caused by F. oxysporum (Nganje 
et al., 2004), F. graminearum (Goswami & Kistler, 2004), F. avenaceum (Yli-
Mattila, 2010), F. culmorum, F. pseudograminearum (Balmas et al., 2015) and 
F. proliferatum (O’Donnell et al., 2010). Other Fusarium diseases include 
sudden death syndrome (SDS), Fusarium wilt, root, stem and seed rots and 
cankers of many fruits and vegetables including tomato, potato, cotton, 
cabbage, cucumbers, melons, date palms, peas, and soybeans (Ahmet, 2011; 
Ajilogba & Babalola, 2013; Gupta et al., 2009; Moretti et al., 2002; Vicente et 
al., 2014; Pilotti et al., 2002; Schroers et al., 2009). A number of Fusarium 
species, for example, F. solani and F. oxysporum, are capable of infecting both 
plants and humans (Moore et al., 2011).  
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2.1.2 Fusarium as Agents of Human Infectious Diseases 
The most frequently cited fungal pathogens of humans include Candida, 
Cryptococcus, Aspergillus, Fusarium, Scedosporium, Rhizopus and Mucor 
(Araujo et al., 2010; Esnakula et al., 2013; Pontón et al., 2000). Invasive 
infections caused by Fusarium species (known as fusariosis) mainly occur in 
immunocompromised humans and, in certain settings, have emerged as the 
second most common opportunistic pathogen after Aspergillus (Boutati & 
Anaissie, 1997; Nucci et al., 2004; Walsh & Groll, 1999), causing localised and 
disseminated infections in humans (Nelson et al., 1994; Nucci & Anaissie, 
2007).  
 
The first case of disseminated infection due to F. solani was reported in an 
immuno-compromised child in 1973 (Cho et al., 1973). Since then, F. solani has 
been recognised as a serious opportunistic pathogen of humans (Mayayo et al., 
1999; Schmidig, 2012; Stanzani et al., 2007). The dramatic increase in 
fusariosis during the last three decades coincides with the ever expanding 
populations of severely immune deficient individuals, including those with 
acquired immune deficiency syndrome (AIDS), BMT and SOT recipients, and 
those who receiving cytotoxic agents such as immunosuppressive drugs, 
intensive broad-spectrum antibiotics, radiotherapy and chemotherapy (Dignani 
& Anaissie, 2004; Muhammed et al., 2011; Schmidig, 2012). Mortality and 
morbidity rates for disseminated fusariosis are estimated to be between  
50-75% (Jensen et al., 2004; Krcmery et al., 1997). However, recent studies 
have suggested that this could even be as high as 100% (Nucci & Anaissie, 
2007). The increasing incidence of invasive fusariosis and high mortality rates 
are likely due to Fusarium virulence factors, the production of mycotoxins and 
Chapter 2         Introduction 
 31 
lytic enzymes, and spore adhesion and biofilm formation. In addition, Fusarium 
is resistant to almost all currently available antifungal drugs (Azor et al., 2007; 
Nelson et al., 1994; Nucci & Anaissie, 2007; Pujol et al., 1997; Tortorano et al., 
2014).  
 
Many other clinically relevant Fusarium species include F. oxysporum,  
F. verticillioidis, F. moniliforme, F. dimerum, F. proliferatum, F. chlamidosporum, 
F. sacchari, F. nygamai, F. napiforme, F. antophilum, and F. vasinfectum 
(Dignani & Anaissie, 2004; Nucci & Anaissie, 2007; Wang et al., 2011).  
The FSSC group is the most frequent and virulent group involved in invasive 
infections (Mayayo et al., 1999; O’Donnell et al., 2010; Diepeningen et al., 
2014), followed by F. chlamydosporum species complex (FCSC),  
F. incarnatum/equiseti  species complex (FIESC), FOSC and F. dimerum 
species complex (FDSC) (Balajee et al., 2009; Diepeningen et al., 2014). 
 
Fusarium infections may occur at various sites of the human body, manifesting 
as superficial, subcutaneous or deep infections. Fusarium infections can be 
localized on the skin (dermatophytosis), cornea (keratitis) (Chang et al., 2006; 
Cuero, 1980; Gungel et al., 2011; Sekeroglu et al., 2012; Verma & Tuft, 2002), 
or nails (onychomycosis) (Brasch & Köppl, 2009; Brasch & Shimanovich, 2012; 
Girmenia et al., 1992). Compared to immunocompetent hosts, infections in 
immunocompromised patients are typically disseminated, due to the lack  
of an innate immune response (Bachmeyer, 2007; Bushelman et al., 1995; 
Cooke et al., 2009; Perez et al., 2007; Yera et al., 2003; Ammari et.al., 1993; 
Ascioglu et al., 2002; Lucca, 2007; Nucci et al., 2004; Nucci & Anaissie, 2002, 
2007; Tortorano et al., 2014; Venditti et al., 1988). Broken skin and the 
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respiratory tract are the primary portals of entry for Fusarium propagules 
(Legrand et al., 1991; Muhammed et al., 2011; Nucci & Anaissie, 2007). 
Additionally, Fusarium can also cause allergic symptoms during the 
aerosolization of spores in dusty indoor environments (Noble et al., 1997). 
 
 
2.1.3 Diagnosis of Fusarium infections 
2.1.3.1 Morphological Characteristics 
As with all other human fungal pathogens, identification of Fusarium infection 
depends on the identification of characteristic morphologic features of cultured 
samples and microscopic examination of clinical samples from sterile sites or 
biopsy (Esnakula et al., 2013; Marcio Nucci et al., 2004; Marcio Nucci & 
Anaissie, 2007). However, the morphological appearance of Fusarium is highly 
variable (O’Donnell et al., 1998; Summerell et al., 2003; Diepeningen et al., 
2015), and its polyphyletic taxonomy makes it one of the most challenging 
groups of fungi to categorise (Leslie & Summerell, 2006). Identification of 
Fusarium species using direct microscopical examination can lead to 
misdiagnosis due to similarities in morphology with other fungal pathogens. 
Acute-branching septate hyaline hyphae with or without sporulation are 
characteristics shared between Fusarium and other hyalohyphomycetes fungi, 
including Aspergillus, Scopulariopsis and Acremonium (Jain et al., 2011; Nucci 
& Anaissie, 2007; Tortorano et al., 2014). Identification based on morphological 
features requires the preparation of axenic cultures which is time-consuming 
and delays diagnosis (Dignani & Anaissie, 2004; Muhammed et al., 2011b). 
Notwithstanding this, mycological culture remains the gold standard test for 
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fungal detection in clinical laboratories (McClenny, 2005) despite its poor 
sensitivity compared to other diagnostic procedures. 
 
 
2.1.3.2 Nucleic Acid-based Techniques 
Diagnostic techniques that detect nucleic acids have been used to identify IFIat 
early stages of clinical manifestations. The need for accurate identification of 
Fusarium at the species level requires construction of an accurate phylogenetic-
based classification (O’Donnell, 1996; O’Donnell, 2000). To this end extensive 
taxonomical studies have been undertaken to identify DNA sequences specific 
to Fusarium species or species complexes (Leslie & Summerell, 2006). 
Barcoding based on the rDNA ITS region has been used to differentiate closely 
related species and to identify inter- and intraspecific variation (Bryan et al., 
1995; O’Donnell, 1996; Seifert, 2009). This technique has enabled accurate 
discrimination of the most common pathogenic fungi involved in invasive 
mycoses at the species level (Spiess et al., 2007). However, in this setting, the 
use of ITS sequencing for Fusarium species identification is inadequate, as it 
does not reveal sufficient information for discriminating Fusarium species 
complex, such as FSSC and FOSC (Balajee et al., 2009; Geiser et al., 2004; 
O’Donnell et al., 2010; O’Donnell & Cigelnik, 1997). For this reason, Fusarium 
protein-encoding genes have been sequenced to identify marker genes for 
diagnosis, including the TEF-1α gene (Geiser et al., 2004; Harrow et al., 2010; 
Kristensen et al., 2005; Yli-Mattila et al., 2002), the β-tubulin gene (Mach et al., 
2004; Seifert & Lévesque, 2004; Yli-Mattila et al., 2004), and two genes 
encoding the largest and second largest subunits of RNA polymerase (RPB1 
and RPB2, respectively) (Boonyuen et al., 2011; O’Donnell et al., 2010) and 
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calmodulin (Mulè et al., 2004). The TEF-1α gene has been validated as a more 
informative gene compared to the other encoding genes sequenced. TEF-1α 
can be used for the identification and phylogenetic analysis of the Fusarium 
genus (O’Donnell et al., 1998), but the use of molecular-based techniques for 
detection of Fusarium infections is used alongside other tests for clinical 
diagnosis (Tortorano et al., 2014).  
 
 
2.1.3.3 Serological Assays 
The chemical composition of the fungal cell wall is unique and presents 
opportunities for the development of diagnostic test based on detection of 
characteristic signature molecules. While the chemical components of the 
fungal cell wall are similar at the level of the phylum, the antigenic composition 
at genus and species levels can vary considerably allowing the identification of 
genus and species-specific biomarkers for diagnostic test development (Free, 
2013). During disseminated infections, antigens are shed into the bloodstream 
and bronchoalveolar lavage fluid (BAL) (Kozel & Wickes, 2014).  
 
 
2.1.3.3.1 Detection of 1,3-β-D-Glucan and Galactomannan 
Detection of the fungal cell wall components BDG and GM form are the main 
serological tests commercially available and used widely in clinical settings for 
invasive fungal pathogens (Kozel & Wickes, 2014). However, the BDG test is 
not specific and is an insufficient tool for the diagnosis of fusariosis, as 
Fusarium species often cross-react with other species like Aspergillus, Candida, 
Acremonium and Trichosporon.  (Esnakula et al., 2013; Ostrosky-Zeichner  
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et al., 2005;  Yoshida et al., 1997). In 1992, Stynes described the development 
of a unique mAb (EB-A2) that strongly reacts  the tetra (15)- -D-
galactofurano-side, a specific glycoprotein epitope of Aspergillus GM (Stynen et 
al., 1992). Ever since the GM test has become a medically important application 
for the early diagnosis of invasive Aspergillus infections, and it is commercially 
available as an ELISA kit (Kappe & Schulzeberge, 1993; Latge et al., 1994; 
Leeflang et al., 2008; Tanriover et al., 2008; Verweij et al., 2006). The GM test 
cross-reacts with several other invasive pathogenic fungi, including Penicillium, 
Fusarium, Alternaria, Histoplasma, Trichothecium, Geotrichum, Cladosporium 
and Acremonium (Aquino et al.,  2007; Giacchino et al., 2006; Huang et al.,  
2007; Kappe & Schulzeberge, 1993; Mikulska et al., 2012; Swanink et al., 1997; 
Tortorano et al., 2012; Wheat et al., 2007). Therefore, serological tests have 
been of limited benefit for the diagnosis of fusariosis (Muhammed et al., 2011). 
 
 
2.1.3.3.2 Polyclonal and Monoclonal Antibodies 
For this reason, diagnosis of invasive mycoses based on cell wall composition 
using a polyclonal antibody is a routin approach employed in clinical 
laboratories (Brandt & Warnock, 2003). MAbs are an attractive diagnostic tool 
for systemic fungal infections and have exclusive specificity for detecting the 
smallest and unique fungal surface epitopes. This technology saves time and is 
sensitive for a definitive diagnosis of fungal infections at a genus or species 
level, and can guide appropriate antifungal therapy usage. Furthermore, antigen 
tests do not require any immune response. They rely only on the tracking of  
a fungal cell, or even cell wall debris in the blood stream or other body fluids  
at any detectable level.  
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2.1.4 Objective of This Chapter 
To date, no studies have been undertaken to develop a diagnostic antibody that 
can detect human pathogenic strains of Fusarium. The purpose of the work 
presented in this chapter was to generate mAbs specific to a constitutively 
expressed extracellular antigen from F. solani that might be appropriate for 
tracking human pathogenic strains and to investigate their interaction with  
cells of the immune system (Chapter 3) and during epidemiological studies  
(Chapter 4). This work takes advantage of hybridoma technology, using 
approaches already successfully exploited in this laboratory for the 
development of murine mAbs for the detection of invasive fungal infections, 
including aspergillosis (Thornton, 2010; Thornton, 2008) and scedosporiosis 
(Thornton, 2009). 
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2.2 Materials and Methods 
2.2.1 Ethics Statement 
All animal work described in this study was conducted under a UK Home Office 
Project License, and was reviewed by the institution’s Animal Welfare Ethical 
Review Board (AWERB) for approval. The work was carried out in accordance 
with The Animals (Scientific Procedures) Act 1986 Directive 2010/63/EU, and 
followed all the Codes of Practice which reinforce this law, including  
all elements of housing, care, and euthanasia of the animals.  
 
 
2.2.2 Fungal Cultures and Media 
Details of the fungi used in this study are in Table 2.1 All fungi were grown and 
maintained on PDA or in PDB (PDB; Difco, 254920) 2.4% containing 2% (w/v) 
agar). For liquid cultures, fungal spores at a concentration of 1 x 103 ml-1, or  
3 x 5 mm agar plugs taken from the leading edge of PDA cultures, were 
inoculated into 250 ml conical flasks containing 100 ml of PDB, or in SDB (SDB; 
Oxoid; CM0147) (3%). All media was autoclaved at 121°C for 15 min prior to 
use. Fungi were grown on slopes or on Petri dishes under a 16-h fluorescent 










Chapter 2                                                                                      Materials and Methods 
 38 
Table 2.1. Details of fungi used in mAb ED7 specificity tests. 
Organism Isolate no. Sourcea 
Aspergillus cervinus 537.65 CBS 
Aspergillus ficuum 555.65 CBS 
Aspergillus flavus 91856iii IMI 
Aspergillus fumigatus AF293 SK 
Aspergillus nidulans A4 FGSC 
Aspergillus niger 102.4 CBS 
Aspergillus oryzae 672.92 CBS 
Aspergillus restrictus 116.5 CBS 
Aspergillus terreus var. terreus 601.65 CBS 
Botrytis cinerea R2 CRT 
Byssochlamys nivea 153.59 CBS 
Candida glabrata 4692 CBS 
Candida krusei 5590 CBS 
Candida parapsilosis 8836 CBS 
Candida tropicalis 1920 CBS 
Cryptococcus neoformans (Serotype D) 5728 CBS 
Cunninghamella elegans 151.8 CBS 
Filobasidiella bacillispora 10865 CBS 
Filobasidiella neoformans 10490 CBS 
Filobasidiella neoformans 10496 CBS 
Fusarium acutatum 402.97 CBS 
Fusarium anthophilum 222.76 CBS 
Fusarium avenaceum 386.62 CBS 
Fusarium cerealis 134.8 CBS 
Fusarium chlamydosporium var. chlamydosporium 491.77 CBS 
Fusarium culmorum 256.51 CBS 
Fusarium dimerum var. dimerum 108944 CBS 
Fusarium incarnatum 678.77 CBS 
Fusarium nygamai 140.95 CBS 
Fusarium oxysporum f.sp. cucurbitacearum 254.52 CBS 
Fusarium oxysporum f.sp. lycopersici 167.3 CBS 
Fusarium oxysporum f.sp. marmaris 420.8 CBS 
Fusarium oxysporum f.sp. radicis-lycopersici 872.95 CBS 
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Fusarium oxysporum f.sp. vasinfectum 409.9 CBS 
Fusarium proliferatum var. proliferatum 181.3 CBS 
Fusarium sacchari 183.32 CBS 
Fusarium solani 224.34 CBS 
Fusarium solani 109696 CBS 
Fusarium solani 188.34 CBS 
Fusarium solani 115659 CBS 
Fusarium solani 117608 CBS 
Fusarium solani 119223 CBS 
Fusarium solani var. petroliphilum 102256 CBS 
Fusarium verticillioides 102699 CBS 
Geotrichum candidum 115.23 CBS 
Haematonectria haematococca 114067 CBS 
Haematonectria haematococca 119603 CBS 
Haematonectria haematococca 130692 CBS 
Lichtheimia corymbifera T14A (FJ713070) CBS 
Magnusiomyces capitatus 207.83 CBS 
Mucor circinellioides f.sp. circinellioides E2A (FJ713065) CRT 
Neosartorya fischeri var. fischeri 687.71 CBS 
Paecilomyces variotii 339.51 CBS 
Penicillium cyclopium 123.14 CBS 
Penicillium islandicum 338.48 CBS 
Penicillium spinulosum 346.61 CBS 
Pichia norvegensis 6564 CBS 
Pseudallescheria boydii 835.96 CBS 
Pythium insidiosum 673.85 CBS 
Rhizomucor miehei MG4(2) (FJ713069) CRT 
Rhizopus stolonifera 389.95 CBS 
Rhodosporidium toruloides 6016 CBS 
Rhodotorula mucilaginosa 326 CBS 
Scedosporium apiospermum 117407 CBS 
Scedosporium aurantiacum 121926 CBS 
Scedosporium aurantiacum 118934 CBS 
Scedosporium prolificans 102176 CBS 
Sporidiobolus salmonicolor 6781 CBS 
Trichoderma hamatum GD12 (AY247559) CRT 
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Trichosporon asahii var. asahii 8973 CBS 
Trichosporon asahii var. asahii 5286 CBS 
Trichosporon asahii var. asahii 7632 CBS 
Trichosporon asahii var. asahii 5599 CBS 
Trichosporon asteroids 6183 CBS 
Trichosporon asteroids 7623 CBS 
Trichosporon asteroids 2481 CBS 
Trichosporon asteroids 7624 CBS 
Trichosporon cutaneum 2466 CBS 
Trichosporon inkin 7630 CBS 
Trichosporon inkin 7655 CBS 
Trichosporon loubieri 7065 CBS 
Trichosporon ovoides 7556 CBS 
Trichosporon mycotoxinovorans 9756 CBS 
Wickerhamomyces anomalus 5759 CBS 
 
a CBS = Centraalbureau voor Schimmelcultures, PO Box 85167, 3508 AD 
Utrecht, The Netherlands; CRT = C.R. Thornton; IMI = International Mycological 
Institute, Egham, England; SV = S. Krappman, Institute of Microbiology and 
Genetics, Department of Molecular Microbiology and Genetics, Georg-August-
University, Gottingen, Germany. 
 
 
2.2.3 Preparation of Immunogen and Immunisation Regime 
BALB/c mice were immunised with soluble antigens prepared from lyophilized 
mycelium of a human pathogenic strain of FSSC 1-a (CBS strain 224.34). 
Conidia were suspended in water after 10-day old PDA slant cultures were 
flooded with 5 ml MQ-H2O and gently agitated with an inoculation loop. Conidial 
suspensions were then filtered through Miracloth to remove mycelium and 
transferred to 1.5 ml micro-centrifuge tubes. The conidia were washed three 
times with MQ-H2O by repeated vortexing and centrifugation at 14,462 g for  
5 min and finally suspended in MQ-H2O to give a concentration of 106 spores 
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ml-1 solution. Flasks containing 100 ml of sterilised PDB were inoculated with 
200 l of the conidial suspension and incubated with shaking (75 rpm) for 48 h 
at 26oC. Hyphal biomass was collected on Miracloth, snap frozen in liquid N2, 
and lyophilized. Culture filtrates were retained for gel electrophoresis and 
Western blotting studies and stored at –20oC until required. One mg of 
lyophilized biomass was suspended in 1 ml PBS (0.8% NaCl; 0.02% KCl; 
0.115% Na2HPO4; 0.02% KH2PO4; pH7.2) and the resultant suspension 
centrifuged for 5 min at 14,462 g. The supernatant, containing solubilized 
antigens, was used as the immunogen and as a source of antigens for 
hybridoma screening assays. For immunisation, 6-wk-old BALB/c female white 
mice were given four intraperitoneal injections (300 μl per injection) of antigen 
extract containing 2.3 mg protein ml-1 PBS at 2-wk intervals and a single 
booster injection five days before fusion. 
 
 
2.2.4 Production and Screening of Hybridomas and Determination  
of Antibody Specificity 
Hybridoma cells were produced by the method described by Thornton (2001). 
The myeloma cell line SP2/0-Ag14, in the exponential phase of growth, was 
prepared at a concentration of 107 cells ml-1 by enumeration using  
a haemocytometer. The mouse selected for hybridoma production was 
euthanised and then doused with 70% (v/v) ethanol. The spleen was removed 
aseptically and placed in a 30-ml Universal tube containing 10 ml warm  
20% TCM. Following this, the spleen was placed in a 9-cm Petri dish containing  
15 ml of fresh 20% TCM and the splenocytes released by teasing the tissues 
with sterile hypodermic needles. The splenocytes were transferred to a sterile 
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50-ml Falcon tube and, alongside the myeloma cells, were centrifugation  
at 250 g for 5 min. The supernatants were discarded and the cells were  
re-suspended in 2.5 ml of RPMI serum-free medium. The two suspensions were 
combined, mixed, and centrifugation in a sterile round-bottomed 10-ml tube at 
250 g for 5 min. Next, the supernatant was aspirated and 0.3 ml of 33% (w/v) 
PEG solution was added allowing exposure of the cells for 7 min including 1 min 
centrifugation at 500 g. The PEG was gently removed and then the pellet was 
slowly re-suspended by adding 5 ml of serum-free medium. The fusion products 
were diluted into 95 ml of selective medium consisting of 10% TCM with 
hypoxanthine, aminopterin and thymidine (HAT; Sigma, H0262) supplement 
and 100 µl volumes of the cell suspension transferred to the wells of 96-well 
culture plates for incubation at 37oC and 5% CO2. After 7 days, the cells were 
fed with 10% TCM supplemented with hypoxanthine and thymidine (HT; Sigma, 
H0137) and wells containing hybridomas identified subsequently. The cell 
supernatants were screened by ELISA against of F. solani (CBS224.34) 
antigens immobilized to the wells of Maxisorp microtitre plates (442404; Nunc) 
(50 μl per well). Selected cell lines were sub-cloned, growing in non-selective 
10% TCM, and then preserved by freezing in LN2. 
 
For antibody specificity tests, fungi were grown on replicate agar slopes and 
surface washings containing water-soluble antigens prepared as described in 
Thornton (2001). Protein concentrations, determined spectrophotometrically  
at 280 nm (Nanodrop, Agilent Technologies Limited, Berkshire, UK), were 
adjusted to 60 μg ml-1 buffer. Fifty μl volumes were then used to coat the wells 
of microtitre plates. After incubating overnight at 4oC, wells were washed four 
times with PBST (PBS containing Tween-20, 0.05% (v/v)), once each with PBS 
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and MQ-H2O and then air-dried at 23oC in a laminar flow hood. The plates were 
stored in sealed plastic bags at 4oC in preparation for the screening of 
hybridoma supernatants by ELISA as described below. 
 
 
2.2.5 Enzyme-Linked Immunosorbent Assay 
Wells containing immobilized antigens were blocked for 10 min with 100 μl of 
blocking solution 1% (wt/vol) BSA (Sigma A-7030) in PBS and incubated 
successively with hybridoma tissue culture supernatant (TCS) for 1 h, followed 
with goat anti-mouse polyvalent (Ig classes IgG, IgA, and IgM) peroxidase 
conjugate (A0412; Sigma Chemical Company, Poole, United Kingdom) diluted  
1 in 1000 in PBST for a further hour. Bound antibody was visualised by 
incubating wells with TMB (T2885; Sigma) substrate solution (Thornton, 2001) 
for 30 min. The reactions were stopped by the addition of 3 M H2SO4 and 
absorbance values were determined at 450 nm with an MRX automated 
microplate reader (Dynex Technologies, Billingshurst, UK). Wells were given 
four 5-min rinses with PBST between incubations and a final rinse with PBS 
before addition of the substrate solution. Working volumes were 50 μl per well 
and control wells were incubated with TCM containing 10% (v/v) FBS. All 
incubation steps were performed at 23oC in sealed plastic bags. The threshold 
for detection of the antigen in ELISA was determined from control means  
(2 x TCM absorbance values) (Sutula et al., 1986). These values were 
consistently in the range (0.05 - 0.10). Consequently, absorbance values  
> 0.100 were considered as positive for the detection of antigen. 
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2.2.6 Determination of Ig Subclass and Sub-cloning Procedure 
The Ig class of mAbs was determined by using antigen-mediated ELISA.  
Wells of microtitre plates coated with F. solani (CBS224.34) water-soluble 
antigens from surface washings were incubated successively with ED7 TCS  
for 1 h, followed with goat anti-mouse IgG1, IgG2a, IgG2b, IgG3, IgM, or IgA-
specific antiserum (ISO-2; Sigma) diluted 1 in 3000 in PBST for 30 min and 
rabbit anti-goat peroxidase conjugate diluted 1 in 1000 (A-5420; Sigma) for  
a further 30 min. Bound antibody was visualised with TMB substrate as 
described above. Hybridoma cells lines were subcloned three times by limiting 
dilution according to the method described in Thornton (2001). 
 
 
2.2.7 Long-term Storage of Hybridoma Cells 
Hybridoma cells were frozen for long-term storage in liquid nitrogen (LN2). 
Culture plates containing 20 ml 10% TCM were seeded with 5 ml of cell 
suspension and incubated for 24 h at 37°C and 5% CO2. Suspended cells were 
transferred to 15-ml sterile Falcon tubes (Sarstedt, 62.547.254). The contents 
were pelleted at 2000 rpm for 5 min in a centrifuge (HERMLE 2323K) and the 
supernatant removed by aspiration. The cell pellet was gently re-suspended in 
600 μl of freezing medium (92:8 (vol/vol) FBS: dimethyl sulphoxide (DMSO; 
Sigma HYBRI-MAX, D-2650). Cell suspensions were transferred at 150 μl 
volumes into separate cryovials. The vials were frozen overnight in a -80C 
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2.2.8 Antigen Characterization  
2.2.8.1 Gel Electrophoresis and Western Blotting  
For sodium-dodecyl-sulphate-polyacrylamide gel electrophoresis (SDS-PAGE), 
culture filtrates from 2-d-old PDB shake cultures of F. solani (CBS224.34) and  
F. oxysporum f.sp. lycopersici (CBS167.30), prepared as described, were 
diluted in Laemmli buffer (Laemmli, 1970) and were denatured by heating at  
95oC for 10 min. Antigens were separated in 4-20% (w/v) polyacrylamide 
gradient gels (161-1159; Bio-Rad) for 1.5 h at 23oC (165V) under denaturing 
conditions, and pre-stained broad range markers (161-0318; Bio-Rad) were 
used for molecular weight determinations. For Westerns, separated antigens 
were transferred electrophoretically to a PVDF membrane (162-0175; Bio-Rad). 
The membranes were blocked for 16 h at 4oC with PBSA (PSB + 1% (w/v) 
BSA) and incubated with ED7 TCS diluted 1 in 2 with PBSA (PBS + 0.5% (w/v) 
BSA) for 2 h at 23oC. After washing three times with PBS, membranes were 
incubated for 1 h with goat anti-mouse IgM (μ - chain specific) alkaline 
phosphatase conjugate (A-9688; Sigma), diluted 1 in 15,000 in PBSA. After the 
membranes were washed twice with PBS and once with PBST, the bound 
antibodies were visualised by incubation in BCIP/NBT substrate solution. 
Reactions were stopped by immersion in MQ-H2O and air-dried between sheets 
of Whatman filter paper.  
 
 
2.2.8.2 Characterization of Antigen by Enzymatic and Chemical 
Modifications and by Heating 
Water-soluble antigens from surface washings of slopes of F. solani 
(CBS224.34) were prepared as described. Heat stability studies were 
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conducted by placing tubes of solubilized antigen in a boiling water bath.  
At 10 min intervals, samples were removed, centrifuged at 14,462 g for 5 min, 
and antigens immobilized to the wells of microtitre plates for assay by ELISA as 
described. For periodate oxidation, microtitre wells containing immobilized 
antigens from surface washings of the fungus were incubated with 50 µl of 
sodium meta-periodate solution (20 mM NaIO4 in 50 mM sodium acetate buffer 
[pH4.5]) or acetate buffer only (control) at 4°C in sealed plastic bags, for time 
course (0, 5, 10 15, 20 hrs). Plates were given four 3-min PBS washes before 
processing by ELISA as described. For protease digestions, microtitre wells 
containing immobilized antigen were incubated with 50 µl of pronase (protease 
XIV; 0.9 mg ml−1 in PBS) or trypsin (1 mg ml−1 in MQ-H2O) solution or MQ-H2O 
or PBS only controls respectively for 4 h at 37°C or 4°C. Plates were given four 
3-min rinses with PBS and then assayed by ELISA with ED7 TCS as described. 
 
 
2.2.8.3 Immunofluorescence and Immunogold Electron Microscopy 
For immunofluorescence (IF), sterilised slides were coated with a washed spore 
suspensions of F. solani (CBS224.34) containing 1% (w/v) glucose solution and 
incubated at 27°C for 16 h to allow spore germination and formation of germ 
tubes. After air-drying, the cells were fixed to the slides as described in 
(Thornton, 2001) and incubated with ED7 TCS or TCM only (negative control) 
for 1 h, followed by three 5 min PBS washes. Slides were then incubated with 
goat anti-mouse polyvalent fluorescein isothiocyanate (FITC) conjugate (diluted 
1 in 40 in PBS) (F1010; Sigma) for 30 min. Slides were given three 5 min 
washes with PBS and mounted in PBS-glycerol mounting medium (F4680; 
Sigma) beforeoverlaying with coverslips. All incubation steps were performed  
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at 23°C in a humid environment to prevent evaporation and slides were stored 
in the dark, at 4°C, prior to examination using an epifluorescence microscope 
(Olympus IX81) fitted with 495 nm (excitation) and 518 nm (emission) filters for 
FITC. For immunogold electron microscopy (IEM) the method described in 
(Thornton & Talbot, 2006) was used. Spores and hyphae of F. solani were 
prepared by incubating washed conidia in 1% (w/v) glucose solution at 27°C for 
16 h to allow spore germination and formation of germ tubes. Cells were 
embedded in LR White resin (Agar Scientific Ltd.) and ultra-thin sections 
prepared for immunolabeling. Sections immobilized to nickel grids were blocked 
by immersion in PBST containing 1% (w/v) BSA (PBST-BSA) which had been 
sterile filtered through a 0.2 μm filter. The grids were washed three times  
(3 min each) in sterile filtered PBST and then incubated in ED7 TCS or TCM 
only (negative control) for 1 h. After four washes (3 min each) with sterile filtered 
PBST, the grids were incubated for a further hour in PBST-BSA containing  
a 1:20 dilution of goat anti-mouse 20 nm gold conjugate (EM GAF20; BBI 
Solutions). The grids were washed four times (3 min each) in sterile filtered 
PBST and then placed on Whatman filter paper to dry. Dried grids were then 
incubated for 20 min in 2% (w/v) uranyl acetate solution followed by 2% (w/v) 
lead citrate solution for 4 min. Working volumes were 100 μl and incubation, 
and washing steps were carried out at 23oC. Immunostained samples were 
examined using a Jeol JEM 1400 transmission electron microscope fitted with  
a Gatan ES 100W CCD camera.  
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2.2.9 Spore Agglutination Assay 
Preliminary investigations showed that mAb ED7 was able to agglutinate spores 
of Fusarium. To study this phenomenon further, a light absorbance assay was 
developed to enable quantification of the agglutination process.  To investigate 
the wavelength at which spores of Fusarium spores absorb light, washed 
spores of F. solani (CBS224.34) were re-suspended at a final concentration of 
106 ml-1 in plastic cuvettes (Greiner Bio-one 613101) using either mAb ED7 TCS 
or 10% TCM only. Absorbance of spore suspensions was determined across  
a range of wavelengths from 290 nm to 610 nm, using a Janeway 7300 
spectrophotometer (Bibby Scientific Limited, UK). The maximum absorbance of 
light for spores suspended in TCM (non-agglutinating condition) was found to 
be 555 nm, and so this wavelength was used for all subsequent Fusarium spore 
agglutination assays. The light absorbance of spore suspensions was recorded 
every 5 min, following suspension in TCM or in mAb ED7 TCS (agglutinating 
conditions) up to 110 to 300 min depends on agglutination status compare with 










2.3.1 Production of Hybridoma Cell Lines, Isotyping of monoclonal  
Antibody and Specificity 
A single fusion was performed, and 389 hybridoma cell lines were screened for 
specificity against a range of clinically relevant yeasts and moulds (Table 2.1). 
The aim was to identify cell lines secreting mAbs specific to Fusarium that could 
be used to track the fungus in environmental samples containing mixed species 
of human pathogenic fungi. To this end, a single cell line, ED7, was identified 
that produced mAb belonging to the immunoglobulin class M (IgM), which  
was genus-specific, reacting in ELISA tests with antigens from Fusarium 
species and with the F. solani teleomorph Haematonectria haematococca only  
(Figure 2.1 A and B). It did not cross-react with antigens from a wide range of 
unrelated mould and yeast species (Figure 2.1 A).  
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Figure 2.1. Specificity of mAb ED7 determined by ELISA tests of surface 
washings containing water-soluble antigens from Fusarium species and related 
and unrelated yeasts and moulds. (A) ELISA absorbance values at 450 nm for 
antigens from F. solani and unrelated yeasts and moulds and (B) for antigens 
from the F. solani teleomorph Haematonectria haematococca and related 
Fusarium species. Wells were coated with 60 g protein ml-1 buffer. Bars are 
the means of three biological replicates ± standard errors and the threshold 
absorbance value for detection of antigen in ELISA is ≥ 0.100 (indicated by lines 
on graphs). Numbers in parentheses after species names denote strain 
numbers with further details of strains provided in Table 2.1. 
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2.3.2 Western Blotting and Antigen Characterization    
Gel electrophoresis and Western blotting studies showed that ED7 binds  
to a major antigen with a molecular weight of ~200 kDa which is secreted 
extracellularly by both F. solani and F. oxysporum (Figure 2.2). F. solani 
antigens were subjected to enzymatic (Figure 2.3 A and B), heat (Figure 2.3 
C) and chemical (Figure 2.4) modifications to characterize the epitope bound 
by ED7. The lack of reduction in ED7 binding following digestion of immobilized 
antigen with trypsin (Figure 2.3 A) and pronase (Figure 2.3 B) shows that  
it does not bind to a protein epitope. There was no significant decrease in ED7 
binding over 70 min of heating, demonstrating that its epitope is heat stable 
(Figure 2.3 C). Reductions in mAb binding following chemical digestion of an 
antigen with periodate oxidation show that its epitope is carbohydrate and 
























Figure 2. 2. Western immunoblot with ED7 using culture fluid from 2-d-old PDB 
cultures of F. solani (CBS224.34) (Lane 1) and F. oxysporum f.sp. lycopersici 
(CBS167.30) (Lane 2). Wells were loaded with 1.6 µg of protein. Mr denotes 
molecular weight in kDa. Note the major extracellular antigen with a molecular 














Figure 2. 3. Characterization of antigens bound by mAb ED7. Absorbance 
values from ELISA tests with ED7 using surface washings containing water-
soluble antigens immobilized to the wells of microtitre plates and treated with 
(A): trypsin, (B): pronase or PBS only (control) at 4oC and 37oC, and (C): 
Stability of the water-soluble ED7 antigen following heating of surface washings 
at 100 oC over a 70 min period. Treated antigen was subsequently immobilized 
to the wells of microtitre plates and assayed by ELISA. Bars are the means of 
three biological replicates ± SE and bars with the same letter are not 
significantly different at p < 0.001 (ANOVA and Tukey-Kramer test).  









Figure 2. 4. Absorbance values from ELISA tests with ED7 using surface 
washings containing water-soluble antigens immobilized to the wells of 
microtitre plates and treated with periodate (open circles) or with acetate only 
control (closed circles) at 4oC over a 20 h period. Each point is the mean of 
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2.3.3 Immunofluorescence and Immunogold Electron Microscopy  
Immuno-localisation studies using IF showed that the ED7 antigen was present 
on the surface of spores and hyphae (Figure 2.5 A to D), while IEM showed 
that the antigen was present in the spore and hyphal cell wall in an extracellular 







    
     
 





Figure 2. 5.  Photomicrographs of F. solani (CBS224.34) cells, immunostained 
with mAb ED (A, B) or TCM only (C, D) and anti-mouse polyvalent Ig 
fluorescein isothiocyanate. (A) Bright field image of germinated conidium with 
hypha; (B) Same field of view as panel A but examined under epifluorescence. 
Note the intense staining of the hyphal and conidium cell wall. (C) Bright field 
image of germinated conidium with hypha. (D) Same field of view as panel (C) 
but examined under epifluorescence. Scale bar = 8 µm.  
 
 






















Figure 2. 6. Immunogold labelling of sections of conidia and hyphae of F. solani 
(CBS224.34). (A) Transverse section of conidium incubated with ED7 and  
anti-mouse immunoglobulin 20 nm gold particles, showing antigen in the cell 
wall in an extracellular fibrial matrix surrounding the spore (Scale bar = 250 
nm); (B) Longitudinal section of hypha incubated with ED7 and anti-mouse 
immunoglobulin 20 nm gold particles, showing antigen in the cell wall and in an 
extracellular matrix surrounding the cell (scale bar = 100 nm); (C) Transverse 
section of a conidium incubated with TCM (negative control) and anti-mouse 
immunoglobulin 20 nm gold particles, showing a lack of staining by the 
secondary gold conjugate. Scale bar = 180 nm. 
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2.3.4 Spore Agglutination Assays 
A peak in light absorbance (absorbance value of 0.20) with F. solani 
(CBS224.34) microconidia suspended in 10% TCM was found at 555 nm, while 
the lowest absorbance (absorbance value of 0.048) was recorded at 340 nm 
(Figure 2.7). Using the wavelength of 555 nm, agglutination of Fusarium spores 
with mAb ED7 was investigated. The result shows that the microconidia of 
Fusarium species suspended in mAb ED7 have two agglutinations and not 
agglutination trends behaviour as shown in Table 2.2 and Appendix 1. Spores 
of F. solani (CBS224.34) and F. dimerum var. dimerum (CBS108944)  were 
represented the agglutination trend in mAb ED7 with rapid decreases in 
absorbance values when compared to the TCM only control (Figure 2.8 and 
Appendix 1). In contrast, spores of F. equiseti (CBS185.34) and F. solani 
(CBS119.223) were represented not agglutinated species by mAb ED7  



















Figure 2. 7. Absorbance of light at different wavelengths by non-agglutinated  
F. solani (CBS224.34) microconidia suspended in 10% TCM at 106 spore ml-1. 
Each point is the mean of 3 replicates ± S.E. Note peak absorbance of spores 
at 555nm. This wavelength was therefore chosen for subsequent agglutination 






















Figure 2. 8. Agglutination of Fusarium species microconidia. (A) F. solani 
(CBS224.34) and (B) F. dimerum var. dimerum (CBS108944), spores 
suspended at 106 spores/ml in ED7 TCS and 10% TCM. Each point is the mean 
of 3 replicates ± S.E. Note rapid decrease in absorbance of light at 555 nm due 
















Figure 2. 9. Agglutination of Fusarium species microconidia. (A) F.  equiseti 
(CBS185.34) and (B) F. solani (CBS119.223) spores in ED7 TCS and 
10%TCM. Each point is the mean of 3 replicates ± S.E. Note lack of 
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Table 2.2. Agglutination trend of Fusarium species microconidia suspended  






F. solani (CBS224.34) 
F. proliferatum var. 
proliferatum (CBS181.30) 
F. chlamydosporium  
var. chlamydosporium 
(CBS491.77) 
F. dimerum var. dimerum 
(CBS108944) 
F. nygami (CBS140.93) 
F.  equiseti 
(CBS185.34) 
F. sacchari (CBS183.32) 
F. oxysporum f.sp. 
radicis-lycopersici 
(CBS872.95) 
F. solani (CBS119.223) 
F. verticilliodes (CBS102.699) 
F. oxysporum f.sp. 
lycopersici (CBS167.30) 
F. oxysporum f.sp. 
cucurbitacearum 
(CBS254.52) 





F. solani var. petroliphilum 
(CBS102256) 
- F. solani (CBS115.659) 
F. anthophilum (CBS222.76) - - 
F. solani (CBS188.34) - - 
F. solani (CBS117.608) - - 
F. solani (CBS109.696) - - 
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2.4 Discussion 
Monoclonal antibodies are highly specific and can be generated and mass-
produced using hybridoma technology. This characteristic feature makes them 
ideal for several applications, including disease diagnosis, as therapeutic 
agents and as reagents for a variety of scientific research applications (Li et al., 
2010; Modjtahedi et al., 2012; Morgan & Levinsky, 1985). 
 
While mAbs have been developed for detecting and differentiating plant 
pathogenic Fusarium species (Arie et al., 1995, 1991; Banks et al., 1996; 
Hayashi et al., 1998; Hu et al., 2012, 2013; Wong et al., 1988), few attempts 
have been made to develop mAbs for the detection of human pathogenic 
species. Nevertheless, Jensen et al. (2011) recently reported the development 
of Fusarium-specific mAbs for immunohistochemical diagnosis of fusariosis.  
 
The IgM mAbs, which recognise 51 and 63 kDa antigens, reacted strongly with 
fungal elements in both experimentally infected animals and biopsy samples 
from patients with fusariosis. The aim of this study was to use hybridoma 
technology to develop Fusarium-specific mAbs for use in tracking human 
pathogenic species during interactions with cells of the immune system 
(Chapter 3) and during environmental studies (Chapter 4). Here, Hybridoma 
technology was used to generate a mAb against immunogenic antigens from 
surface washings prepared from F. solani, which is one of the most frequent 
etiologic agents of systemic fusariosis infections in humans.  
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There were two specific aims required to fulfil this objective. The first was the 
development of a mAb specific to the genus Fusarium. It was important that this 
mAb lacked cross-reactivity with other related and unrelated pathogenic 
filamentous fungi and yeasts involved in disseminated mycosis, such as 
Aspergillus (Thornton, 2010a), Candida (Marcio Nucci & Marr, 2005), 
Scedosporium (Thornton et al., 2015), P. boydii (Thornton, 2009), Trichosporon 
(Davies & Thornton, 2014b), Rhizopus, Mucor, and Rhizomucor (Kauffman, 
2004).  
 
Because immunogenic antigens such polysaccharides and proteins can be 
secreted in blood and other body fluids during invasive infections (Thornton, 
2008), the second specific aim was to produce a mAb against an extracellular 
antigen and to investigate its suitability as a diagnostic target for pathogen 
detection. Using hybridoma technology, murine mAb ED7 was raised against 
surface antigens from a human pathogenic strain of F. solani (strain CBS 
224.34).  
 
Using ELISA tests, it was shown that mAb ED7 is genus-specific, reacting with  
a wide range of species within the genus including the most frequent causes of 
human fusariosis F. solani and F. oxysporum. Importantly, it does not cross-
react with unrelated opportunistic fungal pathogens,  including yeasts and 
moulds in the genera Aspergillus (Thornton & Wills, 2015), Candida, 
Geotrichum, Rhodotorula and Trichosporon (Davies & Thornton, 2014; Miceli et 
al., 2011), Cyphellophora and Phialophora (Feng et al., 2014), Exophiala (Zeng 
et al., 2007), Trichoderma (Sandoval-Denis et al., 2014), Engyodontium 
(Macêdo et al., 2007; Thamke et al., 2015) and Mucor (Petrikkos et al., 2012).  
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The genus specificity of mAb ED7 and the identification of its target antigen 
(through heat, chemical and enzymatic modification) as a heat-stable 
carbohydrate makes it an ideal partnership for tracking pathogenic strains of 
Fusarium in humans and the natural environment. Heat-stable carbohydrate 
antigens have been used successfully as diagnostic targets for mAb-based 
detection during human and animal infection (Wiederhold et al., 2013; Rolle  
et al., 2016) and in environmental monitoring studies (Thornton, 2009; Sharpe 
et al., 2016). 
 
Immunofluorescence and immunogold electron microscopy showed that the 
antigen bound by the mAb ED7 is located in the outer cell wall of hyphae and 
spores in a microfibrillar matrix that surrounds microconidia. The extracellular 
microfibrillar matrix of F. solani spores was first reported in 1975 (Tewari & 
Skoropad, 1975). It was the first immunological study conducted to investigate a 
matrix-associated antigen in Fusarium species. A putative 90 kDa glycoprotein 
is thought to be associated with the adhesive properties of macroconidia of the 
plant pathogen Haematonectria haematococca (the teleomorph stage of  
F. solani) (Kwon & Epstein, 1993), but adhesion negative strains (Att) of the 
fungus also produce the 90 kDa antigen. Furthermore, Att strains produce  
a conidial tip mucilage, suggesting that the 90 kDa glycoprotein is not the only 
molecule involved in adhesion (Schuerger & Mitchell, 1993). In a subsequent 
study, Hayashi and co-workers (Hayashi et al., 1998) showed that a mAb  
(API9-2),  raised against a F. oxysporum hyphal antigen, can recognise the 
antigenic carbohydrate, mannan, with a molecular weight of ~55 kDa. From the 
characterization work conducted here, I have shown that the antigen bound by 
mAb ED7 is an immunodominant, heat-stable, carbohydrate. Western blotting 
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studies demonstrated that the antigen is extracellular and has a molecular 
weight of ~200 kDa, indicating that the antigen recognised by mAb ED7 may be 
a novel high molecular weight antigenic structure. Agglutination by the mAb 
shows that it binds to a previously uncharacterized component on the spore 
surface and may be associated with the spore agglutination process described 
previously. 
 
Previous studies have investigated the process of spore adhesion and 
agglutination prior to germination. The process of spore adhesion occurs 
naturally prior to spore germination in F. solani and is thought to be essential to 
successful plant infection by the fungus. It has been shown that ungerminated 
conidia agglutinate during attachment to host roots, before spore mucilage is 
produced and prior to spore germination. Consequently, adhesion and 
agglutination allow the macroconidia to come into contact with the host root 
after which germination and infection occur (Schuerger & Mitchell, 1993).  
A similar process is believed to occur in H. haematococca. Host nutrients 
stimulate spores to become adhesion competent, allowing macroconidia to 
adhere and agglutinate at their apices during host tissue attachment (Epstein & 
Nicholson, 2006; Jones & Epstein, 1990).   
 
The process of mAb ED7 agglutination was investigated with a strain  
of F. solani whose spore production is dominated by microconidia. The 
agglutinating activity of mAb ED7 was not universal, with certain Fusarium 
species, and even strains of F. solani, failing to agglutinate with the antibody. 
This is consistent with previous studies that have shown that strains of F. solani 
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differ in spore adhesion and agglutination properties (Epstein & Nicholson, 
2006).  
 
Similar to other fungal pathogens (Tucker & Talbot, 2001), the initial stages of 
Fusarium infection include spore adhesion, germination, and hyphal network 
establishment, followed by penetration of the host cells (Stephens et al., 2008). 
The lack of spore adhesion by mAb ED7 in certain isolates of the fungus 
warrants further investigations of the spatio-temporal expression of the antigen 
in agglutinating and non-agglutinating strains of the pathogen. 
 
 
Summary of Key Findings: 
1. A single B-cell line, ED7, produces mAb belonging to the IgM class, 
which is genus-specific, Fusarium-specific, reacting with antigens from 
Fusarium species and it does not cross-react with antigens from a wide 
range of unrelated mould and yeast species.  
2. The mAb ED7 binds to an antigen with a molecular weight of ~200 kDa. 
The antigen epitope is a carbohydrate contains vicinal hydroxyl groups, 
not protein and a heat. 
3. The ED7 antigen is located in an extracellular microfibrillar matrix in the 
outer cell wall surrounding both the of hyphae and spores. 
4. The Fusarium species microconidia suspended in mAb ED7 have two 
agglutinations and non-agglutination trends at wavelength of 555 nm. 
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Chapter 3. Alveolar Macrophage Phagocytosis and Killing of  
F. solani Expressing Green Fluorescent Protein (GFP) 
 
3.1 Introduction 
Fusarium species are emerging as lethal human pathogens and constitute an 
important cause of morbidity and mortality, particularly in severely 
immunocompromised patients. The number of systemic Fusarium infections in 
humans has increased since the mid-1970s (Cho et al., 1973). This upward 
trend has coincided with an expanding  population of immune impaired patients, 
including neutropenic patients with haematological malignancies, recipients  
of haematopoietic stem cell transplants (HSCTs) or SOTs, patients with 
diabetes, AIDS patients, and those having toxic chemotherapy or radiotherapy 
treatments (Dignani & Anaissie, 2004; Guarro et al., 2000; O’Donnell et al., 
2007; Walsh et al., 2004; Zhang et al., 2006). F. solani is the most frequently 
reported species, involved in approximately 50% of fusariosis cases, and 
followed by F. oxysporum and F. verticillioides (Jain et al., 2011; Marcio Nucci & 
Anaissie, 2007). 
 
Fusarium infections can be superficial, local or disseminated (Marcio Nucci & 
Anaissie, 2002). In addition to producing allergens and many types of 
mycotoxins (that cause respiratory infections and organ damage) (Li et al., 
2011), deaths due to invasive fusariosis are being increasingly reported due, in 
part, to inherent resistance to many of the antifungal drugs that are currently 
available for clinical treatment (Azor et al., 2007; Tortorano et al., 2014). 
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Diagnosis of disseminated fusariosis is also a big challenge. Morphological 
identification using traditional microscopic and cultural base methods can lead 
to misdiagnosis, especially in the absence of macroconidia that are 
characteristic of some Fusarium species. These methods are time-consuming 
and required extensive knowledge of mycology (Alexander & Pfaller, 2006). 
Additionally, recent studies have shown serodiagnostic tests, such as GM and 
BDG tests, are not especially effective for diagnosing Fusarium infections 
(Esnakula et al., 2013). 
 
 
3.1.1 Immunity to Fungal Infections 
The skin is the first physical barrier of the innate immune system and is critical 
in isolating the sterile internal tissues from the external environment. This 
physical barrier prevents fungal invasion and provides an initial immunity to 
fungi such as Fusarium. Fungal propagules have to adhere and penetrate 
epithelial tissue under the skin or mucous membranes, to develop into deep-
seated infections and that can lead to tissue damage (Williams et al., 2012). As 
a result of tissue damage, broad-spectrum antimicrobial peptides (AMPs), such 
as defensins, cathelicidins and collectins, are secreted by epithelial cells to 
eliminate fungal infections. AMPs play an integral role in host defence by 
destroying fungal cells directly through binding to the cell membrane or cell wall 
carbohydrates, or indirectly via activation and recruitment of innate immune 
phagocytic cells (Kolar et al., 2013; McDermott, 2009). Cellular innate immunity 
includes residential macrophages and circulated neutrophils. These cells are 
involved in the innate immune host defence and are considered a core immune 
response to fungal invasions (Bain et al., 2014; Grazziutti et al., 2005). PRRs on 
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phagocytic cells are able to recognise effectively a variety of polysaccharide 
antigens found on the fungal cell wall. These antigens are known as PAMPs. 
Common examples include -glucan and mannan (Figueiredo et al., 2011; 
McCann et al., 2005). After antigen recognition, AMØ are associated with the 
clearance of Fusarium propagules via phagocytosis (Brakhage et al., 2010; 
Roilides et al., 2006; Walsh & Groll, 1999). Macrophages and neutrophils can 
damage Fusarium hyphae by producing Interferon gamma (IFNγ), granulocyte-
colony stimulating factor (G-CSF) and granulocyte-macrophage-colony-
stimulating factor (GM-CSF) (Gaviria et al., 1999).  
 
TLRs expressed on the surface of phagocytic cells bind to β-glucan and 
mannose, and play a crucial role in the recognition of Fusarium cell wall 
components. These receptors mediate the phagocytosis process and stimulate 
the adaptive immune response (Gordon & Read, 2002; Guo et al., 2008; Jin  
et al., 2007; Shoham & Levitz, 2005; Tarabishy et al., 2008). Furthermore, these 
receptors cooperate in a complex network to activate the production of 
cytokines and chemokines, including tumour necrosis factor (TNF), interleukins 
(IL-1, IL-1, IL-6) and macrophage inflammatory proteins (MIP-2 and 1) to 
attract other innate phagocytic cells to the site of invasion (Abbas et al., 2007). 
Recent studies have shown a novel way of neutrophil-mediated killing of 
pathogenic bacteria, via the release of extracellular networks (NETs) 
(Brinkmann et al., 2004). Since then, subsequent studies have revealed the 
effector role of NETs in trapping pathogenic fungi and eliminating infections, 
such as Aspergillus fumigatus (Bruns et al., 2010), and Candida albicans 
(Branzk et al., 2014) infections. This unique phenomenon has also been 
reported in macrophages as an initial process for host defence, resulting in 
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microorganism clearance and destruction via the release of macrophage 
extracellular traps (METs). MET formation is induced by microbial cell invasion, 
such as by Mannheimia haemolytica (Aulik et al., 2012; Hellenbrand et al., 
2013) and Candida albicans (Liu et al., 2014). The MET is a structure of nuclear 
DNA fibres supported with active proteins. This trap has fungistatic and 
fungicidal affectivity to prevents fungal dissemination, and may recruit other 
phagocytic cells to the infection site (Aulik et al., 2012, Guimarães-Costa et al., 
2012, Brakhage et al., 2010).  
 
In healthy individuals, innate immune responses can detect and clear most 
fungal invaders within a short time (Blanco & Garcia, 2008). However, 
disseminated Fusarium infections often occur in immunocompromised patients 
and these patients have defective or completely lack an innate immune 
response, often due to having immunosuppressive therapy (Abbas et al., 2007; 
Jain et al., 2011; Nucci & Anaissie, 2007; Roilides et al., 2006). 
 
 
3.1.2 GFP Transformation 
GFP isolated from the luminescent jellyfish, Aequorea victoria, absorbs blue 
light, and then re-emits it as green fluorescence. This characteristic feature has 
been used to monitor microbial cells via gene expression, without affecting 
natural microbial behaviour (Chalfie et al., 1994). This technique has also been 
used as a reporter for macromolecular localization in bacterial cells (Margolin, 
2000). Furthermore, a synthetic GFP method has been successfully used as  
a reporter gene expression tool, for transformant cell isolation and cellular gene 
expression quantification. This has allowed the study of host-fungal pathogen 
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interactions and the assessment fungal or yeast biomass (Cormack et al., 1997; 
Lorang et al., 2001). In addition, GFP techniques have been used for yeast cell 
quantitative analysis (Barelle et al., 2004) and have been applied to many 
filamentous fungi for monitoring growth, behaviour in different environments, 
and to study fungal pathogenicity and assess antifungal activity (Bae & 
Knudsen, 2000; Knudsen & Dandurand, 2014; Spellig et al., 1996). 
 
Studies have shown the application of GFP techniques to quantitatively 
investigate fungi and follow the plant infection processes  of a number of 
Fusarium plant pathogens, including F. oxysporum (Inoue et al., 2002; 
Lagopodi et al., 2002; Zhang et al., 2013), F. equiseti (Maciá-Vicente et al., 
2009), F. graminearum (Skadsen & Hohn, 2004) and F. verticillioides (Oren et 
al., 2003). Additionally, transformation with GFP is considered to be  
an appropriate tool for studying the phagocytic cell response of the cellular 
innate immune system against fungal pathogen invasion in vitro. Expression of 
GFP facilitates fungal propagule visualisation, allowing the assessment of the 
efficiency of pathogenic fungal cell internalisation and clearance. This method 
has been used for both Aspergillus (Wasylnka & Moore, 2002) and Candida 
(Katragkou et al., 2010) species. To the best of my knowledge, no studies have 
been undertaken to transform F. solani with GFP or to use it to track F. solani 
during phagocytosis by AMØ. 
 
 
3.1.3 Aims and objectives 
Presently, very little is known about the cellular innate immune response to 
human pathogenic Fusarium species, particularly F. solani. AMØs and the 
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phagocytic processes of engulfment and destruction are important topics that 
are under-studied (Gaviria et al., 1999a; Schäfer et al., 2014). Recognition of 
PAMPs present in the pathogen cell wall, via PRRs on the phagocytic cell 
membrane, is the initial step for engulfment and pathogen clearance (Brown, 
2011; Luigina Romani, 2011). Some studies have been conducted to identify 
immunodominant epitopes on surface antigens of pathogenic fungi and to follow  
antigen production during the activation of the phagocytic cells of the innate 
immune system (Figueiredo et al., 2011; Karthikeyan et al., 2011; Tarabishy  
et al., 2008). Identification of the molecular form of the antigenic structures of 
the fungal spore cell wall is incompletely defined. Knowledge of these 
immunodominant molecules is required to understand their role in inducing pro-
inflammatory cytokine and chemokine responses through host cell receptor 
binding. Identification and characterization of fungal cell wall antigenic epitopes 
that evoke immune response might lead to their use as vaccines to immunise 
human patients against fungal infections (Levitz et al., 2014). They may also 
drive novel therapeutic approaches to prevent or control opportunistic fungal 
infections, such as F. solani.  
 
The overall aim of the work in this chapter was to investigate the innate immune 
response to F. solani spores by studying phagocytosis of conidia by mouse 
AMØs. No studies examining the phagocytic clearance of F. solani by AMØs 
have been conducted and there is an apparent need to evaluate innate immune 
cell responses to this emerging opportunistic pathogen since it is the most 
frequent Fusarium species causing life-threating disease among 
immunocompromised patients. To achieve this aim, the following objectives 
were identified:  
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1.Generation of a F. solani strain expressing GFP to enable the interaction of 
spores with AMØ to be visualised; To develop a live-cell imaging system, to 
allow the phagocytosis of F. solani spores by AMØ to be investigated in real-
time; To determine the effect of spore agglutination by mAb ED7 in the 
phagocytic process.Current techniques to quantify fungal biomass, based on 
measurements of metabolic activity (Wallander et al., 2013), do not allow for 
discrimination between the metabolic activities of the fungus and of the 
engulfing phagocytes. Consequently, fungus-specific techniques need to be 
developed to monitor the effects of phagocytosis on fungal proliferation. Here,  
a murine AMØ method was developed that allows the monitoring and 
quantification of F. solani germination and hyphal development during 
phagocytosis in the presence and absence or the spore-agglutinating mAb 
ED7. This novel approach allowed the quantitative determination of 
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3.2 Materials and Methods 
 
3.2.1 Fungal Transformation with GFP 
3.2.1.1 Protoplast preparation 
F. solani (CBS224.34) conidia were harvested from 7-day old PDA plates after 
flooding with 5 ml SMQ-H2O, conidia suspension was filtered through Miracloth 
then washed three times with SMQ-H2O. Washed conidia were suspended in  
20 ml of PDB media and incubated in Petri dishes at a concentration of  
106 spore ml-1. Plates were incubated at for 48 h at 27C, the mycelium 
collected by filtering through sterile Miracloth (Calbiochem), rinsed with SMQ-
H2O and dried with paper towel. 
 
Fungal protoplasts were prepared by re-suspending 0.3 g of fresh and washed 
mycelium in filter-sterilized enzyme solution (1.2 mg chitinase (Sigma), 7 mg 
lyticase (Sigma), 44 mg cellulase (Sigma), in 2.4 ml of mannitol osmoticum  
(5 ml 1M CaCl2, 9.11 g mannitol, 1.06 g MES [2-(N- Morpholino) ethanesulfonic 
acid hydrate], 95 ml dH2O, pH adjusted to 5.5 with KOH) in a 15-ml Falcon tube 
(Becton Dickinson). The suspensions were mixed by shaking at 225 rpm for  
25 min on a flat-bed shaker (New Brunswick Scientific, USA) at RT. Protoplast 
suspensions were filtered through sterile Miracloth, washed with 5 ml of sterile 
osmotic buffer, and then centrifuged at 3,044 g for 5 min at 4C. The protoplast 
pellets were washed twice by centrifugation and re-suspension and were finally 
suspended in 300 μl of sterile osmoticum. The protoplast numbers were 
determined by using a haemocytometer. 
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3.2.1.2 Fungal Transformation 
For F. solani (CBS224.34) protoplast transformation, 300 μl of washed 
protoplasts, at a concentration 107 ml-1, were mixed with 6 μg of the DNA 
plasmid that containing a modified hygromycin resistance gene under the 
control of the Aspergillus nidulans TRPC promoter together with the SGFP gene 
under the control of the Pyrenophora tritici-repentis TOXA gene promoter was 
isolated from pCT74 (was provided kindly by N. Talbot group – Bioscience, the 
University of Exeter, UK) previously suspended in 34 μl of SMQ (Figure 3.1). 
As a negative control, the same concentration of protoplasts was re-suspended 
in osmotic buffer only. Both suspensions were incubated on ice for 20 min, and 
then each tube was treated with 130 μl of polyethylene glycol solution  
(40% PEG 8000 in osmoticum). Next, the tubes were mixed gently by inversion, 
followed by incubation for 30 min at RT. The treated protoplasts were mixed 
gently with cell wall regeneration medium containing molten PDA (42C) and 
2.2 g/ml of hygromycin B (Caliobiochem) as a selective agent, and 0.8% (w/v) 
sucrose), poured into five Petri dishes, and then incubated for 24 h at  
26C in the dark. Putative Fusarium transformants were selected by adding  
a thin overlay of molten PDA, containing hygromycin B at the same 
concentration 2.2 g/ml, on the top of the plates. Single spore isolates of 
putative transformants were produced on PDA-hygromycin plates and 
transferred to PDA slopes for long-term storage. Expression of the GFP protein 
in putative transformants (hereafter referred to as FS-GFP transformants) was 
determined by examining tissue sections under epifluorescence by using an 
Olympus microscope (IX81, Visitron System, GmbH), fitted with a 365 nm UV 
excitation filter and a GFP absorption filter. Bright-field and fluorescence images 
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3.2.1.3 Determination  of GFP protein expression by Enzyme-Linked 
Immunosorbent Assay 
Expression of the GFP protein in fluorescent-positive FS-GFP transformants 
was further established by confirmatory ELISA, using the ELISA protocol 
essentially as described previously (Section 2.2.5). Wells were blocked for 10 
min with 100 μl of blocking solution (1% (w/v) Bovine Serum Albumin (BSA; 
Sigma, A-7030) in PBS, and then incubated for 1 h with 50 μl of the anti-GFP 
mAb class IgG (Ref-11814460001; Roche, Germany) diluted 1:1 at a final 
concentration 0.02 mg/ml in PBS with Tween 20 (PBST; PBS containing 0.05% 
(v/v) Tween-20 (polyoxyethylene-sorbitan monolaurate) Sigma; P7949)). The 
goat anti-mouse polyvalent (Ig classes IgG, IgA, and IgM) peroxidase conjugate 
(A-0412; Sigma Chemical Company, Poole, United Kingdom) was used as 
secondary antibody. Control wells were incubated with PBST only.  
 
 
3.2.2 Morphological studies 
3.2.2.1 Hyphal Growth and Spore Production 
The hyphal growth of wild-type F. solani (FS) and FS-GFP transformants was 
determined by inoculating replicate PDA plates centrally with 5-mm agar plugs 
of inoculum taken from the leading edge of 5-day old fungal cultures. Plates 
were incubated at 27°C, and colony diameters were measured every 4 days for 
12 days. For spore counts, wild-type and GFP transformants plate cultures were 
flooded with 5 ml SMQ H2O and spore concentration determined by using 
haemocytometer at dilution factor 1:500 after 1, 4, 8 and 12 days.  
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3.2.2.2 Quantification of Hyphal Biomass, Antigen Production and Spore 
Agglutination with mAb ED7  
Hyphal biomass and antigen production were quantified on the abundance of 
fungal propagules for the wild type, F. solani (CBS224.34), and FS-GFP 
transformants isolate. Longer-term (21 days) growth experiments were 
constituted by inoculating three replicates of 250 ml flasks containing 100 ml 
PDB with 1 X 103 spore ml-1 of the isolate. Flasks were incubated with shaking 
(New Brunswick Scientific, USA) at 125 rpm for 21 days at 27°C. Culture 
filtrates and hyphal biomass were collected every 3 days by straining the 
contents of the flasks through a sterile Miracloth and transferred into fresh 
Falcon tubes. The dry weights of hyphal biomass were determined in 
milligramme (mg) using scale (Mettler Toledo AB54-5/Facts, Switzerland) after 
drying at 70°C for 16 h. Culture filtrates containing soluble antigens were stored 
at -20°C until used to perform soluble antigens production using ELISA as 
described in (Section 2.2.5). For testing spore agglutination, the protocol 
followed was previously described in (Section 2.2.9). 
 
 
3.2.3 Live Cell Imaging of Spore Agglutination 
F. solani spores were harvested and washed as described previously.  
One hundred-μl of either mAb ED7 (spore agglutinating) TCS, were mixed with  
6 μl of washed spore suspension at a concentration of 106 spore ml-1. Control 
samples received 10% TCM only. The agglutination process was captured with 
an Olympus microscope (IX81, Visitron System, GmbH) and images were 
recorded every 10 sec for 35 min using a Photometrics CoolSNAP HQ2 camera 
(Roper Scientific, Germany). Image sequences were combined using the 
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Metamorph software package (MDS Analytical Technologies, Winnersh, UK). 
Both agglutinated and unagglutinated spores were counted manually in  
5 independent fields of view with three replicates for each mAb ED7 and TCM 
the control, and the percentage of non-agglutinated spores (S%) were plotted 
as bar charts after 30 mins using this formula: 
 
S% = (Number of Single Spores / Total Number of Spore) X 100 
 
 
3.2.4 Murine Alveolar Macrophage cell line MH-S 
3.2.4.1 Details and Culture of Mouse Alveolar Macrophages 
The mouse AMØ cell line MH-S (ATCC CRL-2019) used in this study was 
developed from mouse lung tissues (Mbawuike & Herscowitz, 1989). The AMØ 
cell line was derived by SV40 transformation of an adherent cell-enriched 
population of mouse AMØ and retains properties of AMØ including 
phagocytosis and typical macrophage morphology. The cell line is esterase 
positive and peroxidase negative, Fc receptor positive, expresses the 
complement receptor CD11b (Mac-1), Class II antigens (I-A) and T antigen, and 
produces the pro-inflammatory cytokine interleukin-1. 
 
The AMØ cell line was cultured for 48 h in 25 cm2 tissue culture flasks, 
containing 10 ml of MH-S tissue culture medium (MH-S TCM; RPMI-1640 
medium, 10%(v/v) heat-inactivated fetal bovine serum (ΔFBS; Biosera), 2 mM 
L-glutamine, 0.05 mM 2-mercaptoethanol, and the antibiotics penicillium and 
streptomycin, which was prepared by dissolving 0.3 g penicillin-G (Duchefa 
Biochemie, P0142) and 0.5 g streptomycin sulphate (Melford, S0148) in 5 ml 
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MQ-H2O, followed by filter sterilization through a 0.2 μm filter disc. The cells 
were incubated in a CO2 incubator (San 
 
3.2.4.2 Quantification of Phagocytic Percentage and Phagocytic Index  
of Engulfed Spores 
Spores of FS-GFP transformants were harvested from 5-day old PDA  
Petri-dish cultures by flooding the plates with 5 ml of sterile SMQ-H2O and 
stroking the surface with a sterile L-shaped spreader. Next, suspensions were 
filtered through sterile Miracloth (Calbiochem) to remove fragments of 
mycelium, and the spores were pelleted by centrifugation at 14,489 g for 5 min. 
Spores were washed twice with sterile SMQ-H2O and re-suspended in 1 ml of 
MHS TCM. 
 
AMØ cell concentration was determined with a hemocytometer. Cells were 
diluted to 5 x 105 ml-1 in MH-S TCM-∆FBS and inoculated into 8-well culture  
µ-Slides (ibidi, 80826, Germany) for use in microscopy. Slide cultures were 
incubated for 24 h at 37°C and 5% CO2. Cells received fresh 10% MH-S TCM-
∆FBS containing washed FS-GFP transformant spores at a final concentration 
of 106 spore ml-1. Inoculated slides were incubated for 2, 12 or 24 h, after which 
wells were washed 3 times with sterile, warmed PBS, to remove any un-
engulfed spores. Phagocytosis of FS-GFP transformant spores was quantified 
by counting 100 AMØ cells in each of five random fields of view (x100 
magnification), using an inverted an Olympus epifluorescence microscope 
(IX81, Visitron System, GmbH), fitted with a 365 nm UV excitation filter and  
a 420 nm GFP absorption filter. 
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The phagocytosis percentage (P%) and phagocytosis index (Pi) were then 
determined for each treatment, according to the following formula, where: 
P% is the percentage of cells containing spores, calculated according to the 
formula: 
 
P% = [(B+C+D+E+F) / (A+B+C+D+E+F)] x 100, where: 
A: is the number of cells with no spores.  
B: is the number of cells with 1 spore.  
C: is the number of cells with 2 spores.  
D: is the number of cells with 3 spores.  
E: is the number of cells with 4 spores.  
F: is the number of cells with >5 spores.  
 
Pi is the average number of phagocytosed spores per macrophage, calculated 
according to the formula: 
Pi = (B+2C+3D+4E+5F) / (B+C+D+E+F), where: 
A: is the number of cells with no spores.  
B: is the number of cells with 1 spore.  
C: is the number of cells with 2 spores.  
D: is the number of cells with 3 spores.  
E: is the number of cells with 4 spores.  
F: is the number of cells with >5 spores.  
 
Spores that remained attached to AMØ cells after 3x PBS washes, but had 
been 50% ingested, were considered to have been phagocytosed (Gill-
Lamaignere et al., 2002).  
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3.2.5 Live Cell Imaging of Spore Phagocytosis 
A model for live cell imaging of FS-GFP spore phagocytosis by AMØ  
and evaluation of P% and Pi following agglutination with mAb ED7  
was established using 8-well culture µ-Slides (ibidi, 80826, Germany) as shown 
in Figure 3.2. The slides were modified by creating cross channels between 
well numbers 1 and 2 and 3 and 4 using a heated 1.25 mm syringe needle. This 
allowed media connectivity between the wells. Wells number 1 and 3 were 
inoculated with fresh cultures of AMØ cells in MH-S TCM-∆FBS  
at a concentration of 104 cells ml-1. Washed spores of the FS-GFP transformant 
were re-suspended in MH-S TCM-∆FBS, and the concentration was adjusted to 
104 spore ml-1 prior to phagocyte challenge. A confocal microscope (Zeiss LSM 
510 META), fitted with an environmental chamber heated to 37°C and 5% CO2 
and 488 nm excitation/ emission filters, was used for live cell imaging of spore 
phagocytosis. MH-S TCM-∆FBS bathing the AMØ cells in wells 1 and 3 was 
aspirated and replaced with the MH-S TCM spore suspension. Well numbers 2 
and 4 were then filled with mAb ED7 TCS or TCM-∆FBS only, respectively. 
Images of spore agglutination and phagocytosis by the AMØ cells were then 
captured every 60 sec, for a total of 8 h, with DIC optics (Plan-Apochromat 
63x/1.40 Oil DIC M27), and 488 nm laser excitation.  
 
 
3.2.6 Statistical analysis 
The data was analysed using the statistical programme Minitab (Minitab 
Express, Minitab®, Coventry, UK). Statistical differences between treatments 
and controls were established by t-test or means of one-way analysis of 
variance (ANOVA). Post hoc Tukey-Kramer analysis was then performed to 
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distinguish which groups were significantly different from one another. Results 
of the test had levels of significance indicate: NS = non-significant, and 





Figure 3.2. Schematic diagram showing the experimental system developed for 
real-time imaging of phagocytosis of FS-GFP spores during agglutination with 
the Fusarium-specific mAb ED7. Adherent AMØ cells in wells 1 and 3 were 
challenged with FS-GFP spores, while ED TCS or TCM-∆FBS only was placed 
in wells 2 and 4 respectively. Antibody permeating through the cross channel 
into well 1 allowed the effect of spore agglutination on AMØ phagocytosis to be 








3.3.1 Transformation of F. solani (CBS224.34) with GFP 
F. solani (CBS224.34) produced a typical spherical protoplast as shown  
in Figure 3.3. Putative FS-GFP transformants appeared as white colonies 
under hygromycin selection, compared to no growth of wild-type control 
protoplasts. Under epifluorescence, putative FS-GFP transformants had green 
fluorescent spores and hyphae (Figure 3.4 A to D), when compared to the 
untransformed wild-type strain, which showed no fluorescence (Figure 3.4  
E and F). Stable FS-GFP transformants were obtained following single spore 





Figure 3.3. Selection of hygromycin-resistant FS-GFP strains following the 
transformation of F. solani protoplasts. Typical F. solani protoplast. Scale bars  
= 10 µm. 





Figure 3.4. Green fluorescent protein expression in a stable FS-GFP 
transformant, following single spore isolation and several rounds of  
sub-culturing onto PDA without hygromycin selection. (A) Brightfield image of 
ungerminated and germinated spore with germ tube. (B) The same image as 
(A), but examined under epifluorescence. (C) Brightfield image of spores. (D) 
The same image as (C), but examined under epifluorescence. (E) Brightfield 
image of control wild-type F. solani (CBS224.34) spores and germlings. (F) The 
same image as (E), but examined under epifluorescence. Note the lack of 
fluorescence of wild-type propagules. The magnification for panel A and B is 
x60 and x100 for the rest panels. Scale bars = 10 μm. 
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3.3.2 Detection of GFP Expression in FS-GFP Transformants by 
Using ELISA  
Expression of GFP in fluorescent FS-GFP transformants was confirmed by 
ELISA tests using anti-GFP antiserum. The ELISA absorbance values  
at 450 nm of antigens extracted from cultures of the FS-GFP strain compare 
with the wild-type are shown in (Figure 3.5). The absorbance value for the 
transformants (A450 1.87) is significantly greater than the control strain  
(A450 0.183) when analysed using the Student’s t-test (p <0.01). The ELISA 




Figure 3.5. Absorbance values from ELISA tests of a stable fluorescent  
FS-GFP transformant and the wild-type strain (CBS224.34). Each bar is the 
mean of 3 replicate samples ± S.E. The level of significance indicates:  
*** < 0.001. Scale bars = 20 m. 
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3.3.3 Phenotypic Analysis of FS-GFP Transformant and Wild-type 
Strain 
 Linear growth of the FS-GFP transformant and F. solani (CBS224.34) was 
determined by measuring colony diameters over a 12-day period (Figure 3.6). 
Three replicate culture plates for both strains were scanned daily with an Epson 
Perfection V750 Pro scanner. The results showed that colony diameters were 
similar for both strains with no significant differences over the experimental 
period (p >0.05) (Figure 3.7 A). The FS-GFP transformant had a significantly 
reduced spore concentration compared to the wild-type strain when grown 






















Figure 3.6. Colony morphologies of wild-type F. solani (CBS224.34) and the 
stable FS-GFP transformant when grown on PDA over a 12-day period. The 
two strains have similar morphologies, showing that transformation with GFP 
has had no discernible effect on gross morphology. 
 








Figure 3.7. Time course of wild-type F. solani (CSB224.34) and putative GFP 
strain over 12 days growth on PDA. (A) colony diameters (mm), the chart shows 
the similarity in linear growth of both the wild-type and FS-GFP strain. (B) spore 
production, note a decrease in spore production by the FS-GFP strain. Each 
point is the mean of 3 replicates ± S.E. The levels of significance indicate:  
NS= non-significant, * < 0.05, *** < 0.001. 
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3.3.4  Antigen Production, Biomass Accumulation and Spore 
Agglutination  
 Antigen production (determine by ELISA) by the FS-GFP transformant did not 
differ significantly to the wild-type strain during the 21 days sampling period  
(p >0.05) (Figure 3.8 A). However, biomass accumulation of the FS-GFP 
transformant was significantly reduced in PDB cultures compared to the wild-
type strain F. solani (CBS224.34) at (p <0.05) (Figure 3.8 B). MAb ED7 
strongly agglutinated spores from both the wild-type F. solani strain 
(CBS224.34) (Figure 3.9 A) and the FS-GFP transformant (Figure 3.9 B), 
compared to the TCM control. This shows that transformation of the fungus with 





























Figure 3.8. (A) Antigen production by the wild-type strain and FS-GFP 
transformant determined by ELISA over the same time period. (B) Biomass 
accumulation of F. solani (CBS224.34) and the FS-GFP transformant during  















Figure 3.9. Agglutination of wild-type F. solani (CBS 224.34) spores (A) and 
spores of the FS-GFP transformant (B) by mAb ED7. Note the rapid decline in 
absorbance for both strains in the presence of the antibody, but the lack of 
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3.3.5 Live Cell Imaging of Spore Agglutination  
Live cell imaging showed that F. solani (CBS224.34) spores agglutinated within 
5 min of re-suspension in mAb ED7 (Figure 3.10 A). Agglutination was not 
exhibited in TCM (Figure 3.10 B). Movies demonstrating the agglutination 
phenomenon over 30 min are archived at 35 mins. Single spores were 
quantified manually using Patina software version 1.0.1 (Atek, Inc., Patina 
























Figure 3.10. Agglutination of F. solani (CBS224.34) spores in TCS of mAb ED7 
(A) and TCM only (B) over a 30 min sampling period. Note agglutination with 
mAb ED7, but the lack of agglutination with TCM. Scale bars = 10 μm. (C) 
Quantification of the agglutination process. The percentage of non-agglutinated 
spores were calculated from 7 fields of view at each time point, three biological 
replicates for each treatment. The number of single spores was significantly 
decreased in the ED7 mAb treatment. The level of significance indicate:  
** < 0.01. 
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3.3.6 Live Cell Imaging of Spore Phagocytosis  
Phagocytosis of FS-GFP spores by AMØs was quantified by determining the  
P% and Pi. The experiments were conducted with the fluorescently-labelled 
strain to facilitate spore counting and to allow live cell imaging of the phagocytic 
process. There was an increase over time in the mean number of engulfed 
spores per AMØ, both with mAb ED7-treated (agglutinated) and with control  
TCM-treated (non-agglutinated) spores (Figure 3.11 A). There was a significant 
reduction in the mean number of spores per AMØ at 2 h under agglutinating 
conditions compared to TCM only and no significant differences in the 
treatments thereafter. This shows that spore agglutination delayed the 
phagocytic process. This finding was corroborated by the significantly greater 
number of AMØs at 2 h, in the ED7 treatment compared to the control, which 
contained no spores (Figure 3.11 B). Thereafter, there were no significant 























Figure 3.11. Phagocytosis of FS-GFP microconidia by AMØ at 2h, 12h, and 24 
h under agglutinating (mAb ED7) or non-agglutinating (10%TCM-∆FCS only) 
conditions. (A) Mean number of engulfed FS-GFP spores per AMØ, and (B) 
Numbers of AMØs containing (0, 1, 2, 3, 4 or >4) spores at each time point. 
Each bar is the mean of three replicates ± S.E. The levels of significance 
indicate: NS = non-significant, * < 0.05. 
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3.3.7 Phagocytic Percentage and Phagocytic Index 
The P% and the Pi values for were not significantly different (p >0.05) between 
the FS-GFP spores treated with mAb ED7 or with TCM only at 2, 12 and 24 h 
as shown in Figure 3.12 A and Figure 3.12 B. Phagocytic percentages 
increased over time under both conditions and while there was no significant 
increase in P% over time under non-agglutinating conditions (TCM only), there 
was a significant increase in P% between 2 h and 12 h under agglutinating 
conditions. This further illustrates the delay in phagocytosis due to spore 






























Figure 3.12. Phagocytic activity of FS-GFP microconidia by AM at 2h, 12h,  
and 24 h under agglutinating (mAb ED7) or non-agglutinating (10% TCM-∆FCS 
only) conditions. (A) Phagocytic percentage (P%), and (B) Phagocytic index 
(Pi). Each bar is the mean of three biological replicates ± S.E. The levels of 
significance indicate: NS = non-significant (p > 0.05). 
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3.4 Discussion 
The fungal genus Fusarium contains opportunistic fungal pathogens that have 
emerged over recent decades as causative agents of life-threatening disease in 
humans (van Diepeningen et al., 2015). F. solani is the most common and 
virulent species and is associated with high rates of mortality and morbidity in 
individuals with impaired immunity. Effector cells of innate immunity 
(macrophages and neutrophils) are a critical first-line of defence against 
infection by the fungus. In the absence of effective phagocytosis and clearance 
of infectious propagules, the fungus can disseminate, causing the frequently 
fatal invasive disease fusariosis. Fusarium infectious propagules (spores) enter 
the human body mainly through the respiratory tract, wounds, catheters, trauma 
sites and contaminated contact lenses (Mukherjee et al., 2012; Marcio Nucci & 
Anaissie, 2007; Sanz et al., 1993). 
 
Phagocytic cells in the lungs AMØ typically phagocytose and destroy spores 
and, along with neutrophils, are highly efficient barrier preventing spore 
germination and dissemination from the lung tissues (Bain et al., 2014). The 
mechanisms of AMØ recognition and destruction of mould spores have been 
investigated in detail in Aspergillus fumigatus, the cause of invasive pulmonary 
aspergillosis. Fungal recognition by AMØ is the first step of the innate immune 
response that leads to phagocytosis and intracellular intra-cellular degradation 
of inhaled conidia of A. fumigatus (Nicola et al., 2008). The antigenic fungal cell 
wall components including β-glucans, chitin and mannose or galactomannan 
are the first point of contact and can be recognised as PAMPs by PRRs that 
present on the phagocytic cell surface (Chotirmall et al., 2013). PRRs that 
include different recognition receptors such as TLR2 and TLR4, dectin-1 and 2, 
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and mannose receptor (MR) are able to detect invading Aspergillus species 
(Gersuk et al., 2006; Luther & Ebel, 2006; Park & Mehrad, 2009).  The PRRs 
and PAMPs interaction induces generation of AMPs such as defensins and 
production of inflammatory cytokines such as interleukins group, TNF-α and 
IFNγ that can play a key role in recognising fungal elements, recruiting other 
phagocytes and activating adaptive immune response resulting in increased 
fungal clearance via phagocytosis (Blanco & Garcia, 2008; Brieland et al., 2001; 
Hegedüs & Marx, 2013; Luther & Ebel, 2006; Park & Mehrad, 2009; Phadke & 
Mehrad, 2005).  
 
Following this interaction, AMØs engulf conidia in an actin-dependent manner 
within phagosome that fuse with lysosomes leading to the killing of conidia by 
oxidative such as and non-oxidative ways depends on phagolysosome 
acidification (Agapov et al., 2009; Brakhage et al., 2010; Ibrahim-Granet et al., 
2003; Nicola et al., 2008). However, Aspergillus species have developed 
inhibitory mechanism against phagolysosome acidification effect resulting in 
conidia germinating, macrophage pierces and escape (Dagenais & Keller, 
2009; Slesiona et al., 2012). 
 
Macrophages like other leukocytes produce METs like a network to further 
control A. fumigatus proliferation that forming of the nuclear DNA with 
antimicrobial molecules to surround and trap fungi (Aulik et al., 2012; Bruns  
et al., 2010). Despite an increasing knowledge of the mechanisms of innate 
immunity to other mould pathogens, our understanding of the interactions 
between phagocytic immune cells and spores of pathogenic Fusarium species 
remains limited. 
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To study the interactions between F. solani propagules and AMØ, the major 
phagocytes present in lung alveoli, a GFP-expressing isolate of F. solani was 
constructed. This allowed the process of spore phagocytosis to be more easily 
observed in live cell imaging investigations. 
 
The use of the GFP-expression technique to study the interaction and 
phagocytosis process between macrophages and fungi has been reported in 
Aspergillus fumigatus (Wasylnka & Moore, 2002) and C. albicans (Katragkou  
et al., 2010). Also, this tool was used to investigate plant infections by 
pathogenic Fusarium species, including F. oxysporum (Lagopodi et al., 2002), 
F. equiseti (Maciá-Vicente et al., 2009), F. graminearum (Skadsen & Hohn, 
2004), and F. verticillioides (Oren et al., 2003).  
 
To the best of my knowledge, this work has two novel aspects not previously 
undertaken by others: (1) F. solani was transformed with GFP to allow the 
phagocytosis process by AMØ to be studied in real-time. This work 
demonstrates that GFP is an excellent reporter system in F. solani. (2) An  
in-vitro system was developed to mimic Fusarium-innate immune cell 
interactions. These two developments enabled me to track internalization of  
FS-GFP spores by mouse AMØ using live-cell imaging for up to 8 hr, and  
(to assess the effect of spore agglutination by the Fusarium-specific mAb ED7 
on the phagocytosis process. 
 
In this study, a total of four hygromycin-B resistant colonies were recovered on 
selection plates for F. solani GFP transformation. In contrast to the wild-type 
strain, the putative transformants displayed GFP expression under 
epifluorescence. One of the four transformants (FS-GFP) was selected for the 
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phagocytosis studies. The GFP expression and hygromycin-B resistance of the 
selected transgenic isolate were stable after five generations on non-selective 
media, with the fluorescent protein expressed in both fungal hyphae and 
conidia. Previous studies have reported similar observations in F. oxysporum  
f. sp. radicis-lycopersici GFP transformants (Lagopodi et al., 2002) and  
F. equesiti (Maciá-Vicente et al., 2009). Apart from a decrease in spore and 
biomass production, compared to the wild-type strain, the FS-GFP transformant  
had a similar morphological appearance in axenic culture and had similar 
antigenic properties, both regarding extracellular antigen production and spore 
agglutination by mAb ED7. This gave confidence that the FS-GFP strain could 
be used to investigate phagocytosis of antigenic F. solani spores and also to 
determine how spore agglutination might affect the phagocytic process. 
 
Opsonization and agglutination of micro-organisms by antibodies can have  
a profound effect on phagocytosis by complexing infectious propagules and 
increasing their accessibility to macrophages and neutrophils. Besides 
antibodies have a significant role in microbial toxin neutralization, they are able 
to coat and opsonize microbial cell surface leading to enabling efficient 
recognition by phagocytic cells, then promote and accelerate pathogen uptaking 
by efficiently (Casadevall & Pirofski, 2012; Lindow et al., 2011; McCullough  
et al., 1988; van Kessel et al., 2014). Furthermore, antibodies can prevent 
fungal biofilm and cell adherence resulting in biomass agglutination and 
facilitating phagocytosis (Casadevall & Pirofski, 2007; Martinez & Casadevall, 
2005; Mishra et al., 2014). 
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Opsonized fungal cell with human serum antibody or a specifically targeted 
antibody can be recognised by mediated phagocytosis receptor such as  
Fc receptors (Fc-Rs) located on the phagocytic cell surface (Levitz, 2010; van 
Kessel et al., 2014; Wellington et al., 2003; Wellington et al., 2007). Recent 
studies have shown that the shape and size of agglutinated microbial cells by 
antibodies have a critical impact on phagocytosis rate of macrophages cells 
(Litvack et al., 2011). A large agglutinated biomass exceeds macrophage cells 
can inhibit and block engulfment (Champion & Mitragotri, 2006; Litvack et al., 
2011). 
 
In this study, I investigated the effect of spore agglutination by using two 
measures of AMØ phagocytic efficiency, P% and Pi, under agglutinating and 
non-agglutinating conditions. P% is the percentage of cells containing spores, 
while Pi is the average number of phagocytosed spores per macrophage.  
 
Using this technique, no significant overall variation was found in P% and Pi for 
agglutinated and non-agglutinated spores. However, the percentage of AMØ 
that did not engulf spores was higher after the spores were treated with mAb 
ED7 during the first two hours of challenge. This suggests that spore 
agglutination by mAb ED7 delays the process of phagocytosis. There are two 
possible explanations for this delay. The first is that the antibody blocks AMØ 
recognition of surface antigen that binds via cell surface receptors. The cell line 
used in this study, MH-S, employs the complement receptor CR3 
(CD11b/CD18) also to recognize fungal -D-glucan and mannan (Xia et al., 
1999). While the extracellular antigen bound by mAb ED7 has been shown to 
be an immunodominant high molecular weight glycoprotein (see Section 2.3.2, 
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Chapter 2), its full molecular identity and involvement in phagocyte recognition 
have yet to be determined. Notwithstanding this, it is feasible that ED7 blocks 
receptor binding to an immunodominant antigen on the spore surface is thereby 
delaying recognition and engulfment by the phagocyte. An alternative 
explanation for the delay in phagocytosis is physical impairment. The increase 
in fungal biomass due to spore agglutination may simply prevent efficient 
uptake by the AMØ. A combination of reduced recognition by cell surface 
receptors and physical impairment may also account for the delay. Currently, 
little is known about the cell wall components of F. solani involved in recognition 
and uptake by macrophages, which warrants further investigation. 
 
The work conducted here shows that murine AMØs efficiently internalize  
FS-GFP conidia and germinated spores, even despite delays in phagocytosis 
due to spore agglutination Indeed, single AMØ were able to phagocytose up to 
12 spores. However, it was observed that engulfed FS-GFP conidia were able 
to germinate and continued to grow within the AMØ, ultimately leading to their 
escape from the macrophages and host cell lysis. Attempts were made by 
neighbouring macrophages to engulf developing hyphae, but no apparent 
damage appeared to occur to hyphae, which continued to proliferate into  
a hyphal network. Similar observations of cell lysis and death of murine 
macrophages by hyphae have been reported in the related fungus F.oxysporum 
(Schäfer et al., 2014) and the dimorphic yeast Candida albicans (Bain et al., 
2012). Further analysis of the time-lapse movies generated here revealed  
a very rapid expulsion of FS-GFP conidia from intact macrophages. Importantly, 
this phenomenon during F. solani phagocytosis was only observable because 
of the real-time imaging system employed here. While the process of 
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vomocytosis has been reported in the yeasts Cryptococcus neoformans 
(Alvarez & Casadevall, 2006; Ma et al., 2006) and C. albicans (Bain et al., 
2012), this is the first time this phenomenon has been reported for a mould 
pathogen and might explain, in part, how F. solani is able to escape innate 
immune cell killing. 
 
Summary of Key Findings: 
1. Transformation of F. solani (CBS224.34) with GFP marker is  
a convenient, fast, and effective approach for studying the cellular innate 
immunity–fungus interaction without using chemical stains. To the best of 
my knowledge, this work is novel. 
2. The level of gfp expression in single-spore isolated transformant is high 
and stable for long term in the vegetative and reproductive forms of the 
fungus, including the mycelium and microconidia.  
3. The putative FS-GFP transformants colony has similar morphology, 
growth and antigenic characteristics to the wild-type isolate. However, 
there is a significantly reduction in spore production compare to the wild-
type strain. 
4. The developed in-vitro system to mimic Fusarium-innate immune cell 
interactions is simple, effective and can be used for visualization and live 
cell imaging of the phagocytosis process in real-time. To the best of my 
knowledge, this system is novel. 
5. The FS-GFP spore agglutination by Fusarium-specific mAb ED7 delays 
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Chapter 4. Tracking Human Pathogenic Fusarium species in Sink 
Drain Biofilms by Using mAb ED7 
 
4.1 Introduction  
Species in the fungal genus Fusarium are ubiquitous environmental moulds, 
and pathogens of both plants and animals (Thornton & Wills, 2015; Zhang  
et al., 2006). In immunocompromised humans, such as patients with 
haematological malignancies and HSCT and SOT recipients, Fusarium species 
are significant emerging pathogens, causing a frequently fatal disseminated 
disease known as fusariosis with an associated mortality rate of 50 - 100% 
(Boutati & Anaissie, 1997; Dignani & Anaissie, 2004; Girmenia et al., 2000; 
Jensen et al. 2004; Musa et al., 2000; Nucci & Anaissie, 2007; O’Donnell et al., 
2008), and have appeared in some tertiary cancer centres as the second most 
common mould pathogen after Aspergillus (Boutati & Anaissie, 1997; Walsh & 
Groll, 1999). Regardless of immunocompetency, Fusarium species can cause 
localised nail infections (onychomycosis) (Arrese et al., 1996), bone and joint 
infections (Koehler et al., 2014), infections of burn wounds (Latenser, 2003), 
skin infections (Bodey et al., 2002; Gupta et al., 2000; Gurusidappa & 
Mamatha, 2011; Nucci & Anaissie, 2002), and are the most frequent cause of 
fungal keratitis (Jurkunas et al., 2009), leading to progressive corneal 
destruction and endophthalmitis, with loss of vision or even loss of the affected 
eye (Dursun et al., 2003; Edelstein et al., 2012). 
 
A recent outbreak of fungal keratitis in the USA, Singapore and Hong Kong was 
associated with contact lens solution contaminated with multiple strains  
of Fusarium and which led to a visual loss in many patients and the need  
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for corneal transplantation (Chang et al., 2006). While such outbreaks are rare, 
disseminated Fusarium infections and keratomycosis have increased in 
frequency over the past decade (Koehler et al., 2014) and an increasing body of 
evidence suggests that the main environmental sources of human pathogenic 
Fusarium species are contaminated water systems (Adams et al., 2013; 




4.1.2 Environmental Sources of Human Pathogenic Fusarium 
Species  
Increasing incidences of nosocomial fungal infections caused by Candida, 
Aspergillus, Mucor, Rhizopus, Fusarium, Acremonium, Alternaria, Bipolaris and 
Curvularia species have been reported (Fridkin & Jarvis, 1996; Scheel et al., 
2013), necessitating improved identification and monitoring of hospitals for 
potentially infectious propagules.    
 
As with many fungal pathogens, Fusarium species have adapted to survive in  
a wide range of ecosystems, with the dispersal of spores into terrestrial and 
aquatic habitats (Short et al., 2011) through air, soil, wind, rain, river water and 
sewage (Defra, 2011). Additionally, a number of studies have recovered 
pathogenic Fusarium species from plumbing fixtures and it is hypothesised that 
microbial biofilms on fixtures may serve as important reservoirs of infectious 
Fusarium propagules in hospitals and domestic environments (Anaissie et al., 
2001; Mehl & Epstein, 2008; Scheel et al., 2013; Short et al., 2011; Zhang  
et al., 2006). The idea of water-borne infections has been suggested for other 
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opportunistic fungal pathogens such as Aspergillus (Anaissie et al., 2002; 
Gangneux et al., 2002), Cladosporium (Mesquita-Rocha et al., 2013), Exophiala 
(Marcio Nucci et al., 2002), Candida and Penicillium (Arvanitidou et al., 1999). 
 
Tracking environmental sources of pathogenic fungi is critical to the prevention 
and control of outbreaks of hospital infections (Anaissie et al., 2001). A number 
of pathogenic Fusarium species have been recovered from naturally-infested 
water samples, including F. anthophilum, F. acuminatum, F. chlamydosporum,  
F. culmorum, F. equiseti, F. verticillioides, F. oxysporum, F. dimerum,  
F. proliferatum, F. solani, F. sambucinum and F. sporotrichioides (Anaissie  
et al., 2001; Palmero et al., 2009; Sautour et al., 2012). However, the most 
frequent human pathogenic species recovered from water tanks, sink drains, 
shower heads and plumbing systems in hospitals and domestic residences 
belong to the FSSC, FOSC and FDSC (Anaissie et al., 2001; Arvanitidou et al., 
1999; Hageskal et al., 2006; Mehl & Epstein, 2007; O’Donnell et al., 2007, 
2009, 2010; Sautour et al., 2012; Schroers et al., 2009; Short et al., 2011; 
Steinberg et al., 2015; Zhang et al., 2006). Immuno-compromised individuals 
exposed to these water-borne species complexes are at increased risk of 
disseminated fusariosis (Anaissie et al., 2003; Carneiro et al., 2011; Garnica & 
Nucci, 2013; Nucci & Anaissie, 2007; O’Donnell et al., 2004). 
 
 
4.1.3 Fusarium Biofilms 
Fusarium species complexes can form thick biofilms in plumbing systems in 
which the fungal spores and hyphae are proliferate and enmeshed in an 
extracellular matrix allowing adhesion to surfaces (Pierce et al., 2008). The 
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formation of biofilms is thought to contribute to Fusarium antifungal resistance 
and pathogenicity (Mukherjee et al., 2012). Fungal spore adhesion to living cells 
or surfaces is a crucial step to the establishment of biofilms and the 
development infections (Ramage et al., 2009). Fusarium spores adhere to 
surfaces through interaction with an extracellular fibrillar matrix located on the 
outer layer of the spore cell wall. The process of adhesion starts within few 
minutes and construction a biofilm is completed within a few hours (Kwon & 
Epstein, 1997; Kwon & Epstein, 1993; Pan et al., 2011). The extracellular matrix 
typically consists of glycoprotein with mannose residues that act as an adhesive 
for spore attachment (Gauthier & Keller, 2013; Kwon & Epstein, 1997). 
Involvement of extracellular matrices in adhesion of other pathogenic fungi has 
also been reported for Aspergillus (Wasylnka & Moore, 2000; Yang et al., 
2000), Penicillium (Srinoulprasert et al., 2009), Candida (Tournu & Van Dijck, 
2011) and Rhizopus (Bouchara et al., 1996). At present, little is known about 
Fusarium biofilm formation and its role in survival and pathogenicity of the 
fungus (Peiqian et al., 2014). 
 
 
4.1.4 Objective of Chapter 4 
In Chapter 2 of this thesis, I described the development and characterization of 
the Fusarium-specific mAb, ED7, that binds to an abundant extracellular 
glycoprotein antigen present in a fibrillar matrix surrounding the spores and 
hyphae of F. solani. Furthermore, I showed that the antibody was able to 
agglutinate spores of F. solani and other pathogenic species. In this Chapter,  
I set out to determine whether mAb ED7 could be used to track the fungus  
in environmental samples by detecting the water-soluble diagnostic antigen in 
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swabs of communal and hospital sink drain biofilms. By using the mAb in an 
ELISA, I show that it can differentiate Fusarium species from other human 
pathogenic yeasts and moulds present in mixed fungal communities in sink 
drain biofilms. In doing so, I show that the ELISA represents a simple method 
for specific detection of Fusarium species in environmental reservoirs and for 
identifying water systems contaminated with the fungus.   
 
The work described in this chapter and accompanying work in Chapter 2 forms 
the basis of a paper published in 2016 in the journal Environmental 
Microbiology (Al-Maqtoofi, M. and Thornton, C.R. [2016] Detection of human 
pathogenic Fusarium species in hospital and communal sink biofilms by using  
a highly specific mAb. Environmental Microbiology, in press. DOI:10.1111/1462-
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4.2 Materials and Methods 
4.2.1 Study Location 
A total of 65 drain and water samples were collected between March and 
December 2014 from communal sinks located on the University of Exeter 
Streatham Campus (Exeter, Devon, UK) and from sinks located at the Royal 
Devon & Exeter tertiary care hospital (Exeter, Devon, UK). At the start of the 
study, 33 sink drain samples from six locations on the University campus were 
collected. An additional 32 samples were then collected from five areas of the 
hospital, namely the Intensive care unit (ICU), Intensive Therapy Unit (ITU), 
Haematology Unit, Ophthalmology Unit and Oncology unit. Permission for sink 
sampling at the Royal Devon and Exeter Hospital was granted by the Director of 
Infection Prevention and Control. 
  
 
4.2.2 Collection of Biofilm Swabs and Water Samples  
Sink drain biofilms were collected using sterile 15-cm cotton-tipped applicators 
(Technical Service Consultants Ltd., UK) as illustrated in Figure 4.1 and  
Figure 4.2. The cotton tips were wetted with sterile PBS buffer, inserted into the 
drain pipes through the sink strainers and used to scour the interior surface of 
drain pipes for approximately 10 sec. Applicators with visible detritus were 
immersed into 1.5 ml microcentrifuge tubes containing 1 ml of sterile PBS buffer 
to dislodge biofilm debris (Figure 4.1 A to C). For sink water samples, 1 ml of 
tap water was collected in sterile microcentrifuge tubes. Sealed tubes were 
immediately transferred to the laboratory for processing by mycological culture 
and ELISA. Samples were vortexed vigorously for 1 min (Figure 4.1 D to E), 
centrifuged at 14,462 g for 10 min and supernatants (Figure 4.1 F to G) 
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transferred to clean tubes prior and stored at – 20 °C before processing by 
ELISA. For mycological culture pelleted biofilm debris (Figure 4.1 H) were  
re-suspended in 250 μl sterile PBS buffer, homogenized by vortex, and 200 μl 
of suspension spread on the surface of PDA containing 0.1 mg/ml of the broad-
spectrum antibiotic  Rifampicin (Cat. No. 195490, MB Biomedicals LLC, 
Germany) using a sterile L-shape spreader. The culture plates were incubated 
at 26 °C, fungal colonies were separated on the basis of gross morphological 
characteristics (Figure 4.1 I) and were sub-cultured on PDA until axenic 
cultures were generated (Figure 4.1 J). A reference code was allocated to each 
of the 225 strains recovered, and isolates were maintained as PDA slopes at 
room temperature before identification by ITS sequencing and TEF-1α 
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Figure 4.1. Biofilm sampling protocol and preparation of axenic cultures  
of recovered fungi. (A - C) Recovery of biofilms from sink drain using a cotton-
tipped swab and immersion of biofilm-coated tip in PBS. (D) Vigorous vortexing 
of biofilm debris, (E) pelleted debris and (F) supernatant containing soluble 
antigens following centrifugation to test by (G) ELISA using mAb ED7 and (H) 
debris culturing on PDA supplemented with Rifampicin. (I) Typical mycological 
culture is showing different morphologies of culturable fungi on mixed culture 
plates. (J) Fungi were separated on the basis of gross morphologies and were 
sub-cultured until axenic cultures were obtained.     
 
 




Figure 4.2. Schematic diagram showing diagnostic work-flow for identification 
of Fusarium species and unrelated yeasts and moulds recovered from sink 
drain biofilms. 
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4.2.3 Immunodetection of Fusarium Species in Sink Swabs and 
Mixed and Axenic Cultures by ELISA 
The ELISA described in Chapter 2 was used for detection of the ED7 diagnostic 
antigen in swab samples (Table 4.1 and Table 4.2; Swab-ELISA) and mixed 
cultures and axenic cultures (Table 4.1 and Table 4.2; Mixed culture-ELISA and 
Axenic culture-ELISA, respectively). Swab samples stored at -20oC were 
thawed and 50 μl samples transferred to the wells of microtitre plates for 
overnight antigen immobilization and assay by ED7 ELISA as described. Crude 
antigen extracts were prepared as surface washings from mixed cultures and 
axenic cultures and, following overnight antigen immobilization of 50 μl samples 
to the wells of microtitre plates, similarly assayed by ED7 ELISA.  
 
 
4.2.4 Fungal DNA Extraction 
A rapid method for fungal DNA extraction was developed from the protocol used 
by Wand and co-workers (Wang et al., 1993). For a collection of fungal 
biomass, axenic PDA slope cultures were flooded with 3 ml of sterile MQ-H2O 
and the surfaces stroked using sterile pipette tips. The washings containing 
spores and hyphal fragments were transferred to 1.5 ml micro-centrifuge tubes 
and tissues were pelleted by centrifugation at 14,462 g for 5 min. The 
supernatants were discarded, and 50 – 100 mg of biomass were transferred to 
clean microcentrifuge tubes to which were added 500 μl of 350 mM NaOH. The 
mixtures were vortexed for 30 sec, and 10 μl of suspension were diluted in 490 
μl of 100 mM Tris-HCl, pH 8.0. All steps were performed at room temperature 
and the mixtures were stored at – 20°C before use. 
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4.2.4.1 Identification of Fungi by Analysis of the ITS Regions of the  
rRNA-encoding Gene Unit 
Fungi were identified by sequencing of the ITS1-5.8S-ITS2 region of the rRNA-
encoding gene unit (White et al., 1990) according to procedures described 
elsewhere (Thornton et al., 2002), using the primers ITS1ext (5’-GTAACAAGGT 
TTCCGTAGGTG-3’) and ITS4 ext (5’TTCTTTTCCTCCGCTTATTGATATGC-
3’). PCR mixtures contained the following components: 1 μl DNA template,  
12.5 μl of GoTaq® G2 Green Master Mix DNA polymerase (Promega, MF7112), 
9.5 μl of nuclease free water (Promega) and 1 μl of each at 20 picomoles 
(pmol). The PCR cycling parameters (Figure 4.3) were: an initial denaturation 
step for 5 min at 95°C; 35 cycles of 30 sec at 94°C (denaturation), 30 sec  
at the 55°C (annealing), 1.5 min at 72°C (extension), followed by a final 10 min 
extension step at 72°C (Thornton et al., 2002). Species identity was predicted 
based on >95% sequence identity (E-value = 0.0) (Altschul et al., 1997) of the 




Figure 4.3. PCR cycling parameters for ITS region amplification. 
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4.2.4.2 Nucleotide Sequence Accession Numbers 
Newly determined ITS sequences (Appendix 3) were submitted to GenBank 
and the ITS accession numbers KT876496 to KT876723 were obtained. 
Species designations of recovered fungi are shown in Table 4.1.  
 
 
4.2.4.3 Identification of Fusarium Species Complexes by Using 
Translation Elongation Factor-1α PCR  
Fusarium species were further identified to species complex level by using the 
forward primer tef-1 (5’-ATGGGTAAGGA(A/G)GACAAGAC-3’) and reverse 
primer tef-2 (5’-GGA(G/A)GTACCAGT(G/C)ATCATGTT-3’), which amplify an 
~700 bp region of TEF-1α, the single-locus identification tool in Fusarium 
(Geiser et al., 2004). PCR reactions were carried out in a total volume of 25 μl 
consisting of 1 μl DNA at a concentration of 30 - 75 ng μl-1, 12.5 μl of GoTaq® 
Green Master Mix DNA polymerase (Promega, MF7112), 9.5 μl of nuclease 
free water (Promega) and 1 μl of each primer at 20 pmol. The following cycling 
parameters (Figure 4.4) were used: an initial denaturation step at 95°C for  
8 min; 35 cycles of 15 sec at 95°C (denaturation); 20 sec at 54°C (annealing),  
1 min at 72°C (extension) followed by a final 5 min extension step at 72°C. 
Phylogenetic sub-groups of Fusarium species (Table 4.3) were determined by 
interrogation of the FUSARIUM-ID v. 1.0 database (isolate.fusariumdb.org) 
(O’Donnell et al., 2010), with the newly acquired TEF-1α sequences  
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Figure 4.4. PCR cycling parameters for TEF gene amplification. 
 
 
4.2.5 Phylogenetic Analysis 
A total of 225 ITS sequences were compared with those deposited  
in the National Center for Biotechnology Information (NCBI) databases by using 
NCBI BLAST® (https://blast.ncbi.nlm.nih.gov). A combination of software were 
utilized for basic editing and analysis to establish the phylogeny tree (Appendix 
2) including SeaView Version 4.5.4 (http://doua.prabi.fr/software/seaview) 
(Manolo Gouy, Laboratoire de Biométrie et Biologie Evolutive CNRS/ Université 
de Lyon “Licensed under the GNU General Public Licence.”), FigTree Version 
1.4.2 (http://tree.bio.ed.ac.uk/software/figtree/) (Andrew Rambaut Institute of 
Evolutionary Biology, University of Edinburgh), REFGENE bioinformatics tool 
(http://richardslab.exeter.ac.uk/refgen.html) and TREENAMER bioinformatics 
tool(http://richardslab.exeter.ac.uk/treenamer.html) as published by (Leonard  
et al., 2009). 
  
ITS sequences were blasted in NCBI, and at least 8 of the closest species 
based on high identity (Ident) percentage were selected and downloaded in 
FASTA format and saved as (Plain.txt) file by Microsoft word. The accession 
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number for NCBI isolates was extracted by loading the last file on REFGENE 
website, and data were saved as a (*.csv) file and text file. A master file was 
established by adding ITSs and NCBI (accession numbers) DNA sequences 
data within one file by word office and finally saved as the (plain.txt) file format. 
For DNA sequences alignment, Master file was uploaded on MAFFT website 
(http://mafft.cbrc.jp/alignment/server/) (Katoh & Standley, 2013) and aligned 
DNA sequences were saved as FASTA format file on word Microsoft Office and 
then as a (plain.txt) format. Next, for extra basic edition and construction of 
phylogenetic trees the Master (plain.txt) files were exhibited by SeaView 
software, followed by serial of process to select one of the closest alignment to 
each ITS sequence and built pre-final phylogeny tree (PhyML) files and then 
were saved with (*.mase) extension. Last files were displayed by FigTree 
programme and saved.  
 
Following, NCBI isolate names were re-extracted from accession numbers 
to identify ITS data by TREENAMER website through uploading two files were 
generated previously (*.csv) file and (PhyML) file as a result, Newick file saved 
on word Microsoft office and converted to (plain.txt) to be displayed on FigTree. 
For cosmetic editing of phylogeny tree, Inkscape v 0.91 software 
(https://inkscape.org/en/download/) (Free Software Foundation, Inc., 59 Temple 
Place, Suite 330, Boston, MA  02111-1307 USA) was used. ITS sequence did 
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4.3 Results 
4.3.1 Immunodetection of Fusarium Species In Sink Swabs  
Monoclonal antibody ED7 was highly specific for the three human pathogenic 
species of Fusarium, F. solani, F. oxysporum and F. dimerum, which  
were culturable from 75% of the sink swabs (Table 4.1 and Table 4.2). ELISA 
tests of the saline sink swabs showed that 52% contained detectable levels of 
Fusarium antigen (Table 4.1 and Table 4.2), with ELISA absorbance values in 
the range ≥0.100 (the threshold value for antigen detection) and up to 1.500. In 
four hospital samples (samples S47, S48 and S49 from ophthalmology and 
sample S64 from oncology) Fusarium strains could not be recovered for 
identification by ITS sequencing despite detection of the diagnostic antigen in 
swab samples with absorbance values of 0.264, 0.530, 0.187 and 0.193 
respectively (Table 4.1). This was likely due to the Fusarium isolates being 
outgrown in the mixed culture plates by faster growing or more abundant 
unrelated fungi. Importantly, ED7 was shown not to cross-react with unrelated 
fungi (axenic culture absorbance values of ≤ 0.100 in all cases) including the 
human pathogenic yeast or yeast-like fungi Candida, Exophiala, Meyerozyma, 
Rhodotorula, Trichosporon, the human pathogenic hyaline or dematiaceous 
moulds Aspergillus, Phialophora, Phoma, Trichoderma, and the human 
pathogenic mucormycete Mucor (Table 4.1). The remaining 93% of samples 
positive for Fusarium antigen, either at the swab stage or following periods of 
biological amplification in mixed or axenic cultures (Table 4.2), yielded strains of 
the three Fusarium species. In addition to drain swabs, water samples were 
collected from the taps of sinks in the hospital haematology and oncology units 
and the main water tanks feeding the ophthalmology unit. The ED7 diagnostic 
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antigen could not be detected in any of the water samples directly. However, 
the oncology samples W57 and W60 contained Fusarium strains that belonged 
to FDSC ET-gr. and were detectable by ELISA at the mixed culture stage 
(Table 4.3). The sink biofilms corresponding to these water samples were also 
positive at the swab ELISA stage (Table 4.1).  
 
 
4.3.2 Identification of Fungi by Analysis of the ITS Regions of the rRNA-
Encoding Gene Unit and by Translation Elongation Factor-1 PCR 
There was 100% agreement between Fusarium genus identification by ELISA 
and species identification by ITS sequencing (Table 4.1). The species of  
F. solani and F. oxysporum recovered from sink swabs were subsequently 
shown by TEF-1 PCR (Table 4.3) to belong to FSSC 1-a, 1-c, 2-a, 2-v, 5-d,  
5-k, 9-a, 15-a, 20-d and FOSC 16, 33, 99, 111, 126, 134, 183 (Table 4.3). All of 
the recovered F. dimerum isolates belonged to the FDSC ET-gr (Table 4.3). ITS 
analysis of axenic cultures (Table 4.1) showed that a number of sink samples 
(e.g. S2, S6, S17, S19, S21, S24, S30, S38) contained mixtures of Fusarium 
species, while ITS and TEF-PCR analysis (Table 4.1 and Table 4.3) showed 
that others contained mixtures of species complexes of the same species  
(e.g. S8, S9, S25, S28). Only two of the tap samples (oncology W57 and W60) 
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4.3.3 Frequencies and Distributions of Fusarium Species Complexes  
By combining the ITS and TEF-PCR data, the dominant species complex 
recovered from the University sink drain biofilms was shown to be FOSC 
(47.6%), followed by FSSC (11.2%) and then FDSC (7.4%) (Figure 4.5 A).  
At the RD&E hospital, FDSC (27.1%) was found the most frequent grouping, 
followed by FSSC (9.3%) and then by FOSC (3.3%) (Figure 4.5 A). Different 
species complexes dominated in the different hospital units tested  






















Figure 4.5. Frequency of F. species complex recovered from sink drain biofilms 
based on ITS and TEF-PCR identification. (A) depends on collection area and 
(B) depends on RD&E hospital units. The total number of samples is 225. 
FOSC, F. oxysporum species complex; FDSC, F. dimerum species complex; 
FSSC, F. solani species complex. 
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Table 4. 1. Locations and identities of sink swabs and water samples and 
results of ELISA tests and fungal identification based on ITS sequencing. The 





























































































A1 University (S1) 0.0763 0.0575 A1-1 1.3736 Fusarium oxysporum KT876668 
 University (S1)   A1-2 0.7646 Fusarium oxysporum KT876662 
 University (S1)   A1-3 0.0196 Penicillium crustosum KT876719 
 University (S1)   A1-4 0.0139 Penicillium expansum KT876718 
A2 University (S2) 0.5472 0.0045 A2-1 1.5723 Fusarium solani KT876635 
 University (S2)   A2-3 0.6554 Fusarium oxysporum KT876690 
 University (S2)   A2-5 1.1312 Fusarium solani KT876631 




 University (S3)   A3-2 0.0162 Cadophora fastigiata KT876615 




 University (S3)   A3-4 0.0093 Penicillium crustosum KT876714 
 
A4 
University (S4) 0.0297 0.0049 A4-1 0.0105 Phoma herbarum KT876697 












A5 University (S5) 0.0206 0.0039 A5-1 1.1815 Fusarium oxysporum KT876692 
 University (S5)   A5-2 0.0034 Penicillium crustosum KT876715 
 University (S5)   A5-5 0.0088 Aspergillus niger KT876702 
 University (S5)   A5-6 1.0630 Fusarium oxysporum KT876667 








A6 University (S6) 0.0251 0.0412 A6-1 1.1130 Fusarium oxysporum KT876648 
 University (S6)   A6-2 0.9410 Fusarium oxysporum KT876678 
 University (S6)   A6-3 0.6377 Fusarium oxysporum KT876688 
 University (S6)   A6-4 1.0020 Fusarium solani KT876640 
 
A7 
University (S7) 0.1716 0.0082 A7-1 0.0098 Exophiala pisciphila KT876618 




 University (S7)   A7-3 1.0556 Fusarium oxysporum KT876684 
 University (S7)   A7-4 1.0077 Fusarium oxysporum KT876671 
A8 University (S8) 0.0431 0.0008 A8-1 1.1045 Fusarium oxysporum KT876672 
 University (S8)   A8-2 0.9707 Fusarium oxysporum KT876654 
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University (S9) 0.3806 0.0052 A9-1 0.9087 Fusarium solani KT876639 
 
 
University (S9)   A9-2 0.8849 Fusarium solani KT876638 
 
 
University (S9)   A9-3 0.9004 Fusarium solani KT876632 
 
 
University (S9)   A9-4 0.8093 Fusarium solani KT876636 
A10 University (S10) 0.0034 0.0028 A10-1 0.0188 Rhodotorula slooffiae KT876705 
 University (S10)   A10-2 0.0020 Exophiala pisciphila KT876616 
B1 University (S11) 0.0231 0.0005 B1-1 0.6064 Fusarium dimerum KT876625 
 University (S11)   B1-6 0.8138 Fusarium dimerum KT876628 
B2 University (S12) 0.0200 0.0020 B2-1 0.5678 Fusarium dimerum KT876626 
 University (S12)   B2-5 0.4827 Fusarium dimerum KT876624 
B3 University (S13) 0.0091 0.0023 B3-4 0.0026 Phoma herbarum KT876696 
B4 University (S14) 0.0163 0.0008 B4-1 0.6992 Fusarium dimerum KT876627 
B5 University (S15) 0.0132 0.0003 B5-1 0.8008 Fusarium oxysporum KT876674 
 University (S15)   B5-2 0.0048 Mucor circinelloides KT876701 
 University (S15)   B5-3 0.8851 Fusarium oxysporum KT876677 
B6 University (S16) 0.0229 0.0002 B6-1 0.8193 Fusarium oxysporum KT876676 
 University (S16)   B6-2 0.7582 Fusarium oxysporum KT876661 
B7 University (S17) 0.0395 0.0014 B7-1 0.8201 Fusarium oxysporum KT876675 
 University (S17)   B7-6 0.7758 Fusarium dimerum KT876623 
B8 University (S18) 0.0133 0.0011 B8-1 0.7347 Fusarium solani KT876637 








 University (S19)   B9-2 0.8104 Fusarium oxysporum KT876657 
 University (S19)   B9-3 0.6302 Fusarium solani KT876634 
 University (S19)   B9-5 0.0017 Penicillium crustosum KT876720 
B10 University (S20) 0.5467 0.0394 B10-1 0.7467 Fusarium oxysporum KT876680 
 University (S20)   B10-2 0.7667 Fusarium oxysporum KT876659 
 University (S20)   B10-6 0.0071 Candida parapsilosis KT876703 












C1 University (S21) 0.0083 0.0269 C1-1 0.0044 Clavispora lusitaniae KT876708 
 University (S21)   C1-3 0.8875 Fusarium oxysporum KT876682 
 University (S21)   C1-4 0.8884 Fusarium dimerum KT876629 
 University (S21)   C1-7 0.0003 Exophiala pisciphila KT876617 
C2 University (S22) 0.2977 0.0047 C2-1 0.9443 Fusarium oxysporum KT876658 
 University (S22)   C2-4 0.9825 Fusarium oxysporum KT876694 
 University (S22)   C2-7 0.8677 Fusarium oxysporum KT876687 
C3 University (S23) 0.0808 0.0116 C3-1 0.9853 Fusarium oxysporum KT876683 
 University (S23)   C3-2 1.0160 Fusarium oxysporum KT876693 
 University (S23)   C3-4 0.7485 Fusarium oxysporum KT876644 
C4 University (S24) 0.1113 0.0202 C4-1 0.8930 Fusarium oxysporum KT876670 
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 University (S24)   C4-2 0.0028 Candida intermedia KT876709 
 University (S24)   C4-5 0.9008 Fusarium dimerum KT876630 
C5 University (S25) 0.5741 0.0097 C5-1 0.9874 Fusarium oxysporum KT876652 
 University (S25)   C5-2 1.0996 Fusarium oxysporum KT876656 
 University (S25)   C5-3 1.1236 Fusarium oxysporum KT876649 
 University (S25)   C5-4 1.0355 Fusarium oxysporum KT876669 
 University (S25)   C5-5 1.0672 Fusarium oxysporum KT876660 
C6 University (S26) 0.0603 0.0348 C6-1 1.0135 Fusarium oxysporum KT876665 
 University (S26)   C6-2 0.9362 Fusarium oxysporum KT876681 
 University (S26)   C6-3 0.8898 Fusarium oxysporum KT876673 
 University (S26)   C6-4 1.0577 Fusarium oxysporum KT876686 
 University (S26)   C6-5 0.9445 Fusarium oxysporum KT876646 
C7 University (S27) 0.1279 0.0113 C7-1 0.9724 Fusarium oxysporum KT876666 
C8 University (S28) 0.0607 0.0035 C8-1 0.8694 Fusarium oxysporum KT876685 
 University (S28)   C8-2 0.9599 Fusarium oxysporum KT876655 
 University (S28)   C8-3 0.0031 Penicillium expansum KT876716 
 University (S28)   C8-4 0.0049 Phoma herbarum KT876698 
 University (S28)   C8-6 0.9003 Fusarium oxysporum KT876679 
C9 University (S29) 0.0310 0.0001 C9-1 1.0488 Fusarium oxysporum KT876651 
 University (S29)   C9-2 0.9254 Fusarium oxysporum KT876645 
 University (S29)   C9-3 0.9711 Fusarium oxysporum KT876664 
 University (S29)   C9-4 1.035 Fusarium oxysporum KT876647 
 University (S29)   C9-5 0.9604 Fusarium oxysporum KT876663 
C10 University (S30) 0.1002 0.0333 C10-1 0.9254 Fusarium oxysporum KT876689 
 University (S30)   C10-2 1.0198 Fusarium solani KT876642 
 University (S30)   C10-4 0.9007 Fusarium solani KT876641 
 University (S30)   C10-7 1.0697 Fusarium solani KT876643 
CRT-1 University (S31) 0.6175 0.1129 CRT1-1 0.4639 Fusarium oxysporum KT876691 
 University (S31)   CRT1-2 0.9086 Fusarium oxysporum KT876650 
 University (S31)   CRT1-3 0.7503 Fusarium oxysporum KT876652 










University (S33) 0.0663 0.0028 CRT3-1 0.0256 Phoma herbarum KT876699 
R1 ICU (S34) 0.0285 0.3620 R1-1 1.5057 Fusarium solani KT876550 
 ICU (S34)   R1-2 1.5154 Fusarium solani KT876551 
 ICU (S34)   R1-3 1.5555 Fusarium solani KT876549 
R2 ICU (S35) 0.0071 0.0147 R2-4 0.0096 Clonostachys rosea KT876552 
 ICU (S35)   R2-5 0.0018 Clonostachys rosea KT876553 
 ICU (S35)   R2-6 0.0035 Clonostachys rosea KT876554 




R5 ITU (S37) 0.7291 0.7724 R5-1 1.5606 Fusarium dimerum KT876561 
 ITU (S37)   R5-2 1.3481 Fusarium dimerum KT876565 
 ITU (S37)   R5-3 1.4990 Fusarium dimerum KT876567 
R6 ITU (S38) 1.2086 0.3691 R6-1 1.3388 Fusarium dimerum KT876572 
 ITU (S38)   R6-2 1.4734 Fusarium dimerum KT876563 
 ITU (S38)   R6-3 1.4312 Fusarium dimerum KT876562 
 ITU (S38)   R6-9 1.2648 Fusarium oxysporum KT876557 
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R7 ITU (S39) 0.1121 0.8186 R7-1 1.3266 Fusarium dimerum KT876570 
 ITU (S39)   R7-2 1.2352 Fusarium dimerum KT876564 
R8 ITU (S40) 1.0157 0.3612 R8-1 1.2399 Fusarium dimerum KT876568 
 ITU (S40)   R8-2 1.1552 Fusarium dimerum KT876566 
 ITU (S40)   R8-3 1.1856 Fusarium dimerum KT876558 




R10 ITU (S42) 0.0549 0.0097 R10-2 0.0072 Cadophora fastigiata KT876556 




X2 ITU (S43) 0.0630 1.5751 X2-2 1.1492 Fusarium dimerum KT876571 
 ITU (S43)   X2-4 1.2505 Fusarium dimerum KT876560 
 ITU (S43)   X2-5 1.1397 Fusarium dimerum KT876569 




































































































  X9-5 0.0705 Engyodontium album KT876519 











































































































































0.0021 0.0182 G10-1 0.0051 Engyodontium album KT876539 
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a. S, sink; W, tap water from corresponding sink number; T, water sample from 
main tank. 
b. Threshold absorbance value for detection in ELISA ≥0.100. Shading 
indicates earliest point in sampling process at which antigen was detectable in 
ELISA tests with ED7. 
c. Fusarium strains in bold further characterized by TEF-1 PCR analysis 
(Table 4.3 and Appendix 4). 
 
 
Table 4. 2. Summary of ELISA tests and mycological culture of sink swabs. 
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Table 4. 3. Summary of species complex identities following TEF-1 PCR 
analysis of Fusarium isolates recovered from sinks. The TEF-1 gene 




Location TEF-1 ID 
A1-1 University F. oxysporum species complex 33 
A1-2 University F. oxysporum species complex 33 
A2-1 University F. solani species complex 1-a 
A2-3 University F. oxysporum species complex 33 
A2-5 University F. solani species complex 1-a 
A5-1 University F. oxysporum species complex 33 
A5-6 University F. oxysporum species complex 33 
A6-1 University F. oxysporum species complex 33 
A6-2 University F. oxysporum species complex 33 
A6-3 University F. oxysporum species complex 33 
A6-4 University F. solani species complex 9-a 
A7-3 University F. oxysporum species complex 183 
A7-4 University F. oxysporum species complex 126 
A8-1 University F. oxysporum species complex 33 
A8-2 University F. oxysporum species complex 33 
A9-1 University F. solani species complex 5-d 
A9-2 University F. solani species complex 5-d 
A9-3 University F. solani species complex 1-c 
A9-4 University F. solani species complex 1-a 
B1-1 University F. dimerum species complex ET-gr. 
B1-6 University F. dimerum species complex ET-gr. 
B2-1 University F. dimerum species complex ET-gr. 
B2-5 University F. dimerum species complex ET-gr. 
B4-1 University F. dimerum species complex ET-gr. 
B5-1 University F. oxysporum species complex 16 
B5-3 University F. oxysporum species complex 16 
B6-1 University F. oxysporum species complex 16 
B6-2 University F. oxysporum species complex 16 
B7-1 University F. oxysporum species complex 16 
B7-6 University F. dimerum species complex ET-gr. 
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B8-1 University F. solani species complex 15-a 
B9-2 University F. oxysporum species complex 99 
B9-3 University F. solani species complex 1-a 
B10-1 University F. oxysporum species complex 33 
B10-2 University F. oxysporum species complex 33 
C1-3 University F. oxysporum species complex 33 
C1-4 University F. dimerum species complex ET-gr. 
C2-1 University F. oxysporum species complex 33 
C2-4 University F. oxysporum species complex 33 
C2-7 University F. oxysporum species complex 33 
C3-1 University F. oxysporum species complex 134 
C3-2 University F. oxysporum species complex 134 
C3-4 University F. oxysporum species complex 134 
C4-1 University F. oxysporum species complex 33 
C4-5 University F. dimerum species complex ET-gr. 
C5-1 University F. oxysporum species complex 33 
C5-2 University F. oxysporum species complex 126 
C5-3 University F. oxysporum species complex 33 
C5-4 University F. oxysporum species complex 33 
C5-5 University F. oxysporum species complex 33 
C6-1 University F. oxysporum species complex 33 
C6-2 University F. oxysporum species complex 33 
C6-3 University F. oxysporum species complex 33 
C6-4 University F. oxysporum species complex 33 
C6-5 University F. oxysporum species complex 33 
C7-1 University F. oxysporum species complex 134 
C8-1 University F. oxysporum species complex 134 
C8-2 University F. oxysporum species complex 134 
C8-6 University F. oxysporum species complex 33 
C9-1 University F. oxysporum species complex 134 
C9-2 University F. oxysporum species complex 134 
C9-3 University F. oxysporum species complex 134 
C9-4 University F. oxysporum species complex 134 
C9-5 University F. oxysporum species complex 134 
C10-1 University F. oxysporum species complex 111 
C10-2 University F. solani species complex 2-v 
C10-4 University F. solani species complex 2-v 
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C10-7 University F. solani species complex 2-v 
CRT1-1 University F. oxysporum species complex 33 
CRT1-2 University F. oxysporum species complex 33 
CRT1-3 University F. oxysporum species complex 33 
R1-1 ICU F. solani species complex 1-a 
R1-2 ICU F. solani species complex 1-a 
R1-3 ICU F. solani species complex 1-a 
R5-1 ITU F. dimerum species complex ET-gr. 
R5-2 ITU F. dimerum species complex ET-gr. 
R5-3 ITU F. dimerum species complex ET-gr. 
R6-1 ITU F. dimerum species complex ET-gr. 
R6-2 ITU F. dimerum species complex ET-gr. 
R6-3 ITU F. dimerum species complex ET-gr. 
R6-9 ITU F. solani species complex 20-d 
R7-1 ITU F. dimerum species complex ET-gr. 
R7-2 ITU F. dimerum species complex ET-gr. 
R8-1 ITU F. dimerum species complex ET-gr. 
R8-2 ITU F. dimerum species complex ET-gr. 
R8-3 ITU F. dimerum species complex ET-gr. 
X2-2 ITU F. dimerum species complex ET-gr. 
X2-4 ITU F. dimerum species complex ET-gr. 
X2-5 ITU F. dimerum species complex ET-gr. 
X2-6 ITU F. dimerum species complex ET-gr. 
X3-1 Ophthalmology Unit F. dimerum species complex ET-gr. 
X3-3 Ophthalmology Unit F. dimerum species complex ET-gr. 
X4-1 Ophthalmology Unit F. dimerum species complex ET-gr. 
X4-2 Ophthalmology Unit F. dimerum species complex ET-gr. 
X5-2 Ophthalmology Unit F. dimerum species complex ET-gr. 
X5-4 Ophthalmology Unit F. dimerum species complex ET-gr. 
K2-3 Haematology Unit F. solani species complex 5-k 
K2-4 Haematology Unit F. solani species complex 5-k 
K6-1 Haematology Unit F. oxysporum species complex 33 
K8-1 Haematology Unit F. solani species complex 5-k 
K8-2 Haematology Unit F. solani species complex 5-k 
K9-5 Haematology Unit F. solani species complex 2-a 
K9-6 Haematology Unit F. solani species complex 2-a 
K10-1 Haematology Unit F. solani species complex 2-a 
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K10-2 Haematology Unit F. solani species complex 2-a 
H1-1 Oncology Unit F. dimerum species complex ET-gr. 
H2-1 Oncology Unit F. dimerum species complex ET-gr. 
H3-1 Oncology Unit F. oxysporum species complex 33 
H4-1 Oncology Unit F. dimerum species complex ET-gr. 
H5-1 Oncology Unit F. dimerum species complex ET-gr. 
H6-1 Oncology Unit F. dimerum species complex ET-gr. 
H7-1 Oncology Unit F. oxysporum species complex 33 
H10-1 Oncology Unit F. dimerum species complex ET-gr. 
P2-1 Oncology Unit F. dimerum species complex ET-gr. 
P2-2 Oncology Unit F. dimerum species complex ET-gr. 
P2-3 Oncology Unit F. dimerum species complex ET-gr. 
P5-1 Oncology Unit F. dimerum species complex ET-gr. 
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4.4. Discussion 
The genus Fusarium comprises ubiquitous environmental moulds capable of 
infecting plants and humans (Zhang et al., 2006). Unlike agriculture, where the 
most economically damaging pathogens are considered to be F. graminearum 
and F. oxysporum (Dean et al., 2012), the species most commonly cited as 
human pathogens belong to the FSSC, responsible for 50% of reported 
infections in humans, followed by strains in the FOSC (Torres and Kontoyiannis, 
2011). The FDSC is less frequently reported as causing human disease, but it is 
similarly capable of causing disseminated infections in immunocompromised 
patients (Bigley et al., 2004; Schroers et al., 2009).  
 
While the natural habitats of plant pathogenic Fusarium strains are well 
characterized as soil and decaying plant material, habitats providing direct 
human exposure to infectious propagules are largely unexplored. The 
increasing frequency of opportunistic fungal infections in humans means that 
improved surveillance methods are needed to identify environmental reservoirs 
of pathogens to limit the exposure of vulnerable individuals to potentially 
infective propagules. For Fusarium, there is a growing body of evidence to 
suggest that domestic and municipal water systems are potential reservoirs of 
human pathogenic strains in the FSSC, FOSC and FDSC groups (Short et al., 
2011).  
 
Accurate techniques that can be used to identify the fungus in environmental 
samples containing mixed populations of fungi are currently lacking and, while 
nucleic acid-based technologies have been developed for the differentiation of 
Fusarium from other human pathogenic species and to identify Fusarium 
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species complexes, such techniques have typically been used in retrospective 
analysis of axenic cultures collected during human and environmental 
population studies (Bouchara et al., 2009; Steinmann et al., 2011; Lackner et 
al., 2012). Furthermore, these studies have often employed Fusarium-selective 
medium that eliminate other fungi present in polymicrobial communities (Short 
et al., 2011). While mAbs and antibody fragments have been developed for 
detecting and differentiating Fusarium species in vitro or in planta (Wong et al., 
1988; Arie et al., 1991, 1995; Danks et al., 1996; Hayashi et al., 1998; Hu et al., 
2012, 2013), no attempts have been made to use mAbs to track human 
pathogenic strains in environmental samples. Jensen et al. (2011) recently 
reported the development of Fusarium-specific mAbs for immunohistochemical 
diagnosis of fusariosis. The IgM mAbs, which recognise 51 and 63 kDa 
antigens, reacted strongly with fungal elements in both experimentally infected 
animals and biopsy samples from patients with fusariosis sepsis and 
dissemination to the skin.  
 
In this prospective study, we set out to determine whether human pathogenic 
species of Fusarium could be identified in sink drains directly by using crude 
antigen extracts of biofilms and detection using a genus-specific IgM mAb, ED7, 
that binds to an extracellular ~ 200kDa carbohydrate antigen present on the 
surface of spores and hyphae (Chapter 2). While the function of the antigen is 
currently unknown we were able, in ELISA tests, to detect its presence in 52% 
of swab samples and, following biological amplification of biofilms on a non-
selective mycological medium, were able to identify additional biofilm samples 
containing pathogenic strains of Fusarium. This is the first time, to our 
knowledge, that the mAb-based detection method has been used to track 
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Fusarium in environmental samples. The mAb was able to differentiate 
Fusarium from a broad spectrum of unrelated fungi, including the human 
pathogens Aspergillus (Thornton and Wills, 2015), Candida, Geotrichum, 
Rhodotorula and Trichosporon (Davies and Thornton, 2014; Miceli et al., 2011), 
Cyphellophora and Phialophora (Feng et al., 2014), Exophiala (Zeng et al., 
2007), Trichoderma (Sandoval-Denis et al., 2014), Engyodontium (Macêdo et 
al., 2007; Thamke et al., 2015) and Mucor (Petrikkos et al., 2012), several of 
which have been reported previously to inhabit biofilms in water distribution 
systems (Dogget, 2000). The 100% accuracy of the ED7 ELISA, confirmed by 
using ITS sequencing and TEF PCR analysis of recovered isolates, 
demonstrates its robustness in detecting potentially infectious Fusarium species 
in polymicrobial communities. Importantly, ED7 reacted with all of the species 
complex strains isolated including the most common clinical pathotypes of 
Fusarium, FSSC 1-a, FOSC 33 and FDSC ET-gr (Schroers et al., 2009; Short 
et al., 2011).  
 
While the ED7 ELISA was able to identify Fusarium to the level of genus only, 
the simplicity of the mAb-based approach to detection, even when combined 
with a standard mycological isolation procedure, means that a recognised 
environmental niche of this group of pathogenic fungi can be monitored readily. 
The widespread occurrence of human pathogenic Fusarium species in sinks of 
a tertiary care hospital and sinks of a heavily populated university campus, 
show that indoor plumbing-associated biofilms and water sources are an 
unseen source of Fusarium infectious propagules for nosocomial and 
community-acquired infections of vulnerable individuals, an observation 
consistent with previous studies (Annaisie et al., 2011; Short et al., 2011). While 
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no cases of fusariosis were reported during the course of this study, the close 
proximity of the patients to hospital sinks colonised with both pathogenic fusaria 
and with other opportunistic fungal pathogens is a serious concern given the 
known vulnerability of immunocompromised individuals to invasive fungal 
infections. 
 
Summary of Key Findings: 
1. The mAb ED7 is 100% accurate in detecting Fusarium species antigens by 
ELISA in mixed community of fungal biofilms with no cross-react with 
unrelated human pathogenic fungi or yeasts. 
2. Three major human pathogenic Fusarium species belong to F. solani,  
F. oxysporum and F. dimerum were isolated at 52% out of a total number 
225 of fungi recovered from sink swabs and water system samples that 
collected across a University campus and tertiary care hospital units. 
3. The ITS sequencing 100% validated identification of Fusarium genus by 
ELISA.  
4. The TEF-1 analysis data for identification of Fusarium at species complex 
level showed that FSSC 1-a, FOSC 33 and FDSC ET-gr are the most clinical 
frequent pathotypes recovered from swabs and water samples.  
5. The dominant species complex recovered from the University sink drain 
biofilms related to FOSC (47.6%), followed by FSSC (11.2%) and then FDSC 
(7.4%). At the RD&E hospital, FDSC (27.1%) was found the most frequent 
grouping, followed by FSSC (9.3%) and then by FOSC (3.3%). 
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Chapter 5. General Discussion 
5.1 Epidemiology of fungal infections 
Over the past decade, the incidence of disseminated infections caused  
by opportunistic fungal pathogens has increased in line with the ever expanding 
populations of at-risk patients including BMT and SOT recipients, AIDS patients 
and those receiving broad-spectrum antibiotics, high-dose corticosteroids and 
aggressive anti-cancer treatments (Badiee et al., 2009; Crabol et al., 2014; 
Slavin & Grist, 2013). 
 
Aspergillus and Candida species are the most frequently cited opportunistic 
pathogens of immune impaired humans (Menzin et al., 2009; Nucci & Marr, 
2005; Pagano et al., 2006; Pfaller et al., 2006) which, along with other moulds 
and yeasts, are responsible for high rates of mortality and morbidity in 
susceptible patient populations (Dictar et al., 2000; Menzin et al., 2009; 
Montagna et al., 2013). Indeed, Fusarium species are the second most 
common opportunistic fungi after Aspergillus, involved in superficial infections of 
the skin and eyes but also as invasive pathogens of the severely 
immunocompromised (Boutati & Anaissie, 1997; Nucci et al., 2004; van 
Diepeningen et al., 2015).  The principle portal of entry of  Fusarium infectious 
propagules is the respiratory tract through the inhalation of indoor or outdoor air 
laden with air-borne conidia, the skin, and the digestive system through 
ingestion of contaminated water or food (Araujo et al., 2010; Legrand et al., 
1991; Lockhart et al., 2009; Nucci & Anaissie, 2007). Fusarium species cause  
a range of infections including dermatomycosis, keratitis, onychomycosis for 
both immunocompetent and impaired immune system individuals such 
neutropenic patients (Brasch & Köppl, 2009; Brasch & Shimanovich, 2012; 
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Chang et al., 2006; Cuero, 1980; Girmenia et al., 1992; Godoy et al., 2004; 
Gungel et al., 2011; Sekeroglu et al., 2012; Verma & Tuft, 2002; Zhang et al., 
2006). Invasive fusariosis among immunocompromised patients with 
haematological disorders commonly associated with relatively high mortality 
rate 50% to ~90% (Dignani & Anaissie, 2004; Horn et al., 2014; Hsiue et al., 
2010; Stempel et al., 2015).  
 
The epidemiology of fusariosis infections varies and corresponding to many 
factors such the host health situation and geographic region (Garnica & Nucci, 
2013). Given the ubiquity of the Fusarium species in the environment, climate 
factors such wind and rain are more likely play an effective way in the Fusarium 
spores dispersion by which fusariosis may potentially be acquired in the clinic or 
non-clinic areas (Dignani & Anaissie, 2004; Garnica & Nucci, 2013; Palmero  
et al., 2010). In prospective studies, pathogenic Fusarium species in the USA 
were recovered from a hospital water system including sink biofilms, tap water 
and water storage tanks, shower and sink drains, shower heads and sink faucet 
aerators from hospital air and other environments (Anaissie et al., 2001; Short 
et al., 2011). Recently, similar this observation has been reported at a tertiary 
care hospital in the UK (Al-Maqtoofi & Thornton, 2016). More than 70% of 
clinical Fusarium species that isolated from water system in the hospitals were 
genetically similar to those isolated from the environment and that suggested 
the geographical widespread (O’Donnell et al., 2004).  
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5.2 Diagnosis and Treatment of Fusarium Infections  
Diagnosis and treatment of fusariosis in immunocompromised patients is a real 
challenge due to the lack of accurate diagnostic test and resistance to 
practically all available antifungal drugs (Muhammed et al., 2011; Thornton, 
2011; van Diepeningen et al., 2015). Diagnosis of the Fusarium infections is 
critical for timely and appropriate treatment. At present, the gold standard for 
detection of fusariosis and other IFI is mycological culture of the fungus from 
blood samples or from biopsy samples. As with any IFI, diagnosis must confirm 
to standards set out in the European Organization for Research and Treatment 
of Cancer and the the National Institute of Allergy and Infectious Diseases 
Mycoses Study Group (EORTC/MSG diagnostic criteria. In 2002, the 
EORTC/MSG classified potential cases of IFI into possible, probable and 
proven case to o facilitate drawing a policy for epidemiological studies, clinical 
practice guide, treatment and diagnosis tests validation (Ascioglu et al., 2002). 
Based on that, fungus propagules has to be detected from a specimen of sterile 
site by histological analysis or culture based method to be considered as 
proven infection (Ascioglu et al., 2002; De Pauw et al., 2008; Tsitsikas et al., 
2012). Possible and probable delimitations depends on a host factor for 
immune deficiency patients, clinical symptoms and microbiological observations 
including culture based method with microscopic analysis and non–culture-
based diagnostic tests by high resolution scan, molecular detection, and 
through fungal antigen detection using ELISA test for GM and BDG (De Pauw 
et al., 2008). Therefore, isolation of Fusarium from blood or other sterile site 
biopsy with clinical symptoms is recognized as proven invasive infection, while 
recovering of Fusarium from respiratory tract secretion with demonstrating 
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clinical signs can be defined as probable (Garnica et al., 2015; Nucci et al., 
2004).  
 
Clinically, skin lesions and positive blood cultures for the mould consider 
characteristic feature of invasive fusariosis (Jain et al., 2011; Nucci & Anaissie, 
2007). This procedure is time-consuming, require skilled mycologists and have 
poor diagnostic sensitivities since Fusarium species exhibit similar 
morphological appearances with other hyalohyphomycete fungi such as 
Aspergillus leading to misdiagnosis (Tortorano et al., 2014; van Diepeningen et 
al., 2015;). An added complication is that skin lesions, which are the most 
common clinical presentation associated with disseminated fusariosis, appear 
at the later stage of infection (Boutati & Anaissie, 1997; Dignani & Anaissie, 
2004).  
 
Commercially, GM and BDG assay cross react with other emerging pathogens 
resulting in losing specificity and sensitivity to use for diagnosis of Fusarium  
at species or even genus level (Mikulska et al., 2012; Nucci et al., 2014; 
Tortorano et al., 2012; Yoshida, 2006;). In addition, Recently,  
an immunochromatographic lateral-flow device (LFD) has been developed 
using a highly specific mouse mAb, JF5, specific to a protein epitope expressed 
on an extracellular glycoprotein antigen of Aspergillus in human serum with no 
cross reactivity with other clinically important fungal pathogens, including 
Candida, Cryptococcus neoformans, F. solani, Penicillium marneffei, P. boydii, 
and Rhizopus oryzae (Thornton, 2008). The mAb JF5 has been engineered to 
draw a new view for monitoring Aspergillus infection and treatment progress 
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through positron emission tomography and magnetic resonance (immune 
PET/MR) imaging (Rolle et al., 2016).  
 
Molecular amplification technique using PCR might provide a promising tool for 
the IFI diagnosis (Lass-Flörl et al., 2013; Lau et al., 2007), with consideration of 
avoiding misdiagnosis due DNA contamination (Barnes, 2008; Donnelly, 2006; 
Dornbusch et al., 2010). Using imaging methods such chest radiography and 
computed tomography (CT) for diagnosis of invasive fusariosis among 
immunocompromised patients has limited help for early diagnosis and track the 
treatment progress (Barnes, 2008; van Diepeningen et al., 2015; Marom et al., 
2008).  
 
The lack of diagnostic test for the Fusarium can be due to missing the general 
infrequency of the infection cases over world wild (Guarro, 2013). In addition, 
developing species-specific or genus-specific monoclonal antibodies is 
problematic because Fusarium shares the antigenic cell wall determinants, such 
as GM and BDG with other related and unrelated pathogenic fungi (Aquino  
et al., 2007; Kedzierska, 2007; Khan et al., 2008; Mikulska et al., 2012; Odabasi 
et al., 2004; Ostrosky-Zeichner et al., 2005; Tortorano et al., 2012). There are 
few studies managed to generate mAb specific for Fusarium to quantify fungal 
biomass in plant hosts (Arie et al., 1995; Gan et al.,  1997; Hayashi et al.,  
1998) or Fusarium mycotoxins that affected economical crops (Hill et al., 2006; 
Maragos et al., 2013). However, these works have never been validated for 
medical usage against a broad range of clinically important opportunistic 
pathogenic filamentous fungi or yeasts. Therefore, this study provides powerful 
findings in developing a rapid and accurate immunodiagnostic test can 
Chapter 5                                                                                           General Discussion  
 144 
specifically recognize epitope with a single glycoprotein epitope expressed on 
the extracellular carbohydrate antigen and located on the Fusarium propagules 
with a molecular mass of ~200 kDa with no cross reactivity with other 
pathogenic fungi. This fitful the urgent needs for early, rapid and accurate 
diagnostic test specific for Fusarium, in particular F. solani, that can lead to 
manage fusariosis infections (Araujo et al., 2010; Hue et al., 1999; Nucci et al., 
2003; Richardson & Warnock, 2003; Roilides et al., 2007; Stevens, 2002; van 
Diepeningen et al., 2015). There is only one study mentioned using developed 
a mAb, IgM, can bind to two antigens of Fusarium with 51 and 63 kDa in 
infected animal model with no cross reactivity with other fungal pathogens 
including Aspergillus, Candida and Scedesporum (Jensen et al., 2011).  
 
Macrophages are professional phagocytes that play a key role as the first line of 
the cellular innate immunity that response to Fusarium invaders. AMØs are able 
to recognize and internalize fungal propagules  through phagocytosis leading to 
eliminate fungal infections and dissemination (Brakhage et al., 2010; Figueiredo 
et al., 2011; Roilides et al., 2006). Thus, patients with an impaired immune 
system due to having cytotoxic therapy will be at the highest risk for developing 
disseminated invasive fusariosis (Cooke et al., 2009; Lucca, 2007; Nucci et al., 
2004; Nucci & Anaissie, 2002; Perez-Perez et al., 2007; Tortorano et al., 2014; 
Yera et al., 2003). Currently, little is known about the interaction between 
Fusarium species and macrophages (Nucci & Anaissie, 2007; Schäfer et al., 
2014). Here, in this phagocytosis of F. solani by the MH-S murine macrophage 
cell line was investigated and the findings demonstrate the ability of AMØs for 
uptaking spores and germinated spores. Moreover, this data highlighted two 
novel observations. First, the ability of phagocytosed spores to germinate inside 
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AMØ phagosome resulting in macrophage lysis and escape. Second, scape of 
internalized spore without macrophage lysis. These observations might indicate 
to a way of Fusarium resist the fungicidal mechanisms of phagosome including 
reactive oxygen species (ROS) and AMPs for developing disseminated disease. 
To our knowledge, this is the first analysis of the phagocytosis process for the 
important emerging opportunist human pathogen F. solani. These results 
suggested the need of more studies on the interaction between F. solani and 
the AMØs to better understand the recogniation and clearnce mechanisms by 
the cellular innate immunity for managing Fusarium infections. 
 
The Fusarium species most commonly cited as human pathogens belong to 
species complex including FSSC, causes 50% of human infections, followed by 
FOSC (Torres & Kontoyiannis, 2011). The FDSC is less frequently reported as 
causing human disease, but it is similarly capable of causing disseminated 
infections in severely immunosuppressive patients (Bigley et al., 2004; Vismer  
et al., 2002). Identification the environmental reservoirs of pathogenic Fusarium 
species complex is essential for understanding the epidemiology of the 
Fusarium prevalence (Zhang et al., 2006). There is increasing trend of 
opportunistic fusariosis infections in humans associates with surveillance 
methods within environmental reservoirs of fungal propagules (Raad et al., 
2002). Recent studies showed that domestic and municipal water systems are 
potential reservoirs of human pathogenic strains in the FSSC, FOSC and FDSC 
groups (Short et al., 2011). Here, we set out to determine whether human 
pathogenic species of Fusarium could be identified in sink drains directly by 
using crude antigen extracts of biofilms and detection using the mAb, ED7 by 
ELISA. The results showed that the mAb ED7 able to react with Fusarium 
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antigens in swab samples but no other unrelated fungal antigens existed within 
biofilm structures in water distribution systems such as Aspergillus and 
Candida. Interestingly, the Fusarium species were predominately recovered 
from more than 50% of swab and sink samples. Similar observation was 
reported during screening of Fusarium pathogens in hospital water system 
(Anaissie et al., 2001).  
 
The abundance of the Fusarium species in water system indicates to two main 
noteworthy features. First, pathogenic Fusarium species are able to adapt to 
urban aquatic environment of hospital and the university campus. Second, the 
Fusarium species performed strong resistance to antifungal water supply 
treatment. These features might result in nosocomial outbreak infections 
particularly in a hospital area associated with water distribution system. It has 
been suggested that emerging pathogenic Fusarium species are able to adapt 
in hospital and non-hospital water system (Sautour et al., 2012; Steinberg et al., 
2015).  
 
Validation analysis using ITS sequencing and amplification of TEF gene by 
PCR analysis of recovered isolates confirmed the 100% accuracy and 
sensitivity of ED7 for detection a unique epitope of the Fusarium genus 
including medically important species and species complex such as FSSC 1-a, 
FSSC 2, FOSC 33 and FDSC ET-gr in a mixture of fungal biofilms communities 
in skins of a tertiary care hospital and sinks of a heavily populated university 
campus. It is worth to mention that all Fusarium species were recovered from 
haematology unit sink drains related to FSSC. Similar observation had been 
reported (Horn et al., 2014; Scheel et al., 2013). This result revealed an unseen 
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source and the widespread occurrence of human pathogenic Fusarium 
infectious propagules in sinks and water system of a clinic and non-clinic 
environments that could cause outbreak nosocomial infections. This 
observation was reported in previous studies (Anaissie et al., 2001; Short et al., 
2011). To this end, detection of opportunistic fungal pathogens including 
Fusarium and other filamentous and yeasts increases awareness of invasive 




This thesis describes the development of a novel immunodiagnostic assay for 
tracking the emerging human pathogen Fusarium, by using a newly developed 
genus-specific mAb, ED7. Future studies should attempt to develop a rapid 
diagnostic test for the pathogen, employing lateral-flow technology already 
successfully used for other opportunistic pathogens of humans (Thornton, 
2008). This technology could have a significant impact in Fusarium diagnostics, 
delivering accurate and fast detection of the pathogen.  
 
To better understand cellular immune responses to Fusarium solani, the live cell 
imaging studies reported here should be extended. Furthermore, the chemical 
nature of the epitope bound by the spore agglutinating mAb ED7 should be 
investigated as this may provide insights into the recognition of surface antigens 
of infectious propagules by cells of the innate immune system.  
 
Finally, by combining mAb ED7 with the molecular methods of species and sub-
species identification described here, a better understanding of the 
epidemiology of Fusarium and routes of exposure of susceptible individuals to 
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human pathogenic strains, may help to control nosocomial and community 
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APPENDIX 1: Agglutination Data 
 
Figure 5.1. Agglutination of Fusarium species microconidia. (A) F. sacchari 
(CBS183.32), (B) F. verticilliodes (CBS102.699), (C) F. oxysporum var. 
vasinfectum (CBS409.96), (D) F. solani var. petroliphilum (CBS102256), (E)  
F. anthothilum (CBS222.76), (F) F. solani (CBS188.34), (G) F. solani 
(CBS117.608) and (H) F. solani (CBS109.696) spores suspended at 106 spore 
ml-1 in ED7 TCS and 10% TCM. Each point is the mean of 3 replicates ± S.E. 
Note rapid decrease in absorbance of light at 555nm due to agglutination of 








Figure 5.2. Agglutination of Fusarium species microconidia. (A) F. proliferatum 
var. proliferatum (CBS181.30), (B) F. nygami (CBS140.93), (C) F. oxysporum 
f.sp. radicis-lycopersici (CBS872.95) and (D) F. oxysporum f.sp. lycopersici 
(CBS167.30) spores suspended at 106 spore ml-1 in ED7 TCS and 10% TCM. 
Each point is the mean of 3 replicates ± S.E. Note weak agglutination of spores 



















Figure 5.3. Agglutination of Fusarium species microconidia. (A) F. oxysporum 
f.sp. cucurbitacearum (CBS254.52), (B) F. incarnatum (CBS678.77), (C)  
F. solani (CBS115.659) and (D) F. chlamydosporium  var. chlamydosporium 
(CBS491.77) spores suspended at 106 spore ml-1 in ED7 TCS and 10% TCM. 
Each point is the mean of 3 replicates ± S.E. Note lack of spore agglutination of 
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APPENDIX 2: Phylogeny Trees 
 
 
























































Figure 5. 4. Phylogram of the recovered fungal isolates from sink drains and 
water system based on ITS compare with reference isolates from NCBI. The 
trees are divided based on location of swab samples (A and B): University, (C): 
ICU, (D): ITU, (E): Ophthalmology Unit, (F): Haematology Unit and (G): 
Oncology Unit. 
 





































APPENDIX 3: ITS Sequences 
 
>Seq1 [organism=Candida parapsilosis] [isolate X9-2] internal transcribed spacer 1, 5.8S 
ribosomal RNA gene, and internal transcribed spacer 2, complete sequence; and 28S ribosomal 










>Seq2 [organism=Candida parapsilosis] [isolate X9-3] internal transcribed spacer 1, 5.8S 
ribosomal RNA gene, and internal transcribed spacer 2, complete sequence; and 28S ribosomal 











>Seq3 [organism=Candida parapsilosis] [isolate X3-2] internal transcribed spacer 1, 5.8S 
ribosomal RNA gene, and internal transcribed spacer 2, complete sequence; and 28S ribosomal 












>Seq4 [organism=Candida parapsilosis] [isolate X6-1] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq5 [organism=Fusarium dimerum] [isolate X4-2] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 









   
>Seq6 [organism=Rhodotorula mucilaginosa] [isolate X5-3] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 














>Seq7 [organism=Exophiala pisciphila] [isolate X9-7] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 













>Seq8 [organism=Exophiala dermatitidis] [isolate X9-4] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 













>Seq9 [organism=Exophiala phaeomuriformis] [isolate X6-4] internal transcribed spacer 1, 
partial sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete 














>Seq10 [organism=Coniothyrium fuckelii] [isolate W1-1] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 












>Seq11 [organism=Cladosporium macrocarpum] [isolate X8-2] internal transcribed spacer 1, 
partial sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete 











>Seq12 [organism=Cladosporium sphaerospermum] [isolate X10-1] internal transcribed spacer 
1, partial sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete 













>Seq13 [organism=Candida parapsilosis] [isolate X4-3] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq14 [organism=Fusarium dimerum] [isolate X3-1] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq15 [organism=Fusarium dimerum] [isolate X5-2] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 













>Seq16 [organism=Fusarium dimerum] [isolate X4-1] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq17 [organism=Fusarium dimerum] [isolate X3-3] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq18 [organism=Fusarium dimerum] [isolate X5-4] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 













>Seq19 [organism=Gloeotinia temulenta] [isolate X8-3] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 












>Seq20 [organism=Gloeotinia temulenta] [isolate X4-4] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 










GAAAACCC    
 
>Seq21 [organism=Engyodontium album] [isolate W1-3] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 














>Seq22 [organism=Engyodontium album] [isolate W1-2] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 












>Seq23 [organism=Engyodontium album] [isolate X10-3] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 












>Seq24 [organism=Engyodontium album] [isolate X9-5] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 














>Seq25 [organism=Engyodontium album] [isolate X9-1] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 












>Seq26 [organism=Engyodontium album] [isolate X6-3] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 












>Seq27 [organism=Engyodontium album] [isolate X6-2] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 














>Seq28 [organism=Engyodontium album] [isolate X8-4] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 












>Seq29 [organism=Candida parapsilosis] [isolate K6-4] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq30 [organism=Candida parapsilosis] [isolate K9-1] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 













>Seq31 [organism=Rhodotorula dairenensis] [isolate K9-2] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 












>Seq32 [organism=Exophiala castellanii] [isolate G7-2] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 












>Seq33 [organism=Exophiala castellanii] [isolate G6-2] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 














>Seq34 [organism=Exophiala pisciphila] [isolate G1-2] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 













>Seq35 [organism=Exophiala pisciphila] [isolate G2-3] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 













>Seq36 [organism=Cadophora fastigiata] [isolate K8-6] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 















>Seq37 [organism=Cadophora fastigiata] [isolate K9-4] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 













>Seq38 [organism=Trichoderma viride] [isolate K2-1] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 












>Seq39 [organism=Trichoderma asperellum] [isolate K1-1] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 














>Seq40 [organism=Trichoderma asperellum] [isolate K8-7] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 












>Seq41 [organism=Gloeotinia temulenta] [isolate G4-1] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 












>Seq42 [organism=Gloeotinia temulenta] [isolate G9-2] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 














>Seq43 [organism=Engyodontium album] [isolate G8-1] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 












>Seq44 [organism=Engyodontium album] [isolate G10-1] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 














>Seq45 [organism=Engyodontium album] [isolate G2-1] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 












>Seq46 [organism=Fusarium oxysporum] [isolate K6-1] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq47 [organism=Fusarium solani] [isolate K2-4] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 













>Seq48 [organism=Fusarium solani] [isolate K2-3] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq49 [organism=Fusarium solani] [isolate K10-2] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq50 [organism=Fusarium solani] [isolate K9-6] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 













>Seq51 [organism=Fusarium solani] [isolate K10-1] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq52 [organism=Fusarium solani] [isolate K9-5] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq53 [organism=Trichoderma asperellum] [isolate R3-1] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 














>Seq54 [organism=Fusarium solani] [isolate R1-3] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 












>Seq55 [organism=Fusarium solani] [isolate R1-1] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq56 [organism=Fusarium solani] [isolate R1-2] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 












>Seq57 [organism=Bionectria ochroleuca] [isolate R2-4] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq58 [organism=Bionectria ochroleuca] [isolate R2-5] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq59 [organism=Bionectria ochroleuca] [isolat R2-6] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 










>Seq60 [organism=Exophiala phaeomuriformis] [isolate R9-3] internal transcribed spacer 1, 
partial sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete 















>Seq61 [organism=Cadophora fastigiata] [isolate R10-2] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 







>Seq62 [organism=Fusarium oxysporum] [isolate R6-9] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 












>Seq63 [organism=Fusarium dimerum] [isolate R8-3] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 














>Seq64 [organism=Fusarium dimerum] [isolate X2-6] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq65 [organism=Fusarium dimerum] [isolate X2-4] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq66 [organism=Fusarium dimerum] [isolate R5-1] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 













>Seq67 [organism=Fusarium dimerum] [isolate R6-3] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq68 [organism=Fusarium dimerum] [isolate R6-2] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq69 [organism=Fusarium dimerum] [isolate R7-2] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 













>Seq70 [organism=Fusarium dimerum] [isolate R5-2] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq71 [organism=Fusarium dimerum] [isolate R8-2] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq72 [organism=Fusarium dimerum] [isolate R5-3] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 













>Seq73 [organism=Fusarium dimerum] [isolate R8-1] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq74 [organism=Fusarium dimerum] [isolate X2-5] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq75 [organism=Fusarium dimerum] [isolate R7-1] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 












>Seq76 [organism=Fusarium dimerum] [isolate X2-2] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq77 [organism=Fusarium dimerum] [isolate R6-1] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq78 [organism=Candida palmioleophila] [isolate H3-4] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 














>Seq79 [organism=Candida tropicalis] [isolate H5-3] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 










>Seq80 [organism=Candida tropicalis] [isolate H7-3] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq81 [organism=Candida orthopsilosis] [isolate H9-2] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 










>Seq82 [organism=Candida albicans] [isolate H8-3] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 













>Seq83 [organism=Pichia kudriavzevii] [isolate H1-3] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 










>Seq84 [organism=Pichia kudriavzevii] [isolate H9-3] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 










>Seq85 [organism=Phoma herbarum] [isolate H8-1] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 













>Seq86 [organism=Exophiala dermatitidis] [isolate H9-1] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 













>Seq87 [organism=Exophiala dermatitidis] [isolate P1-2] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 













>Seq88 [organism=Fusarium oxysporum] [isolate H7-1] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 













>Seq89 [organism=Fusarium oxysporum] [isolate H3-1] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq90 [organism=Gliomastix polychroma] [isolate P4-2] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 












>Seq91 [organism=Beauveria bassiana] [isolate P4-1] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 













>Seq92 [organism=Fusarium dimerum] [isolate P2-1] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq93 [organism=Fusarium dimerum] [isolate P2-3] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq94 [organism=Fusarium dimerum] [isolate H10-1] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 













>Seq95 [organism=Fusarium dimerum] [isolate H2-1] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq96 [organism=Fusarium dimerum] [isolate P5-1] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq97 [organism=Fusarium dimerum] [isolate P5-2] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 














>Seq98 [organism=Fusarium dimerum] [isolate H5-1] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq99 [organism=Fusarium dimerum] [isolate H6-1] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq100 [organism=Fusarium dimerum] [isolate H1-1] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 













>Seq101 [organism=Fusarium dimerum] [isolate H4-1] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq102 [organism=Fusarium dimerum] [isolate P2-2] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq103 [organism=Rhodotorula glutinis] [isolate H3-5] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 














>Seq104 [organism=Rhodotorula mucilaginosa] [isolate H8-4] internal transcribed spacer 1, 
partial sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete 












>Seq105 [organism=Stereum gausapatum] [isolate P9-1] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 













>Seq106 [organism=Stereum gausapatum] [isolate P8-2] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 














>Seq107 [organism=Stereum gausapatum] [isolate P9-3] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 













>Seq108 [organism=Trametes versicolor] [isolate P1-3] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 












>Seq109 [organism=Trametes versicolor] [isolate P9-2] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 














>Seq110 [organism=Trametes versicolor] [isolate P7-1] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 












>Seq111 [organism=Trametes versicolor] [isolate P8-1] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 












>Seq112 [organism=Trametes ochracea] [isolate P3-1] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 














>Seq113 [organism=Trametes ochracea] [isolate H10-4] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 












>Seq114 [organism=Piptoporus betulinus] [isolate P5-3] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 













>Seq115 [organism=Phaeophlebiopsis peniophoroides] [isolate P10-1] internal transcribed 
spacer 1, partial sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, 















>Seq116 [organism=Magnusiomyces capitatus] [isolate H2-5] internal transcribed spacer 1, 
partial sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete 










>Seq117 [organism=Magnusiomyces capitatus] [isolate H4-3] internal transcribed spacer 1, 
partial sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete 










>Seq118 [organism=Galactomyces candidum] [isolate H7-2] internal transcribed spacer 1, 
partial sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete 







>Seq119 [organism=Cyphellophora oxyspora] [isolate A3-3] internal transcribed spacer 1, 
partial sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete 













>Seq120 [organism=Cyphellophora oxyspora] [isolate A5-8] internal transcribed spacer 1, 
partial sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete 













>Seq121 [organism=Cadophora fastigiata] [isolate A3-2] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 















>Seq122 [organism=Exophiala pisciphila] [isolate A10-2] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 













>Seq123 [organism=Exophiala pisciphila] [isolate C1-7] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 













>Seq124 [organism=Exophiala pisciphila] [isolate A7-1] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 















>Seq125 [organism=Trichoderma asperellum] [isolate CRT2-1] internal transcribed spacer 1, 
partial sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete 












>Seq126 [organism=Trichoderma asperellum] [isolate A4-6] internal transcribed spacer 1, 
partial sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete 












>Seq127 [organism=Trichoderma asperellum] [isolate CRT2-2] internal transcribed spacer 1, 
partial sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete 














>Seq128 [organism=Trichoderma atroviride] [isolate A8-3] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 












>Seq129 [organism=Fusarium dimerum] [isolate B7-6] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq130 [organism=Fusarium dimerum] [isolate B2-5] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 













>Seq131 [organism=Fusarium dimerum] [isolate B1-1] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq132 [organism=Fusarium dimerum] [isolate B2-1] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 












>Seq133 [organism=Fusarium dimerum] [isolate B4-1] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 













>Seq134 [organism=Fusarium dimerum] [isolate B1-6] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq135 [organism=Fusarium dimerum] [isolate C1-4] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq136 [organism=Fusarium dimerum] [isolate C4-5] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 













>Seq137 [organism=Fusarium solani] [isolate A2-5] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq138 [organism=Fusarium solani] [isolate A9-3] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 












>Seq139 [organism=Fusarium solani] [isolate (CBS224.34)] internal transcribed spacer 1, 
partial sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete 













>Seq140 [organism=Fusarium solani] [isolate B9-3] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq141 [organism=Fusarium solani] [isolate A2-1] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 












>Seq142 [organism=Fusarium solani] [isolate A9-4] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 













>Seq143 [organism=Fusarium solani] [isolate B8-1] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 












>Seq144 [organism=Fusarium solani] [isolate A9-2] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq145 [organism=Fusarium solani] [isolate A9-1] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 













>Seq146 [organism=Fusarium solani] [isolate A6-4] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq147 [organism=Fusarium solani] [isolate C10-4] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 












>Seq148 [organism=Fusarium solani] [isolate C10-2] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 













>Seq149 [organism=Fusarium solani] [isolate C10-7] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq150 [organism=Fusarium oxysporum] [isolate C3-4] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq151 [organism=Fusarium oxysporum] [isolate C9-2] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 












>Seq152 [organism=Fusarium oxysporum] [isolate C6-5] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq153 [organism=Fusarium oxysporum] [isolate C9-4] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq154 [organism=Fusarium oxysporum] [isolate A6-1] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 












>Seq155 [organism=Fusarium oxysporum] [isolate C5-3] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq156 [organism=Fusarium oxysporum] [isolate CRT1-2] internal transcribed spacer 1, 
partial sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete 











>Seq157 [organism=Fusarium oxysporum] [isolate C9-1] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 










>Seq158 [organism=Fusarium oxysporum] [isolate C5-1] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 













>Seq159 [organism=Fusarium oxysporum] [isolate CRT1-3] internal transcribed spacer 1, 
partial sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete 











>Seq160 [organism=Fusarium oxysporum] [isolate A8-2] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq161 [organism=Fusarium oxysporum] [isolate C8-2] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 













>Seq162 [organism=Fusarium oxysporum] [isolate C5-2] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq163 [organism=Fusarium oxysporum] [isolate B9-2] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq164 [organism=Fusarium oxysporum] [isolate C2-1] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 













>Seq165 [organism=Fusarium oxysporum] [isolate B10-2] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq166 [organism=Fusarium oxysporum] [isolate C5-5] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq167 [organism=Fusarium oxysporum] [isolate B6-2] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 













>Seq168 [organism=Fusarium oxysporum] [isolate A1-2] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq169 [organism=Fusarium oxysporum] [isolate C9-5] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq170 [organism=Fusarium oxysporum] [isolate C9-3] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 













>Seq171 [organism=Fusarium oxysporum] [isolate C6-1] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq172 [organism=Fusarium oxysporum] [isolate C7-1] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq173 [organism=Fusarium oxysporum] [isolate A5-6] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 













>Seq174 [organism=Fusarium oxysporum] [isolate A1-1] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq175 [organism=Fusarium oxysporum] [isolate C5-4] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq176 [organism=Fusarium oxysporum] [isolate C4-1] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 













>Seq177 [organism=Fusarium oxysporum] [isolate A7-4] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq178 [organism=Fusarium oxysporum] [isolate A8-1] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq179 [organism=Fusarium oxysporum] [isolate C6-3] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 













>Seq180 [organism=Fusarium oxysporum] [isolate B5-1] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq181 [organism=Fusarium oxysporum] [isolate B7-1] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq182 [organism=Fusarium oxysporum] [isolate B6-1] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 













>Seq183 [organism=Fusarium oxysporum] [isolate B5-3] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq184 [organism=Fusarium oxysporum] [isolate A6-2] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq185 [organism=Fusarium oxysporum] [isolate C8-6] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 













>Seq186 [organism=Fusarium oxysporum] [isolate B10-1] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq187 [organism=Fusarium oxysporum] [isolate C6-2] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq188 [organism=Fusarium oxysporum] [isolate C1-3] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 













>Seq189 [organism=Fusarium oxysporum] [isolate C3-1] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq190 [organism=Fusarium oxysporum] [isolate A7-3] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq191 [organism=Fusarium oxysporum] [isolate C8-1] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 













>Seq192 [organism=Fusarium oxysporum] [isolate C6-4] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq193 [organism=Fusarium oxysporum] [isolate C2-7] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq194 [organism=Fusarium oxysporum] [isolate A6-3] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 













>Seq195 [organism=Fusarium oxysporum] [isolate C10-1] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq196 [organism=Fusarium oxysporum] [isolate A2-3] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq197 [organism=Fusarium oxysporum] [isolate CRT1-1] internal transcribed spacer 1, 
partial sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete 













>Seq198 [organism=Fusarium oxysporum] [isolate A5-1] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq199 [organism=Fusarium oxysporum] [isolate C3-2] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq200 [organism=Fusarium oxysporum] [isolate C2-4] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 













>Seq201 [organism=Penicillium brevicompactum] [isolate A7-2] internal transcribed spacer 1, 
partial sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete 












>Seq202 [organism=Phoma herbarum] [isolate B3-4] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq203 [organism=Phoma herbarum] [isolate A4-1] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 













>Seq204 [organism=Phoma herbarum] [isolate C8-4] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq205 [organism=Phoma herbarum] [isolate CRT3-1] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq206 [organism=Rhodotorula mucilaginosa] [isolate A5-7] internal transcribed spacer 1, 
partial sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete 














>Seq207 [organism=Mucor circinelloides] [isolate B5-2] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 













>Seq208 [organism=Aspergillus niger] [isolate A5-5] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 












>Seq209 [organism=Candida parapsilosis] [isolate B10-6] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 













>Seq210 [organism=Rhodotorula slooffiae] [isolate A4-3] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 












>Seq211 [organism=Rhodotorula slooffiae] [isolate A10-1] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 












>Seq212 [organism=Rhodosporidium babjevae] [isolate B8-7] internal transcribed spacer 1, 
partial sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete 














>Seq213 [organism=Meyerozyma guilliermondii] [isolate B9-1] internal transcribed spacer 1, 
partial sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete 












>Seq214 [organism=Clavispora lusitaniae] [isolate C1-1] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 








>Seq215 [organism=Candida intermedia] [isolate C4-2] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 








>Seq216 [organism=Penicillium echinulatum] [isolate A4-2] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 














>Seq217 [organism=Meyerozyma guilliermondii] [isolate B10-7] internal transcribed spacer 1, 
partial sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete 












>Seq218 [organism=Rhodotorula slooffiae] [isolate B10-9] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 












>Seq219 [organism=Trichosporon asteroides] [isolate B10-12] internal transcribed spacer 1, 
partial sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete 













>Seq220 [organism=Penicillium crustosum] [isolate A3-4] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 












>Seq221 [organism=Penicillium crustosum] [isolate A5-2] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 












>Seq222 [organism=Ochroconis mirabilis] [isolate C8-7] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 







>Seq223 [organism=Penicillium expansum] [isolate C8-3] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 












>Seq224 [organism=Trichosporon domesticum] [isolate A3-1] internal transcribed spacer 1, 
partial sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete 











>Seq225 [organism=Penicillium expansum] [isolate A1-4] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 














>Seq226 [organism=Penicillium crustosum] [isolate A1-3] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 












>Seq227 [organism=Penicillium crustosum] [isolate B9-5] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 












>Seq228 [organism=Lecythophora fasciculata] [isolate R10-6] internal transcribed spacer 1, 
partial sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete 














>Seq229 [organism=Fusarium solani] [isolate K8-1] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 











>Seq230 [organism=Fusarium solani] [isolate K8-2] internal transcribed spacer 1, partial 
sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; 



































APPENDIX 4: TEF-1α Sequences 
>Seq1 [organism=Fusarium dimerum] [isolate X4-2](X4-3) translation elongation factor 1 alpha (tef) 
gene, partial cds 






































































































































































































































































































































































































































































































>Seq33 [organism=Fusarium oxysporum] [isolate H7-1] translation elongation factor 1 alpha (tef) 













>Seq34 [organism=Fusarium oxysporum] [isolate H3-1] translation elongation factor 1 alpha (tef) 






















































































































































































































































































































































































































































































>Seq65 [organism=Fusarium oxysporum] [isolate C3-4] translation elongation factor 1 alpha (tef) 
















>Seq66 [organism=Fusarium oxysporum] [isolate C9-2] translation elongation factor 1 alpha (tef) 













>Seq67 [organism=Fusarium oxysporum] [isolate C6-5] translation elongation factor 1 alpha (tef) 













>Seq68 [organism=Fusarium oxysporum] [isolate C9-4] translation elongation factor 1 alpha (tef) 















>Seq69 [organism=Fusarium oxysporum] [isolate A6-1] translation elongation factor 1 alpha (tef) 














>Seq70 [organism=Fusarium oxysporum] [isolate C5-3] translation elongation factor 1 alpha (tef) 













>Seq71 [organism=Fusarium oxysporum] [isolate CRT1-2] translation elongation factor 1 alpha (tef) 















>Seq72 [organism=Fusarium oxysporum] [isolate C9-1] translation elongation factor 1 alpha (tef) 













>Seq73 [organism=Fusarium oxysporum] [isolate C5-1] translation elongation factor 1 alpha (tef) 















>Seq74 [organism=Fusarium oxysporum] [isolate CRT1-3] translation elongation factor 1 alpha (tef) 













>Seq75 [organism=Fusarium oxysporum] [isolate A8-2] translation elongation factor 1 alpha (tef) 













>Seq76 [organism=Fusarium oxysporum] [isolate C8-2] translation elongation factor 1 alpha (tef) 















>Seq77 [organism=Fusarium oxysporum] [isolate C5-2] translation elongation factor 1 alpha (tef) 













>Seq78 [organism=Fusarium oxysporum] [isolate B9-2] translation elongation factor 1 alpha (tef) 













>Seq79 [organism=Fusarium oxysporum] [isolate C2-1] translation elongation factor 1 alpha (tef) 















>Seq80 [organism=Fusarium oxysporum] [isolate B10-2] translation elongation factor 1 alpha (tef) 













>Seq81 [organism=Fusarium oxysporum] [isolate C5-5] translation elongation factor 1 alpha (tef) 













>Seq82 [organism=Fusarium oxysporum] [isolate B6-2] translation elongation factor 1 alpha (tef) 















>Seq83 [organism=Fusarium oxysporum] [isolate A1-2] translation elongation factor 1 alpha (tef) 









>Seq84 [organism=Fusarium oxysporum] [isolate C9-5] translation elongation factor 1 alpha (tef) 
















>Seq85 [organism=Fusarium oxysporum] [isolate C9-3] translation elongation factor 1 alpha (tef) 














>Seq86 [organism=Fusarium oxysporum] [isolate C6-1] translation elongation factor 1 alpha (tef) 













>Seq87 [organism=Fusarium oxysporum] [isolate C7-1] translation elongation factor 1 alpha (tef) 















>Seq88 [organism=Fusarium oxysporum] [isolate A5-6] translation elongation factor 1 alpha (tef) 













>Seq89 [organism=Fusarium oxysporum] [isolate A1-1] translation elongation factor 1 alpha (tef) 














>Seq90 [organism=Fusarium oxysporum] [isolate C5-4] translation elongation factor 1 alpha (tef) 
















>Seq91 [organism=Fusarium oxysporum] [isolate C4-1] translation elongation factor 1 alpha (tef) 













>Seq92 [organism=Fusarium oxysporum] [isolate A8-1] translation elongation factor 1 alpha (tef) 














>Seq93 [organism=Fusarium oxysporum] [isolate C6-3] translation elongation factor 1 alpha (tef) 













>Seq94 [organism=Fusarium oxysporum] [isolate B5-1] translation elongation factor 1 alpha (tef) 













>Seq95 [organism=Fusarium oxysporum] [isolate B7-1] translation elongation factor 1 alpha (tef) 















>Seq96 [organism=Fusarium oxysporum] [isolate B6-1] translation elongation factor 1 alpha (tef) 













>Seq97 [organism=Fusarium oxysporum] [isolate B5-3] translation elongation factor 1 alpha (tef) 














>Seq98 [organism=Fusarium oxysporum] [isolate A6-2] translation elongation factor 1 alpha (tef) 















>Seq99 [organism=Fusarium oxysporum] [isolate C8-6] translation elongation factor 1 alpha (tef) 













>Seq100 [organism=Fusarium oxysporum] [isolate B10-1] translation elongation factor 1 alpha (tef) 















>Seq101 [organism=Fusarium oxysporum] [isolate C6-2] translation elongation factor 1 alpha (tef) 













>Seq102 [organism=Fusarium oxysporum] [isolate C1-3] translation elongation factor 1 alpha (tef) 













>Seq103 [organism=Fusarium oxysporum] [isolate C3-1] translation elongation factor 1 alpha (tef) 















>Seq104 [organism=Fusarium oxysporum] [isolate A7-3] translation elongation factor 1 alpha (tef) 














>Seq105 [organism=Fusarium oxysporum] [isolate C8-1] translation elongation factor 1 alpha (tef) 













>Seq106 [organism=Fusarium oxysporum] [isolate C6-4] translation elongation factor 1 alpha (tef) 















>Seq107 [organism=Fusarium oxysporum] [isolate C2-7] translation elongation factor 1 alpha (tef) 













>Seq108 [organism=Fusarium oxysporum] [isolate A6-3] translation elongation factor 1 alpha (tef) 















>Seq109 [organism=Fusarium oxysporum] [isolate C10-1] translation elongation factor 1 alpha (tef) 














>Seq110 [organism=Fusarium oxysporum] [isolate A2-3] translation elongation factor 1 alpha (tef) 













>Seq111 [organism=Fusarium oxysporum] [isolate CRT1-1] translation elongation factor 1 alpha (tef) 















>Seq112 [organism=Fusarium oxysporum] [isolate A5-1] translation elongation factor 1 alpha (tef) 














>Seq113 [organism=Fusarium oxysporum] [isolate C3-2] translation elongation factor 1 alpha (tef) 












>Seq114 [organism=Fusarium oxysporum] [isolate C2-4] translation elongation factor 1 alpha (tef) 




























































>Seq118 [organism=Fusarium oxysporum] [isolate A7-4] translation elongation factor 1 alpha (tef) 
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Detection of human pathogenic Fusarium species 
in hospital and communal sink biofilms by using  
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The fungus Fusarium is well known as a plant pathogen, 
but has recently emerged as an opportunistic pathogen 
of humans. Habitats providing direct human exposure to 
infectious propagules are largely unknown, but there is 
growing evidence that plumbing systems are sources of 
human pathogenic strains in the Fusarium solani species 
complex (FSSC) and Fusarium oxysporum species 
complex (FOSC), the most common groups infecting 
humans. Here, a newly developed Fusarium-specific 
monoclonal antibody (mAb ED7) was used to track 
FSSC and FOSC strains in sink drain biofilms by 
detecting its target antigen, an extracellular 200 kDa 
carbohydrate, in saline swabs. The antigen was 
detectable in 52% of swab samples collected from sinks 
across a University campus and a tertiary care hospital. 
The mAb was 100% accurate in detecting FSSC, FOSC, 
and F. dimerum species complex (FDSC) strains that 
were present, as mixed fungal communities, in 83% of 
sink drain biofilms. Specificity of the ELISA was 
confirmed by sequencing of the internally transcribed 
spacer 1 (ITS1)-5.8S-ITS2 rRNA-encoding regions of 
culturable yeasts and moulds that were recovered using 
mycological culture, while transla-tion elongation factor 
(TEF)-1α analysis of Fusarium isolates included FSSC 1-
a, FOSC 33, and FDSC ET-gr, the most common clinical 
patho-types in each group. 
 
Received 3 November, 2015; accepted 15 January, 2016. *For 
correspondence: E-mail C.R.Thornton@ex.ac.uk; Tel. 144 (0)1392 







Species in the fungal genus Fusarium are ubiquitous 
environmental moulds, and pathogens of both plants and 
animals (Zhang et al., 2006; Thornton and Wills, 2015). 
In immunocompromised humans, such as patients with 
hematological malignancies and hematopoietic stem cell 
and solid organ transplant recipients, Fusarium species 
are significant emerging pathogens, causing a frequently 
fatal disseminated disease known as fusariosis with an 
associated mortality rate of 50%–75% (Boutati and 
Anaissie, 1997; Girmenia et al., 2000; Musa et al., 2000; 
Dignani and Anaissie, 2004; Jensen et al., 2004; Nucci 
and Anaissie, 2007). In some tertiary cancer cen-ters, 
Fusarium has emerged as the second most common 
mould pathogen after Aspergillus (Walsh and Groll, 
1999; Muhammed et al., 2011). Regardless of human 
immune status, Fusarium species can cause localized 
nail infections (onychomycosis) (Arrese et al., 1996), 
bone and joint infections (Koehler et al., 2014), infections 
of burn wounds (Latenser, 2003), skin infec-tions (Nucci 
and Anaissie, 2002; Gurusidappa and Mamatha, 2011) 
and are the most frequent cause of mycotic eye 
infections known as fungal keratitis (Jurkunas et al., 
2009), leading to progressive corneal destruction and 
endophthalmitis, with loss of vision or even loss of the 
affected eye (Dursun et al., 2003; Edelstein et al., 2012). 
 
A recent multistate outbreak of fungal keratitis in the United 
States and in Singapore and Hong Kong was associated 
with contact lens solution contaminated with multiple strains 
of Fusarium and which led to visual loss in many patients 
and the need for corneal transplantation (Chang et al., 
2006). While such outbreaks are rare, disseminated 
Fusarium infections and keratomycoses have increased in 
frequency over the past decade (Koehler et al., 2014) and 
an increasing body of evidence suggests that the main 
environmental sources of human pathogenic Fusarium 
species are contaminated water systems (Doggett, 2000; 
Anaissie et al., 2002; Mehl and Epstein, 2008; Anaissie et 
al., 2011). A number of studies have recovered pathogenic 
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Fusarium species from plumbing fixtures and it is 
hypothesized that microbial biofilms on fixtures may serve 
as important reservoirs of infectious Fusarium 
propagules in hospitals and homes (Mehl and Epstein, 
2008; Short et al., 2011). 
 
Identification of environmental reservoirs of human 
pathogenic moulds including Fusarium has typically 
relied on nucleic acid-based technologies following 
recovery of fungi using selective media (Anaissie et al., 
2002; Mehl and Epstein, 2008; Short et al., 2011; 
Anaissie et al., 2011; Rougeron et al., 2014). Recently, 
highly specific monoclo-nal antibodies (mAb) have been 
used to identify pathogenic species or species 
complexes in environmental samples containing mixed 
populations of yeasts and moulds (Thornton, 2009; 
Davies and Thornton, 2014; Thornton et al., 2015). While 
mAb-based approaches similarly rely on culture for 
recovery of fungi from environmental samples, detection 
of diagnostic antigens in crude culture extracts using 
genus- or species-specific mAbs offers an attractive 
alternative approach to pathogen detection, particularly 
when combined with unsophisticated diagnostic 
modalities such as lateral-flow technology (Thornton, 
2008, 2012). 
 
In this study, we set out to determine whether a newly 
developed Fusarium-specific mAb (ED7) could be used to 
track the fungus by detecting a water-soluble diagnostic 
antigen in swabs of communal and hospital sinks. By using 
the mAb in an enzyme-linked immunsorbent assay (ELISA), 
we show that it can differentiate Fusarium spe-cies from 
other unrelated yeast and mould pathogens of humans 
present in mixed fungal communities encountered in sink 
biofilms. The ELISA represents a simple method for specific 
detection of Fusarium species in environmental reservoirs 





Production of hybridoma cell lines, isotyping of 
mAb and specificity 
 
A single fusion was performed and 389 hybridoma cell 
lines were screened for specificity against a range of 
clini-cally relevant yeasts and moulds (Supporting 
Information Table S1). The aim was to identify cell lines 
secreting mAbs specific to Fusarium that could be used 
to track the fungus in environmental samples containing 
mixed species of human pathogenic fungi. To this end, a 
single cell line, ED7, was identified that produced mAb 
belonging to the immunoglobulin class M (IgM), which 
was genus-specific, reacting in ELISA tests with antigens 
from Fusarium species and with the F. solani teleomorph 
Haematonectria haematococca only (Fig. 1A and B). It 
did not cross-react with antigens from a wide range of 
unrelated mould and yeast species (Fig. 1A). 
Western blotting of the ED7 antigen and epitope 
characterization 
 
Gel electrophoresis and Western blotting studies showed 
that ED7 binds to a major antigen with molecular weight of 
200 kDa which is secreted extracellularly by both F. solani 
and F. oxysporum (Fig. 2A). Fusarium solani antigens were 
subjected to enzymatic (Fig. 2B and C), heat (Fig. 2D) and 
chemical (Fig. 2E) modifications in order to char-acterize the 
epitope bound by ED7. Reductions in mAb binding following 
treatment with pronase shows that its epi-tope consists of 
protein, while reductions with trypsin indicate a protein 
epitope containing positively charged lysine and arginine 
side chains. The lack of reduction in ED7 binding following 
digestion of immobilized antigen with trypsin (Fig. 2B) and 
pronase (Fig. 2C) shows that it does not bind to a protein 
epitope. Reductions in mAb binding following heat treatment 
shows that an epitope is heat labile. There was no 
significant reduction in ED7 bind-ing over 70 min of heating, 
showing that its epitope is heat stable (Fig. 2D). Reductions 
in mAb binding following chemical digestion of an antigen 
with periodate shows that its epitope is carbohydrate and 
contains vicinal hydroxyl groups. The pronounced 
reductions in ED7 binding follow-ing periodate oxidation 
shows that its epitope consists of carbohydrate residues 
(Fig. 2E). Taken together, these results indicate that ED7 
binds to an extracellular antigen and that its epitope is a 
heat stable carbohydrate moeity containing vicinal hydroxyl 
groups. 
 
Immunofluorescence and immunogold 
electron microscopy 
 
Immuno-localization studies using IF showed that the 
ED7 antigen was present on the surface of spores and 
hyphae (Fig. 2F–I), while IEM showed that the antigen 
was present in the spore and hyphal cell wall and in an 
extracellular fibrillar matrix surrounding both (Fig. 2J–L). 
In the TEM image shown in Fig. 2J, 56% of gold 
particles were distrib-uted in the fibrillar matrix 
surrounding the cell, while 40% and 4% of gold particles 
were distributed in the cell wall and cytoplasm 
respectively. This shows that the ED7 anti-gen is 
predominantly extracellular or located within the cell wall. 
Immunodetection of Fusarium species in sink swabs 
and identification of fungi by analysis of the ITS regions 
of the rRNA-encoding gene unit and by translation 
elongation factor-1α PCR 
 
Monoclonal antibody ED7 was highly specific for the three 
human pathogenic species of Fusarium, F. solani, F. oxy-
sporum and F. dimerum, which were culturable from 75% of 
the sink swabs (Table 1 and Supporting Information Table 
S2). ELISA tests of the saline sink swabs showed 
 



























































Fig. 1. Specificity of ED7 determined by ELISA tests of surface washings containing water-soluble antigens from Fusarium species and related 
and unrelated yeasts and moulds. (A) ELISA absorbance values at 450 nm for antigens from F. solani and unrelated yeasts and moulds and (B) 
for antigens from the F. solani teleomorph Haematonectria haematococca and related Fusarium species. Wells were coated with 60 lg protein 
ml
21
 buffer. Bars are the means of three biological replicates 6 standard errors and the threshold absorbance value for detection of antigen in 
ELISA is 0.100 (indicated by lines on graphs). Numbers in parentheses after species names denote strain numbers with further details of strains 
provided in Supporting Information Table S1. 
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that 52% contained detectable levels of Fusarium antigen 
(Table 1 and Supporting Information Table S2), with ELISA 
absorbance values in the range 0.100 (the threshold value 
for antigen detection) and up to 1.500. In four hospi-tal 
samples (samples S47, S48 and S49 from ophthalmology 
and sample S64 from oncology) Fusarium strains could not 
be recovered for identification by ITS sequencing despite 
















































diagnostic antigen in swab samples with absorbance values 
of 0.264, 0.530, 0.187 and 0.193 respectively (Table 1). 
This was likely due to the Fusarium isolates being outgrown 
in the mixed cul-ture plates by faster growing or more 
abundant unrelated fungi. Importantly, ED7 was shown not 
to cross-react with unrelated fungi (axenic culture 
absorbance values of 0.100 in all cases) including the 
human pathogenic yeast or yeast-like fungi Candida, 
Exophiala, Meyerozyma, Rhodotorula, Trichosporon, the 
human pathogenic hyaline or dematiaceous moulds 
Aspergillus, Phialophora, Phoma, 
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Fig. 2. Characterization of the ED7 antigen and its epitope and spatial distribution of the antigen in spores and hyphae.   
(A) Western immunoblot with ED7 using culture fluid from 2-day-old PDB cultures of F. solani (CBS224.34) (lane 1) and F. oxysporum f.sp. 
lycopersici CBS167.30 (lane 2). Wells were loaded with 1.6 lg of protein. Mr denotes molecular weight in kDa. Note the major extracellular 
antigen with molecular weight of approximately 200 kDa.  
(B) Absorbance values from ELISA tests with ED7 using surface washings containing water-soluble antigens immobilized to the wells of 
microtitre plates and treated with trypsin or PBS only (control) at 4°C and 378C. Bars are the means of three biological replicates 6 standard 
errors and bars with the same letter are not significantly different at p < 0.001 (ANOVA and Tukey–Kramer test).  
(C) Absorbance values from ELISA tests with ED7 using surface washings containing water-soluble antigens immobilized to the wells of 
microtitre plates and treated with pronase or Milli-Q H2O only (control) at 4°C and 378C. Bars are the means of three biological replicates 
6 standard errors and bars with the same letter are not significantly different at p < 0.001 (ANOVA and Tukey–Kramer test).  
(D) Stability of the water-soluble ED7 antigen following heating of surface washings at 1008C over a 70-minute period. Treated antigen was 
subsequently immobilized to the wells of microtitre plates and assayed by ELISA. Bars are the means of three biological replicates 6 standard 
errors and bars with the same letter are not significantly different at p < 0.001 (ANOVA and Tukey–Kramer test).  
(E) Absorbance values from ELISA tests with ED7 using surface washings containing water-soluble antigens immobilized to the wells of 
microtitre plates and treated with periodate (open circles) or with acetate only control (closed circles) at 4°C over a 20-hour period. Each point 
is the mean of three biological replicates 6 standard errors.  
(F to I) Photomicrographs of F. solani CBS224.34 immunostained with ED7 or TCM control and goat anti-mouse polyvalent Ig fluorescein 
isothiocyanate (FITC) conjugate. (F) Brightfield image of germinated conidium with hypha probed with ED7 followed by fluorochrome conjugate 
(scale bar 5 6 lm); (G) Same field of view as panel F but examined under epifluorescence. Note intense staining of the cell wall of microconidium 
and hypha; (H) Brightfield image of germinated conidium with hypha probed with TCM (negative control) followed by FITC conjugate (scale bar 5 
3 lm); (I) Same field of view as panel H but examined under epifluorescence. Note lack of staining, demonstrating specific binding of ED7 to 
surface antigen.  
(J to L) Immunogold labeling of sections of conidia and hyphae of F. solani CBS224.34. (J) Transverse section of conidium incubated with 
ED7 and anti-mouse immunoglobulin 20 nm gold particles, showing antigen in the cell wall and in an extracellular fimbrial matrix surrounding 
the spore (scale bar 5 250 nm); (K) Longitudinal section of hypha incubated with ED7 and anti-mouse immunoglobulin 20 nm gold particles, 
showing antigen in the cell wall and in an extracellular matrix surrounding the cell (scale bar 5 100 nm); (L) Transverse section of a conidium 
incubated with TCM (negative control) and anti-mouse immunoglobulin 20 nm gold particles, showing lack of staining by the secondary gold 
conjugate (scale bar 5 180 nm). 
Trichoderma and the human pathogenic mucormycete 
Mucor (Table 1). The remaining 93% of samples positive for 
Fusarium antigen, either at the swab stage or following 
periods of biological amplification in mixed or axenic cultures 
(Supporting Information Table S2), yielded strains of the 
three Fusarium species. There was 100% concordance 
between Fusarium genus identification by ELISA and 
species identification by ITS sequencing (Table 1). The 
species of F. solani and F. oxysporum recovered from sink 
swabs were subsequently shown by TEF-1α PCR 
(Supporting Information Data Set 1) to belong to F. solani 
species complex (FSSC) 1-a, 1-c, 2-a, 2-v, 5-d, 5-k, 9-a, 15-
a, 20-d and F. oxysporum (FOSC) species complexes 16, 
33, 99, 111, 126, 134, 183 (Supporting Information Table 
S3). All of the recovered F. dimerum isolates belonged to 
the F. dimerum species complex (FDSC) ET-gr (Supporting 
Information Table S3). ITS analysis of axenic cultures (Table 
1) showed that a number of sink samples (e.g., S2, S6, S17, 
S19, S21, S24, S30, S38) contained mixtures of Fusarium 
species, while ITS and TEF-PCR analysis (Table 1 and 
Supporting Information Table S3) showed that others 
contained mixtures of species complexes of the same 
species (e.g., S8, S9, S25, S28). Monoclonal antibody ED7 
was able to detect all of the Fusarium species complexes 
recovered in this study. 
 
In addition to drain swabs, water samples were collected 
from the taps of sinks in the hospital haematology and 
oncology units and from the main water tanks feeding the 
ophthalmology unit. The ED7 diagnostic antigen could not 
be detected in any of the water samples directly and, while 
all of the samples yielded fungi, only two of the tap samples 
(oncology W57 and W60) contained Fusarium strains that 
belonged to FDSC ET-gr. and which were detectable by 
ELISA at the mixed culture stage (Table 1). The sink 
biofilms corresponding to these water samples were also 




The genus Fusarium comprises ubiquitous environmental 
moulds capable of infecting plants and humans (Zhang et 
al., 2006). Unlike agriculture, where the most economically 
damaging pathogens are considered to be 
 
F. graminearum and F. oxysporum (Dean et al., 2012), the 
species most commonly cited as human pathogens belong 
to the Fusarium solani species complex (FSSC), 
responsible for 50% of reported infections in humans, 
followed by strains in the FOSC (Torres and Kontoyiannis, 
2011). The FDSC is less frequently reported as causing 
human dis-ease, but it is similarly capable of causing 
disseminated infections in immunocompromised patients 
(Bigley et al., 2004; Schroers et al., 2009).  
While the natural habitats of plant pathogenic Fusarium 
strains are well characterized as soil and decaying plant 
material, habitats providing direct human exposure to 
infectious propagules are largely unexplored. The 
increasing frequency of opportunistic fungal infections in 
human means that improved surveillance methods are 
needed to identify environmental reservoirs of pathogens to 
limit the exposure of vulnerable individuals to potentially 
infective propagules. For Fusarium, there is a growing body 
of evidence to suggest that domestic and municipal water 
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Table 1. Locations and identities of sink swabs and water samples and results of ELISA tests and fungal identification based on ITS sequencing. 
 
 
    Mixed  Axenic   
    culture  culture   
  Swab ELISA  ELISA Identification based GenBank 












         
A1 University (S1) 0.0763  0.0575 A1-1 1.3736 Fusarium oxysporum KT876668 
 University (S1)    A1-2 0.7646 Fusarium oxysporum KT876662 
 University (S1)    A1-3 0.0196 Penicillium crustosum KT876719 
 University (S1)    A1-4 0.0139 Penicillium expansum KT876718 
A2 University (S2) 0.5472  0.0045 A2-1 1.5723 Fusarium solani KT876635 
 University (S2)    A2-3 0.6554 Fusarium oxysporum KT876690 
 University (S2)    A2-5 1.1312 Fusarium solani KT876631 
A3 University (S3) 0.0053  0.0077 A3-1 0.0082 Trichosporon domesticum KT876717 
 University (S3)    A3-2 0.0162 Cadophora fastigiata KT876615 
 University (S3)    A3-3 0.0014 Cyphellophora oxyspora KT876613 
 University (S3)    A3-4 0.0093 Penicillium crustosum KT876714 
A4 University (S4) 0.0297  0.0049 A4-1 0.0105 Phoma herbarum KT876697 
 University (S4)    A4-2 0.0079 Penicillium echinulatum KT876710 
 University (S4)    A4-3 0.0029 Cytobasidium slooffiae KT876704 
 University (S4)    A4-6 0.0060 Trichoderma asperellum KT876620 
A5 University (S5) 0.0206  0.0039 A5-1 1.1815 Fusarium oxysporum KT876692 
 University (S5)    A5-2 0.0034 Penicillium crustosum KT876715 
 University (S5)    A5-5 0.0088 Aspergillus niger KT876702 
 University (S5)    A5-6 1.0630 Fusarium oxysporum KT876667 
 University (S5)    A5-7 0.0037 Rhodotorula mucilaginosa KT876700 
 University (S5)    A5-8 0.0088 Cyphellophora oxyspora KT876614 
A6 University (S6) 0.0251  0.0412 A6-1 1.1130 Fusarium oxysporum KT876648 
 University (S6)    A6-2 0.9410 Fusarium oxysporum KT876678 
 University (S6)    A6-3 0.6377 Fusarium oxysporum KT876688 
 University (S6)    A6-4 1.0020 Fusarium solani KT876640 
A7 University (S7) 0.1716  0.0082 A7-1 0.0098 Exophiala pisciphila KT876618 
 University (S7)    A7-2 0.0096 Penicillium brevicompactum KT876695 
 University (S7)    A7-3 1.0556 Fusarium oxysporum KT876684 
 University (S7)    A7-4 1.0077 Fusarium oxysporum KT876671 
A8 University (S8) 0.0431  0.0008 A8-1 1.1045 Fusarium oxysporum KT876672 
 University (S8)    A8-2 0.9707 Fusarium oxysporum KT876654 
 University (S8)    A8-3 0.0091 Trichoderma atroviride KT876622 
A9 University (S9) 0.3806  0.0052 A9-1 0.9087 Fusarium solani KT876639 
 University (S9)    A9-2 0.8849 Fusarium solani KT876638 
 University (S9)    A9-3 0.9004 Fusarium solani KT876632 
 University (S9)    A9-4 0.8093 Fusarium solani KT876636 
A10 University (S10) 0.0034  0.0028 A10-1 0.0188 Rhodotorula slooffiae KT876705 
 University (S10)    A10-2 0.0020 Exophiala pisciphila KT876616 
B1 University (S11) 0.0231  0.0005 B1-1 0.6064 Fusarium dimerum KT876625 
 University (S11)    B1-6 0.8138 Fusarium dimerum KT876628 
B2 University (S12) 0.0200  0.0020 B2-1 0.5678 Fusarium dimerum KT876626 
 University (S12)    B2-5 0.4827 Fusarium dimerum KT876624 
B3 University (S13) 0.0091  0.0023 B3-4 0.0026 Phoma herbarum KT876696 
B4 University (S14) 0.0163  0.0008 B4-1 0.6992 Fusarium dimerum KT876627 
B5 University (S15) 0.0132  0.0003 B5-1 0.8008 Fusarium oxysporum KT876674 
 University (S15)    B5-2 0.0048 Mucor circinelloides KT876701 
 University (S15)    B5-3 0.8851 Fusarium oxysporum KT876677 
B6 University (S16) 0.0229  0.0002 B6-1 0.8193 Fusarium oxysporum KT876676 
 University (S16)    B6-2 0.7582 Fusarium oxysporum KT876661 
B7 University (S17) 0.0395  0.0014 B7-1 0.8201 Fusarium oxysporum KT876675 
 University (S17)    B7-6 0.7758 Fusarium dimerum KT876623 
B8 University (S18) 0.0133  0.0011 B8-1 0.7347 Fusarium solani KT876637 
 University (S18)    B8-7 0.0095 Rhodosporidium babjevae KT876706 
B9 University (S19) 0.0212  0.0048 B9-1 0.0051 Meyerozyma guilliermondii KT876707 
 University (S19)    B9-2 0.8104 Fusarium oxysporum KT876657 
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 University (S19)     B9-3  0.6302 Fusarium solani KT876634 
 University (S19)     B9-5 0.0017 Penicillium crustosum KT876720 
B10 University (S20) 0.5467  0.0394  B10-1 0.7467 Fusarium oxysporum KT876680 
 University (S20)     B10-2 0.7667 Fusarium oxysporum KT876659 
 University (S20)     B10-6 0.0071 Candida parapsilosis KT876703 
 University (S20)     B10-7 0.0251 Meyerozyma guilliermondii KT876711 
 University (S20)     B10-9 0.0031 Cystobasidium slooffiae KT876712 
 University (S20)     B10-12 0.0251 Trichosporon asteroides KT876713 
C1 University (S21) 0.0083  0.0269  C1-1 0.0044 Clavispora lusitaniae KT876708 
 University (S21)     C1-3  0.8875 Fusarium oxysporum KT876682 
 University (S21)     C1-4  0.8884 Fusarium dimerum KT876629 
 University (S21)     C1-7 0.0003 Exophiala pisciphila KT876617 
C2 University (S22) 0.2977  0.0047  C2-1 0.9443 Fusarium oxysporum KT876658 
 University (S22)     C2-4 0.9825 Fusarium oxysporum KT876694 
 University (S22)     C2-7 0.8677 Fusarium oxysporum KT876687 
C3 University (S23) 0.0808  0.0116  C3-1  0.9853 Fusarium oxysporum KT876683 
 University (S23)     C3-2 1.0160 Fusarium oxysporum KT876693 
 University (S23)     C3-4 0.7485 Fusarium oxysporum KT876644 
C4 University (S24) 0.1113  0.0202  C4-1 0.8930 Fusarium oxysporum KT876670 
 University (S24)     C4-2 0.0028 Candida intermedia KT876709 
 University (S24)     C4-5 0.9008 Fusarium dimerum KT876630 
C5 University (S25) 0.5741  0.0097  C5-1 0.9874 Fusarium oxysporum KT876652 
 University (S25)     C5-2 1.0996 Fusarium oxysporum KT876656 
 University (S25)     C5-3 1.1236 Fusarium oxysporum KT876649 
 University (S25)     C5-4 1.0355 Fusarium oxysporum KT876669 
 University (S25)     C5-5 1.0672 Fusarium oxysporum KT876660 
C6 University (S26) 0.0603  0.0348  C6-1  1.0135 Fusarium oxysporum KT876665 
 University (S26)     C6-2  0.9362 Fusarium oxysporum KT876681 
 University (S26)     C6-3  0.8898 Fusarium oxysporum KT876673 
 University (S26)     C6-4  1.0577 Fusarium oxysporum KT876686 
 University (S26)     C6-5  0.9445 Fusarium oxysporum KT876646 
C7 University (S27) 0.1279  0.0113  C7-1 0.9724 Fusarium oxysporum KT876666 
C8 University (S28) 0.0607  0.0035  C8-1  0.8694 Fusarium oxysporum KT876685 
 University (S28)     C8-2  0.9599 Fusarium oxysporum KT876655 
 University (S28)     C8-3 0.0031 Penicillium expansum KT876716 
 University (S28)     C8-4 0.0049 Phoma herbarum KT876698 
 University (S28)     C8-6  0.9003 Fusarium oxysporum KT876679 
C9 University (S29) 0.0310  0.0001  C9-1  1.0488 Fusarium oxysporum KT876651 
 University (S29)     C9-2  0.9254 Fusarium oxysporum KT876645 
 University (S29)     C9-3  0.9711 Fusarium oxysporum KT876664 
 University (S29)     C9-4  1.035 Fusarium oxysporum KT876647 
 University (S29)     C9-5  0.9604 Fusarium oxysporum KT876663 
C10 University (S30) 0.1002  0.0333  C10-1 0.9254 Fusarium oxysporum KT876689 
 University (S30)     C10-2 1.0198 Fusarium solani KT876642 
 University (S30)     C10-4 0.9007 Fusarium solani KT876641 
 University (S30)     C10-7 1.0697 Fusarium solani KT876643 
CRT1 University (S31) 0.6175  0.1129  CRT1-1 0.4639 Fusarium oxysporum KT876691 
 University (S31)     CRT1-2 0.9086 Fusarium oxysporum KT876650 
 University (S31)     CRT1-3 0.7503 Fusarium oxysporum KT876652 
CRT2 University (S32) 0.0303  0.0021  CRT2-1 0.0040 Trichoderma asperellum KT876619 
 University (S32)     CRT2-2 0.0417 Trichoderma asperellum KT876621 
CRT3 University (S33) 0.0663  0.0028  CRT3-1 0.0256 Phoma herbarum KT876699 
R1 ICU (S34) 0.0285  0.3620  R1-1 1.5057 Fusarium solani KT876550 
 ICU (S34)     R1-2 1.5154 Fusarium solani KT876551 
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R2 ICU (S35) 0.0071  0.0147 R2-4 0.0096 Clonostachys rosea KT876552 
 ICU (S35)    R2-5 0.0018 Clonostachys rosea KT876553 
 ICU (S35)    R2-6 0.0035 Clonostachys rosea KT876554 
R3 ICU (S36) 0.0391  0.045 R3-1 0.0006 Trichoderma asperellum KT876548 
R5 ITU (S37) 0.7291  0.7724 R5-1 1.5606 Fusarium dimerum KT876561 
 ITU (S37)    R5-2 1.3481 Fusarium dimerum KT876565 
 ITU (S37)    R5-3 1.4990 Fusarium dimerum KT876567 
R6 ITU (S38) 1.2086  0.3691 R6-1 1.3388 Fusarium dimerum KT876572 
 ITU (S38)    R6-2 1.4734 Fusarium dimerum KT876563 
 ITU (S38)    R6-3 1.4312 Fusarium dimerum KT876562 
 ITU (S38)    R6-9 1.2648 Fusarium oxysporum KT876557 
R7 ITU (S39) 0.1121  0.8186 R7-1 1.3266 Fusarium dimerum KT876570 
 ITU (S39)    R7-2 1.2352 Fusarium dimerum KT876564 
R8 ITU (S40) 1.0157  0.3612 R8-1 1.2399 Fusarium dimerum KT876568 
 ITU (S40)    R8-2 1.1552 Fusarium dimerum KT876566 
 ITU (S40)    R8-3 1.1856 Fusarium dimerum KT876558 
R9 ITU (S41) 0.0391  0.0477 R9-3 0.0113 Exophiala phaeomuriformis KT876555 
R10 ITU (S42) 0.0549  0.0097 R10-2 0.0072 Cadophora fastigiata KT876556 
 ITU (S42)    R10-6 0.0124 Coniochaeta fasciculata KT876721 
X2 ITU (S43) 0.0630  1.5751 X2-2 1.1492 Fusarium dimerum KT876571 
 ITU (S43)    X2-4 1.2505 Fusarium dimerum KT876560 
 ITU (S43)    X2-5 1.1397 Fusarium dimerum KT876569 
 ITU (S43)    X2-6 1.1716 Fusarium dimerum KT876559 
X3 Ophthalmology Unit (S44) 1.0313  1.5035 X3-1 1.1353 Fusarium dimerum KT876509 
 Ophthalmology Unit (S44)    X3-2 0.0224 Candida parapsilosis KT876498 
 Ophthalmology Unit (S44)    X3-3 1.1856 Fusarium dimerum KT876512 
X4 Ophthalmology Unit (S45) 1.4582  1.4049 X4-1 1.1322 Fusarium dimerum KT876511 
 Ophthalmology Unit (S45)    X4-2 1.1523 Fusarium dimerum KT876500 
 Ophthalmology Unit (S45)    X4-3 0.0622 Candida parapsilosis KT876508 
 Ophthalmology Unit (S45)    X4-4 0.1245 Gloeotinia temulenta KT876515 
X5 Ophthalmology Unit (S46) 0.3325  1.4466 X5-2 1.0654 Fusarium dimerum KT876510 
 Ophthalmology Unit (S46)    X5-3 0.0599 Rhodotorula mucilaginosa KT876501 
 Ophthalmology Unit (S46)    X5-4 1.0862 Fusarium dimerum KT876513 
X6 Ophthalmology Unit (S47) 0.2640  1.3729 X6-1 0.0616 Candida parapsilosis KT876499 
 Ophthalmology Unit (S47)    X6-2 0.063 Engyodontium album KT876522 
 Ophthalmology Unit (S47)    X6-3 0.0603 Engyodontium album KT876521 
 Ophthalmology Unit (S47)    X6-4 0.0657 Exophiala phaeomuriformis KT876504 
X8 Ophthalmology Unit (S48) 0.5299  0.0223 X8-2 0.0118 Cladosporium macrocarpum KT876506 
 Ophthalmology Unit (S48)    X8-3 0.0985 Gloeotinia temulenta KT876514 
 Ophthalmology Unit (S48)    X8-4 0.0662 Engyodontium album KT876523 
X9 Ophthalmology Unit (S49) 0.1872  0.0061 X9-1 0.0686 Engyodontium album KT876520 
 Ophthalmology Unit (S49)    X9-2 0.0611 Candida parapsilosis KT876496 
 Ophthalmology Unit (S49)    X9-3 0.0641 Candida parapsilosis KT876497 
 Ophthalmology Unit (S49)    X9-4 0.0677 Exophiala dermatitidis KT876503 
 Ophthalmology Unit (S49)    X9-5 0.0705 Engyodontium album KT876519 
 Ophthalmology Unit (S49)    X9-7 0.0660 Exophiala pisciphila KT876502 
X10 Ophthalmology Unit (T1) 0.0132  0.0159 X10-1 0.0868 Cladosporium sphaerospermum KT876507 
 Ophthalmology Unit (T1)    X10-3 0.0130 Engyodontium album KT876518 
W1 Ophthalmology Unit (T2) 0.0117  0.0883 W1-1 0.0114 Paraconiothyrium fuckelii KT876505 
 Ophthalmology Unit (T2)    W1-2 0.0139 Engyodontium album KT876517 
 Ophthalmology Unit (T2)    W1-3 0.0108 Engyodontium album KT876516 
K1 Haematology Unit (S50) 0.2694  0.0093 K1-1 0.0172 Trichoderma asperellum KT876534 
K2 Haematology Unit (S51) 0.7466  1.1746 K2-1 0.0144 Trichoderma viride KT876533 
 Haematology Unit (S51)    K2-3 1.1385 Fusarium solani KT876543 
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K6 Haematology Unit (S52) 1.0621  1.3090  K6-1 1.1544 Fusarium oxysporum KT876541 
 Haematology Unit (S52)     K6-4 0.0071 Candida parapsilosis KT876524 
K8 Haematology Unit (S53) 1.0120  1.2628  K8-1 1.2376 Fusarium solani KT876722 
 Haematology Unit (S53)     K8-2 1.2983 Fusarium solani KT876723 
 Haematology Unit (S53)     K8-6 0.0084 Cadophora fastigiata KT876531 
 Haematology Unit (S53)     K8-7 0.0051 Trichoderma asperellum KT876535 
K9 Haematology Unit (S54) 0.9843  1.2903  K9-1 0.0046 Candida parapsilosis KT876525 
 Haematology Unit (S54)     K9-2 0.0090 Rhodotorula dairenensis KT876526 
 Haematology Unit (S54)     K9-4 0.0073 Cadophora fastigiata KT876532 
 Haematology Unit (S54)     K9-5 1.1652 Fusarium solani KT876547 
 Haematology Unit (S54)     K9-6 1.0316 Fusarium solani KT876545 
K10 Haematology Unit (S55) 0.8638  1.0753  K10-1 1.0684 Fusarium solani KT876546 
 Haematology Unit (S55)     K10-2 1.0386 Fusarium solani KT876544 
G1 Haematology Unit (W50) 0.0082  0.0451  G1-2 0.0097 Exophiala pisciphila KT876529 
G2 Haematology Unit (W51) 0.0581  0.0553  G2-1 0.0104 Engyodontium album KT876540 
 Haematology Unit (W51)     G2-3 0.0062 Exophiala pisciphila KT876530 
G6 Haematology Unit (W52) 0.0125  0.0118  G6-2 0.0161 Exophiala castellanii KT876528 
G8 Haematology Unit (W53) 0.0075  0.0219  G8-1 0.0065 Engyodontium album KT876538 
G9 Haematology Unit (W54) 0.0002  0.0164  G9-2 0.0005 Gloeotinia temulenta KT876537 
G10 Haematology Unit (W55) 0.0021  0.0182  G10-1 0.0051 Engyodontium album KT876539 
H1 Oncology Unit (S56) 0.4822  1.2287  H1-1 0.9022 Fusarium dimerum KT876595 
 Oncology Unit (S56)     H1-3 0.0151 Pichia kudriavzevii KT876578 
H2 Oncology Unit (S57) 1.0579  1.1650  H2-1 0.9312 Fusarium dimerum KT876590 
 Oncology Unit (S57)     H2-5 0.0061 Magnusiomyces capitatus KT876611 
H3 Oncology Unit (S58) 1.0938  1.2091  H3-1 0.8909 Fusarium oxysporum KT876584 
 Oncology Unit (S58)     H3-4 0.0075 Candida palmioleophila KT876573 
 Oncology Unit (S58)     H3-5 0.0140 Rhodotorula glutinis KT876598 
H4 Oncology Unit (S59) 0.0253  1.0856  H4-1 0.8884 Fusarium dimerum KT876596 
 Oncology Unit (S59)     H4-3 0.0004 Magnusiomyces capitatus KT876612 
H5 Oncology Unit (S60) 1.0856  1.0193  H5-1 1.1148 Fusarium dimerum KT876593 
 Oncology Unit (S60)     H5-3 0.005 Candida tropicalis KT876574 
H6 Oncology Unit (S61) 0.5256  1.1898  H6-1 1.1238 Fusarium dimerum KT876594 
H7 Oncology Unit (S62) 1.0789  1.1588  H7-1 1.1513 Fusarium oxysporum KT876583 
 Oncology Unit (S62)     H7-3 0.0045 Candida tropicalis KT876575 
H8 Oncology Unit (S63) 0.0953  0.0152  H8-1 0.0063 Phoma herbarum KT876580 
 Oncology Unit (S63)     H8-3 0.0126 Candida albicans KT876577 
 Oncology Unit (S63)     H8-4 0.0088 Rhodotorula mucilaginosa KT876599 
H9 Oncology Unit (S64) 0.1926  0.0162  H9-1 0.0152 Exophiala dermatitidis KT876581 
 Oncology Unit (S64)     H9-2 0.0049 Candida orthopsilosis KT876576 
 Oncology Unit (S64)     H9-3 0.0109 Pichia kudriavzevii KT876579 
H10 Oncology Unit (S65) 0.4961  1.1005  H10-1 0.9606 Fusarium dimerum KT876589 
 Oncology Unit (S65)     H10-4 0.0163 Trametes ochracea KT876608 
P1 Oncology Unit (W56) 0.0030  0.0247  P1-2 0.0082 Exophiala dermatitidis KT876582 
 Oncology Unit (W56)     P1-3 0.0024 Trametes versicolor KT876603 
P2 Oncology Unit (W57) 0.0061  1.0891  P2-1 0.8451 Fusarium dimerum KT876587 
 Oncology Unit (W57)     P2-2 0.9429 Fusarium dimerum KT876597 
 Oncology Unit (W57)     P2-3 0.8627 Fusarium dimerum KT876588 
P3 Oncology Unit (W58) 0.0016  0.0202  P3-1 0.0177 Trametes ochracea KT876607 
P4 Oncology Unit (W59) 0.0035  0.0125  P4-1 0.0164 Beauveria bassiana KT876586 
 Oncology Unit (W59)     P4-2 0.0084 Gliomastix polychroma KT876584 
P5 Oncology Unit (W60) 0.0025  1.1746  P5-1 0.8563 Fusarium dimerum KT876591 
 Oncology Unit (W60)     P5-2 0.8066 Fusarium dimerum KT876592 
 Oncology Unit (W60)     P5-3 0.0024 Piptoporus betulinus KT876609 
P7 Oncology Unit (W62) 0.0011  0.0417  P7-1 0.0097 Trametes versicolor KT876605 
P8 Oncology Unit (W63) 0.0044  0.0060  P8-1 0.0144 Trametes versicolor KT876606 
 Oncology Unit (W63)     P8-2 0.0106 Stereum gausapatum KT876601 
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P9 Oncology Unit (W64) 0.0022 0.0163 P9-1 0.0101 Stereum gausapatum KT876600 
 Oncology Unit (W64)   P9-2 0.0068 Trametes versicolor KT876604 
 Oncology Unit (W64)   P9-3 0.0140 Stereum gausapatum KT876602 
P10 Oncology Unit (W65) 0.0051 0.0280 P10-1 0.0032 Phaeophlebiopsis peniophoroides KT876610 
 
a. S, sink; W, tap water from corresponding sink number; T, water sample from main tank.  
b. Threshold absorbance value for detection in ELISA 0.100. Shading indicates earliest point in sampling process at which antigen was 
detectable in ELISA tests with ED7.  





systems are potential reservoirs of human pathogenic 
strains in the FSSC, FOSC and FDSC groups (Short et 
al., 2011).  
Accurate techniques that can be used to identify the fun-
gus in environmental samples containing mixed populations 
of fungi are currently lacking and, while nucleic acid-based 
technologies have been developed for the differentiation of 
Fusarium from other human pathogenic species and to 
identify Fusarium species complexes, such techniques have 
typically been used in retrospective analysis of axenic 
cultures collected during human and environmental 
population studies (Bouchara et al., 2009; Steinmann et al., 
2011; Lackner et al., 2012). Furthermore, these studies 
have often employed Fusarium-selective media that 
eliminate other fungi present in polymicrobial communities 
(Short et al., 2011). While monoclonal anti-bodies (mAbs) 
and antibody fragments have been developed for detecting 
and differentiating Fusarium species in vitro or in planta 
(Wong et al., 1988; Arie et al., 1991, 1995; Danks et al., 
1996; Hayashi et al., 1998; Hu et al., 2012, 2013), no 
attempts have been made to use mAbs to track human 
pathogenic strains in environmental samples. Jensen et al. 
(2011) recently reported the development of Fusarium-
specific mAbs for immunohistochemical diagnosis of 
fusariosis. The IgM mAbs, which recognize 51 and 63 kDa 
antigens, reacted strongly with fungal elements in both 
experimentally infected animals and biopsy samples from 
patients with fusariosis sepsis and dissemination to the skin. 
 
In this prospective study, we set out to determine whether 
human pathogenic species of Fusarium could be identified 
in sink drains directly by using crude antigen extracts of 
biofilms and detection using a genus-specific 
immunoglobulin M (IgM) mAb, ED7, that binds to an 
extracellular approximately 200kDa carbohydrate antigen 
present on the surface of spores and hyphae. While the 
function of the antigen is currently unknown we were able, in 
Enzyme-Linked Immunosorbent Assay (ELISA) tests, to 
detect its presence in 52% of swab samples and, following 
biological amplification of biofilms on a non-selective 
mycological medium, were able to identify additional biofilm 
samples containing pathogenic strains of Fusarium. This is 
the first time, to our knowledge, that a mAb-based detec-tion 
method has been used to track Fusarium in environmental 
samples. The mAb was able to differentiate Fusarium from a 
wide spectrum of unrelated fungi, including the human 
pathogens Aspergillus (Thornton and Wills, 2015), Candida, 
Geotrichum, Rhodotorula and Trichosporon (Miceli et al., 
2011; Davies and Thornton, 2014), Cyphellophora and 
Phialophora (Feng et al., 2014), Exophiala (Zeng et al., 
2007), Trichoderma (Sandoval-Denis et al., 2014), 
Engyodontium (Macedo^ et al., 2007; Thamke et al., 2015) 
and Mucor (Petrikkos et al., 2012), several of which have 
been reported previously to inhabit biofilms in water 
distribution systems (Dogget, 2000). The 100% accuracy of 
the ED7 ELISA, confirmed by using ITS sequencing and 
TEF PCR analysis of recovered isolates, demonstrates its 
robustness in detecting potentially infec-tious Fusarium 
species in polymicrobial communities. Importantly, ED7 
reacted with all of the species complex strains isolated 
including the most common clinical patho-types of 
Fusarium, FSSC 1-a, FOSC 33 and FDSC ET-gr (Schroers 
et al., 2009; Short et al., 2011).  
While the ED7 ELISA was able to identify Fusarium to the 
level of genus only, the simplicity of the mAb-based 
approach to detection, even when combined with a stand-
ard mycological isolation procedure, means that a 
recognized environmental niche of this group of patho-genic 
fungi can be monitored readily. The widespread occurrence 
of human pathogenic Fusarium species in sinks of a tertiary 
care hospital and sinks of a heavily popu-lated university 
campus, show that indoor plumbing-associated biofilms and 
water sources are an unseen source of Fusarium infectious 
propagules for nosocomial and community-acquired 
infections of vulnerable individu-als, an observation 
consistent with previous studies (Annaisie et al., 2011; Short 
et al., 2011). While no cases of fusariosis were reported 
during the course of this study, the close proximity of the 
patients to hospital sinks colon-ized with both pathogenic 
fusaria and with other opportunistic fungal pathogens is a 
serious concern given the known vulnerability of 
immunocompromised individuals to invasive fungal 
infections. 
 




All animal work described in this study was conducted under 
a UK Home Office Project License, and was reviewed by 
the institution’s Animal Welfare Ethical Review Board 
(AWERB) for approval. The work was carried out in 
accordance with The Animals (Scientific Procedures) Act 
1986 Directive 2010/63/ EU, and followed all the Codes of 
Practice which reinforce this law, including all elements of 
housing, care, and euthanasia of the animals. Permission 
for sink sampling at the Royal Devon and Exeter Hospital 






Fungi (Supporting Information Table S1) were routinely cul-
tured on Potato Dextrose Agar (PDA: 70139; Sigma), 
Sabouraud Dextrose Agar (SDA: Sabouraud Dextrose Broth 
(SDB: S3306; Sigma) containing 2% (w/v) agar), Malt Yeast 
extract Agar (MYA: Y3127; Sigma), or Oatmeal Agar (OA: 
O3506; Sigma), sterilized by autoclaving at 121°C for 15 
minutes. Cultures were grown at 26°C under a 16 hours 
fluo-rescent light regime. 
 
 
Development of mAb, preparation of 
immunogen and immunization regime 
 
BALB/c mice were immunized with soluble antigens prepared 
from lyophilized mycelium of a human pathogenic strain of 
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Fusarium solani species complex 1-a (CBS strain 224.34). 
Conidia were suspended in water after 10-day-old PDA slant 
cultures were flooded with 5 ml dH2O and gently agitated with 
an inoculation loop. Conidial suspensions were then filtered 
through Miracloth to remove mycelium and transferred to 1.5 ml 
micro-centrifuge tubes. The conidia were washed three times 
with dH2O by repeated vortexing and centrifugation at 14 462g 
for 5 min and finally suspended in dH2O to give a concentration 
of 106 conidia ml-1 solution. Flasks containing 100 ml of 
sterilized Potato Dextrose Broth (PDB: P6685; Sigma) were 
inoculated with 200  
μl of the conidial suspension and incubated with shaking (75 
rpm) for 48 h at 26°C. Hyphal biomass was collected on 
Miracloth, snap frozen in liquid N2, and lyophilized. Culture 
filtrates were retained for gel electrophoresis and Western 
blotting studies and stored at 22°C until required. About 1 mg of 
lyophilized biomass was sus-pended in 1 ml phosphate buffered 
saline (PBS: 0.8% NaCl; 0.02% KCl; 0.115% Na2HPO4; 0.02% 
KH2PO4; pH7.2) and the resultant suspension centrifuged for 5 
min at 14 462g. The supernatant, containing solubilized 
antigens, was used as the immunogen and as a source of 
antigens for hybridoma screening assays. For immunization, 6-
week-old BALB/c female white mice were given four 
intraperitoneal injections (300 μl per injection) of antigen extract 
containing 2.3 mg protein ml
-1
 PBS at 2-week intervals and a 
single booster injection 5 days before fusion. 
 
Production and screening of 
hybridomas and determination of 
antibody specificity 
 
Hybridoma cells were produced by the method described else-
where (Thornton, 2001) and the supernatants were screened by 
Enzyme-Linked Immunosorbent Assay (ELISA) against anti-
gens immobilized to the wells of Maxisorp microtiter plates 
(442404; Nunc) (50 μl per well). For antibody specificity tests, 
fungi were grown on replicate agar slopes and surface wash-
ings containing water-soluble antigens prepared as described in 
Thornton (2001). Protein concentrations, determined spec-
trophotometrically at 280 nm (Nanodrop, Agilent Technologies 
Limited, Berkshire, UK), were adjusted to 60 μg ml-1 buffer. Fifty 
μl volumes were then used to coat the wells of microtitre plates. 
After incubating overnight at 4°C, wells were washed four times 
with PBST (PBS containing Tween-20, 0.05% (v/v)), once each 
with PBS and dH2O and then air-dried at 238C in a laminar flow 
hood. The plates were stored in sealed plastic bags at 4°C in 
preparation for screening of hybridoma superna-tants by ELISA 
as described below. 
 
Enzyme-linked immunosorbent assay 
 
Wells containing immobilized antigens were incubated succes-
sively with hybridoma tissue culture supernatant (TCS) for 1 
hour, followed with goat anti-mouse polyvalent (immunoglobulin 
classes IgG, IgA and IgM) peroxidase conjugate (A-0412; 
Sigma Chemical Company, Poole, United Kingdom) diluted 1 in 
1000 in PBST for a further hour. Bound antibody was visualized 
by incubating wells with tetramethyl benzidine (TMB: T-2885; 
Sigma) substrate solution (Thornton, 2001) for 30 minutes. The 
reactions were stopped by the addition of 3 M H2SO4 and 
absorbance values were determined at 450 nm with an MRX 
automated microplate reader (Dynex Technologies, Billing-
shurst, UK). Wells were given four 5-minute rinses with PBST 
between incubations and a final rinse with PBS before addition 
of the substrate solution. Working volumes were 50 μl per well 
and control wells were incubated with tissue culture medium 
(TCM) containing 10% (v/v) fetal bovine serum. All incubation 
steps were performed at 238C in sealed plastic bags. The 
threshold for detection of the antigen in ELISA was determined 
from control means (23 TCM absorbance values) (Sutula et al., 
1986). These values were consistently in the range 0.050–
0.100. Consequently, absorbance values > 0.100 were 
considered as positive for the detection of antigen. 
 
Determination of Ig subclass and cloning procedure 
 
The Ig class of mAbs was determined by using antigen-
mediated ELISA. Wells of microtitre plates coated with F. solani 
CBS224.34 water-soluble antigens from surface washings were 
incubated successively with ED7 TCS for 1 hour, followed with 
goat anti-mouse IgG1, IgG2a, IgG2b, IgG3, IgM or IgA-specific 
antiserum (ISO-2; Sigma) diluted 1 in 3000 in PBST for 30 
minutes and rabbit anti-goat peroxidase conju-gate diluted 1 in 
1000 (A-5420; Sigma) for a further 30 minutes. Bound antibody 
was visualized with TMB substrat as described above. 
Hybridoma cells lines were sub-cloned three times by 
limiting dilution. They were preserved by slowly freezing in 
fetal bovine serum/dimethyl sulfoxide (92:8 [v/v]), and stored 
in liquid nitrogen. 
 
 
Gel electrophoresis and Western blotting 
 
For sodium-dodecyl-sulphate-polyacrylamide gel electropho-
resis (SDS-PAGE), culture filtrates from 2-days-old PDB shake 
cultures of F. solani CBS224.34 and F. oxysporum f.sp. 
lycopersici CBS167.30, prepared as described, were diluted in 
Laemmli buffer (Laemmli, 1970) and were denatured by heating 
at 958C for 10 min. Antigens were separated in 4%– 20% (w/v) 
polyacrylamide gradient gels (161-1159; Bio-Rad) for 1.5 hours 
at 238C (165V) under denaturing conditions, and pre-stained 
broad range markers (161-0318; Bio-Rad) were used for 
molecular weight determinations. For Westerns, sep-arated 
antigens were transferred electrophoretically to a PVDF 
membrane (162-0175; Bio-Rad). The membranes were blocked 
for 16 hours at 4°C with PBS containing 1% (w/v) bovine serum 
albumin (BSA) and incubated with ED7 TCS diluted 1 in 2 with 
PBS containing 0.5% (w/v) BSA (PBSA) for 2 hours at 238C. 
After washing three times with PBS, mem-branes were 
incubated for 1 hour with goat anti-mouse IgM (l-chain specific) 
alkaline phosphatase conjugate (A-9688; Sigma), diluted 1 in 15 
000 in PBSA. After the membranes were washed twice with 
PBS and once with PBST, the bound antibodies were visualized 
by incubation in BCIP/NBT sub-strate solution. Reactions were 
stopped by immersion in dH2O and air-dried between sheets of 
Whatman filter paper. 
 
Characterization of antigen by enzymatic and 
chemical modifications and by heating 
 
Water-soluble antigens from surface washings of slopes of  
F. solani CBS224.34 were prepared as described. Heat stability 
studies were conducted by placing tubes of solubilized antigen 
in a boiling water bath. At 10 minutes intervals, samples were 
removed, centrifuged at 14 462g for 5 minutes, and antigens 
immobilized to the wells of microtitre plates for assay by ELISA 
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as described. For periodate oxidation, microtitre wells containing 
immobilized antigens from surface washings of the fungus were 
incubated with 50 ml of sodium meta-periodate solution (20 mM 
NaIO4 in 50 mM sodium acetate buffer (pH4.5)) or acetate 
buffer only (control) at 4°C in sealed plastic bags. Plates were 
given four 3-minute PBS washes before processing by ELISA 
as described. For protease digestions, microtitre wells 
containing immobilized antigen were incubated with 50 ml of 
pronase (protease XIV; 9 mg ml-1 in PBS) or trypsin (1 mg ml-1 
in Milli-Q H2O) solution or Milli-Q H2O or PBS only controls 
respectively for 4 hours at 378C or 4°C. Plates were given four 
3-minute rinses with PBS and then assayed by ELISA with ED7 
TCS as described. 
 
Immunofluorescence and immunogold 
electron microscopy 
 
For immunfluorescence (IF), sterilized slides were coated with a 
washed spore suspensions of F. solani CBS224.34 containing 
1% (w/v) glucose solution and incubated at 26°C for 16 hours to 
allow spore germination and formation of germ tubes. After air-
drying, the cells were fixed to the slides as described in Thornton 
(2001) and incubated with ED7 TCS or TCM only (negative control) 
for 1 hour, followed by three 5 minute PBS washes. Slides were 
then incubated with goat anti-mouse poly-valent fluorescein 
isothiocyanate (FITC) conjugate (diluted 1 in 40 in PBS) (F1010; 
Sigma) for 30 minutes. Slides were given three 5 minute washes 
with PBS and mounted in PBS-glycerol mounting medium (F4680; 
Sigma) before overlaying with cover-slips. All incubation steps were 
performed at 238C in a humid environment to prevent evaporation 
and slides were stored in the dark, at 4°C, prior to examination using 
an epifluorescence microscope (Olympus IX81) fitted with 495 nm 
(excitation) and 518 nm (emission) filters for FITC. For immunogold 
BSA (PBST-BSA) which had been sterile filtered through a 0.2 lm 
filter. The grids were washed three times (3 minutes each) in sterile 
filtered PBST and then incubated in ED7 TCS or TCM only (negative 
control) for 1 hour. Afterffour washes (3 minutes each) with sterile 
filtered PBST, the grids  
were incubated for a further hour in PBST-BSA containing a 1:20 
dilution of goat anti-mouse 20 nm gold conjugate (EM.GAF20; BBI 
Solutions). The grids were washed four times (3 minutes each) in 
electron microscopy (IEM) the method described in Thornton & 
Talbot (2006) was used. Spores and hyphae of F. solani were pre-
pared by incubating washed conidia in 1% (w/v) glucose solution at 
26°C for 16 hours to allow spore germination and for-mation of germ 
tubes. Cells were embedded in LR White resin (Agar Scientific Ltd.) 
and ultra thin sections prepared for immu-nolabeling. Sections 
immobilized to nickel grids were blocked by immersion in PBST 




Unless otherwise stated, numerical data were analysed using 
the statistical programme Minitab (Minitab 16, MinitabVR, Cov-
entry, UK). Analysis of variance (ANOVA) was used to compare 
means of more than two data sets and Post-hoc Tukey–Kramer 
analysis was then performed to distinguish which sets were 
significantly different from one another. 
 
Sampling from drains 
 
A total of 65 sinks were swabbed, comprising 32 sinks across 
the ICU, ITU, hematology, oncology and ophthalmology units of 
the Royal Devon and Exeter tertiary care hospital (Exeter, 
Devon, UK) and 33 restroom sinks located around the Univer-
sity of Exeter campus (Exeter, Devon, UK). In addition, cold-
water samples were collected from taps connected to the sinks 
in the hematology and oncology unit, and from the two main 
water tanks feeding the ophthalmology unit. To isolate fungi 
from sink biofilms, sterile cotton buds (Boots, UK) wetted with 
PBS were used to scour the inner surfaces of sink drain-pipes 
for approximately 10 seconds. Swabs with visible ditritus were 
immersed in 1.5-ml micro-centrifuge tubes containing 1 ml 
PBS to dislodge biofilm debris, and the sealed tubes 
transferred to the laboratory for processing by ELISA and 
mycological culture. 
 
Immunodetection of Fusarium species in sink 
swabs and identification of fungi by analysis of the 
ITS regions of the rRNA-encoding gene unit and 
Translation elongation factor-1α PCR 
 
Biofilm debris was pelleted by centrifugation at 14 462g for 5 
minutes and 50 μl samples of supernatant transferred to the 
wells of microtitre plates for assay by ELISA (Table 1 and Sup-
porting Information Table S2; Swab-ELISA) as described. The 
biofilm pellet was re-suspended in 1 ml dH2O, 200 μl samples 
spread on the surface of PDA containing 1 μg ml-1 of the broad-
spectrum antibiotic rifampicin, and the plates incubated for 2 
days at 26°C under a 16 hours fluorescent light regime. Fungi in 
these mixed culture plates were separated on the basis of gross 
morphological characteristics and axenic slope cultures 
generated following sub-culture on PDA. Crude anti-gen 
extracts were prepared as surface washings from mixed 
cultures and from axenic cultures and assayed by ELISA (Table 
1 and Supporting Information Table S2; Mixed culture-ELISA 
and Axenic culture-ELISA, respectively) as described.  
Fungal DNA was extracted from axenic culture material by 
using the CTAB method (Chow & Kafer, 1993) and fungi were 
identified by sequencing of the ITS1-5.8S-ITS2 region of the 
rRNA-encoding gene unit (White et al., 1990) according to 
procedures described elsewhere (Thornton et al., 2002), using 










Species identity was predicted based on > 95% sequence 
identity  
(E-value 5 0.0) (Altschul et al. 1997) of the ITS1-5.8S-ITS2 
region of recovered species to species recorded in Gen-Bank. 
Fusarium species were further identified to species complex 










), which amplify an 
approximately 700 bp region of Translation Elongation Factor 1-
alpha (TEF-1α), the single-locus identification tool in Fusar-ium 
(Geiser et al., 2004). PCR reactions were carried out in a total 
volume of 25 μl consisting of 1 μl DNA at a concentration of 30–
75 ng μl-1, 12.5 μl of GoTaqVR Green Master Mix DNA 
polymerase (Promega, MF7112), 9.5 μl of nuclease free water 
(Promega) and 1 μl of each primer at 20 pmol. The following 
cycling parameters were used: an initial denaturation step at 
958C for 8 minutes; 35 cycles of 15 seconds at 958C (denatu-
ration); 20 seconds at 54°C (annealing), 1 minutes at 728C 
(extension) followed by a final 5 minutes extension step at 
728C. Phylogenetic sub-groups of Fusarium species were 
determined by interrogation of the FUSARIUM-ID v. 1.0 data-
base (http://isolate.fusariumdb.org) (O’Donnell et al., 2010), with 
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the newly acquired TEF-1α sequences (Supporting Infor-mation 
Data Set 1). 
 
Nucleotide sequence accession numbers 
 
Newly determined ITS sequences were submitted to GenBank 
and the ITS accession numbers KT876496 to KT876723 were 
 
obtained. Species designations of recovered fungi are 
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